country,term,count
AF,HEPATIC NECROSIS,1
AF,LIVER FUNCTION TEST ABNORMAL,1
AF,PNEUMONIA,1
AS,ANGIOEDEMA,1
AS,APNOEA,1
AS,BRADYCARDIA,1
AS,CYANOSIS,1
AS,DRUG DOSE OMISSION,1
AS,UNRESPONSIVE TO STIMULI,1
AR,ABDOMINAL DISTENSION,1
AR,ABDOMINAL PAIN,1
AR,COLITIS,1
AR,DIARRHOEA HAEMORRHAGIC,1
AR,GASTRIC DISORDER,1
AR,GASTROINTESTINAL HAEMORRHAGE,1
AR,HEPATIC FAILURE,1
AR,LARGE INTESTINAL HAEMORRHAGE,1
AR,OSTEOARTHRITIS,1
AR,RED BLOOD CELL COUNT DECREASED,1
AU,HYPERTENSION,10
AU,RENAL IMPAIRMENT,7
AU,OVERDOSE,6
AU,NAUSEA,5
AU,COMA SCALE ABNORMAL,4
AU,FALL,4
AU,HYPOTENSION,4
AU,BLOOD CREATININE INCREASED,3
AU,DIARRHOEA,3
AU,DYSPNOEA,3
AU,LOWER RESPIRATORY TRACT INFECTION,3
AU,PULMONARY EMBOLISM,3
AU,PYREXIA,3
AU,RASH,3
AU,RECTAL HAEMORRHAGE,3
AU,RENAL FAILURE ACUTE,3
AU,SUICIDE ATTEMPT,3
AU,TRANSAMINASES INCREASED,3
AU,ANGIOEDEMA,2
AU,BACK PAIN,2
AU,CELLULITIS,2
AU,DRUG INEFFECTIVE,2
AU,FEELING ABNORMAL,2
AU,GASTROINTESTINAL CARCINOMA,2
AU,LETHARGY,2
AU,LIP SWELLING,2
AU,MALABSORPTION,2
AU,MALAISE,2
AU,MULTIPLE ORGAN DYSFUNCTION SYNDROME,2
AU,MYOCARDIAL INFARCTION,2
AU,PANCREATIC INSUFFICIENCY,2
AU,PANCREATITIS,2
AU,PRURITUS,2
AU,RENAL FAILURE,2
AU,RESPIRATORY FAILURE,2
AU,SEPSIS,2
AU,SWELLING FACE,2
AU,TREMOR,2
AU,UPPER RESPIRATORY TRACT INFECTION,2
AU,WEIGHT INCREASED,2
AU,ABDOMINAL DISCOMFORT,1
AU,ABDOMINAL DISTENSION,1
AU,ACUTE KIDNEY INJURY,1
AU,ADENOMA BENIGN,1
AU,ADVERSE EVENT,1
AU,AGGRESSION,1
AU,ALOPECIA,1
AU,ANAPHYLACTIC REACTION,1
AU,ANTIPSYCHOTIC DRUG LEVEL ABOVE THERAPEUTIC,1
AU,APHASIA,1
AU,APPENDICITIS,1
AU,BALANCE DISORDER,1
AU,BLOOD GLUCOSE ABNORMAL,1
AU,BLOOD GLUCOSE INCREASED,1
AU,BLOOD IRON DECREASED,1
AU,BLOOD TRIGLYCERIDES INCREASED,1
AU,BONE MARROW FAILURE,1
AU,BRADYCARDIA,1
AU,CEREBELLAR TUMOUR,1
AU,CHEST PAIN,1
AU,CHOLECYSTECTOMY,1
AU,CHROMATURIA,1
AU,COLITIS ISCHAEMIC,1
AU,CONCOMITANT DISEASE AGGRAVATED,1
AU,CONFUSIONAL STATE,1
AU,CONSTIPATION,1
AU,CONVULSION,1
AU,COUGH,1
AU,CRYING,1
AU,DEAFNESS NEUROSENSORY,1
AU,DEATH,1
AU,DECREASED APPETITE,1
AU,DEPRESSION,1
AU,DILATATION VENTRICULAR,1
AU,DISTURBANCE IN ATTENTION,1
AU,DIVERTICULITIS INTESTINAL HAEMORRHAGIC,1
AU,DIZZINESS,1
AU,DRUG HYPERSENSITIVITY,1
AU,DRY SKIN,1
AU,ERYTHEMA,1
AU,FATIGUE,1
AU,FEELING HOT,1
AU,FOETAL EXPOSURE DURING PREGNANCY,1
AU,FREQUENT BOWEL MOVEMENTS,1
AU,GAIT DISTURBANCE,1
AU,GASTROENTERITIS SHIGELLA,1
AU,GASTROOESOPHAGEAL REFLUX DISEASE,1
AU,GENERAL PHYSICAL HEALTH DETERIORATION,1
AU,HAEMATOCHEZIA,1
AU,HAEMOGLOBIN DECREASED,1
AU,HEADACHE,1
AU,HEART RATE INCREASED,1
AU,HEART RATE IRREGULAR,1
AU,HYPERHIDROSIS,1
AU,HYPERTHYROIDISM,1
AU,HYPOKALAEMIA,1
AU,HYPOTHYROIDISM,1
AU,ILEUS PARALYTIC,1
AU,INCORRECT DOSE ADMINISTERED,1
AU,INFECTIVE EXACERBATION OF CHRONIC OBSTRUCTIVE AIRWAYS DISEASE,1
AU,INTESTINAL OBSTRUCTION,1
AU,IRRITABILITY,1
AU,JOINT SWELLING,1
AU,LICHEN PLANUS,1
AU,LUNG INFECTION,1
AU,MALIGNANT HYPERTENSION,1
AU,MEMORY IMPAIRMENT,1
AU,MIGRAINE,1
AU,MITRAL VALVE INCOMPETENCE,1
AU,MULTI-ORGAN FAILURE,1
AU,MULTIPLE CONGENITAL ABNORMALITIES,1
AU,MUSCULOSKELETAL STIFFNESS,1
AU,MYALGIA,1
AU,NEPHRITIS,1
AU,NEPHROTIC SYNDROME,1
AU,NEUTROPENIC SEPSIS,1
AU,OBSTRUCTIVE UROPATHY,1
AU,OEDEMA PERIPHERAL,1
AU,PARAESTHESIA,1
AU,PELVIC FRACTURE,1
AU,PERSONALITY CHANGE,1
AU,PNEUMONIA,1
AU,POISONING DELIBERATE,1
AU,POLYDIPSIA,1
AU,POLYURIA,1
AU,PROCTITIS,1
AU,PULMONARY FIBROSIS,1
AU,RASH PRURITIC,1
AU,REPETITIVE SPEECH,1
AU,RESPIRATORY ARREST,1
AU,RHABDOMYOLYSIS,1
AU,SINUS DISORDER,1
AU,SKIN CANCER,1
AU,SKIN EXFOLIATION,1
AU,SKIN GRAFT,1
AU,SKIN NEOPLASM EXCISION,1
AU,SUICIDAL IDEATION,1
AU,SWOLLEN TONGUE,1
AU,SYNCOPE,1
AU,SYSTEMIC LUPUS ERYTHEMATOSUS,1
AU,THROAT TIGHTNESS,1
AU,TOOTH DISORDER,1
AU,TOXICITY TO VARIOUS AGENTS,1
AU,TRICUSPID VALVE INCOMPETENCE,1
AU,TYPE 2 DIABETES MELLITUS,1
AU,URINARY RETENTION,1
AU,URTICARIA,1
AU,VENTRICULAR TACHYCARDIA,1
AU,VOMITING,1
AU,WEIGHT DECREASED,1
AU,WHEEZING,1
AU,WITHDRAWAL SYNDROME,1
AT,NAUSEA,9
AT,COAGULATION TIME PROLONGED,7
AT,GENERAL PHYSICAL HEALTH DETERIORATION,7
AT,PNEUMONIA,7
AT,DIARRHOEA,6
AT,HYPERTENSION,6
AT,PYREXIA,6
AT,REDUCED FACIAL EXPRESSION,6
AT,TARDIVE DYSKINESIA,6
AT,ANAEMIA,5
AT,ASTHENIA,5
AT,CARDIAC FAILURE,5
AT,URINARY TRACT INFECTION,5
AT,ATRIAL FIBRILLATION,4
AT,FATIGUE,4
AT,GAMMA-GLUTAMYLTRANSFERASE INCREASED,4
AT,LYMPHOCYTE COUNT INCREASED,4
AT,MYOCARDIAL INFARCTION,4
AT,WHITE BLOOD CELL COUNT INCREASED,4
AT,ABDOMINAL PAIN,3
AT,ABDOMINAL PAIN UPPER,3
AT,ACUTE MYOCARDIAL INFARCTION,3
AT,ALANINE AMINOTRANSFERASE INCREASED,3
AT,BETA 2 MICROGLOBULIN INCREASED,3
AT,BLOOD ALKALINE PHOSPHATASE INCREASED,3
AT,BLOOD CREATININE INCREASED,3
AT,BRADYCARDIA,3
AT,CEREBROVASCULAR ACCIDENT,3
AT,COUGH,3
AT,DEATH,3
AT,DEPRESSIVE SYMPTOM,3
AT,DRUG INEFFECTIVE,3
AT,DYSPNOEA,3
AT,ELECTROCARDIOGRAM QT PROLONGED,3
AT,EPISTAXIS,3
AT,FALL,3
AT,MALAISE,3
AT,NEUTROPENIA,3
AT,ORAL HERPES,3
AT,PANCREATITIS,3
AT,RASH,3
AT,RENAL FAILURE,3
AT,RENAL FAILURE ACUTE,3
AT,VOMITING,3
AT,ACUTE KIDNEY INJURY,2
AT,ARTHRALGIA,2
AT,ASPARTATE AMINOTRANSFERASE INCREASED,2
AT,BLOOD BILIRUBIN INCREASED,2
AT,BLOOD CREATINE PHOSPHOKINASE INCREASED,2
AT,BLOOD LACTATE DEHYDROGENASE INCREASED,2
AT,BLOOD PRESSURE INCREASED,2
AT,C-REACTIVE PROTEIN INCREASED,2
AT,CITROBACTER INFECTION,2
AT,CONFUSIONAL STATE,2
AT,CONSTIPATION,2
AT,CORONARY ARTERY DISEASE,2
AT,DEPRESSION,2
AT,DRUG LEVEL INCREASED,2
AT,DRUG WITHDRAWAL SYNDROME,2
AT,DRUG-INDUCED LIVER INJURY,2
AT,DYSPNOEA EXERTIONAL,2
AT,EJECTION FRACTION DECREASED,2
AT,ELECTROCARDIOGRAM T WAVE INVERSION,2
AT,FEBRILE NEUTROPENIA,2
AT,GASTRIC ULCER,2
AT,GASTROINTESTINAL HAEMORRHAGE,2
AT,HEPATIC ENZYME INCREASED,2
AT,HEPATIC LESION,2
AT,HYPERCHOLESTEROLAEMIA,2
AT,HYPERHIDROSIS,2
AT,HYPERKALAEMIA,2
AT,HYPOKALAEMIA,2
AT,KETOACIDOSIS,2
AT,LOSS OF LIBIDO,2
AT,LUNG ABSCESS,2
AT,METASTASES TO LIVER,2
AT,N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED,2
AT,NASOPHARYNGITIS,2
AT,OBESITY,2
AT,OEDEMA PERIPHERAL,2
AT,PERICARDIAL EFFUSION,2
AT,PRURITUS,2
AT,RENAL IMPAIRMENT,2
AT,RESPIRATORY TRACT INFECTION,2
AT,SINUS BRADYCARDIA,2
AT,SINUSITIS,2
AT,SUICIDE ATTEMPT,2
AT,SYNCOPE,2
AT,TACHYCARDIA,2
AT,THROMBOSIS,2
AT,TRANSAMINASES INCREASED,2
AT,WEIGHT DECREASED,2
AT,WEIGHT INCREASED,2
AT,ABDOMINAL TENDERNESS,1
AT,ACCIDENTAL OVERDOSE,1
AT,ACUTE HEPATIC FAILURE,1
AT,ACUTE RESPIRATORY FAILURE,1
AT,ADENOCARCINOMA,1
AT,ADENOCARCINOMA GASTRIC,1
AT,ADENOCARCINOMA PANCREAS,1
AT,AMYLASE INCREASED,1
AT,ANOSMIA,1
AT,ANTICONVULSANT DRUG LEVEL ABOVE THERAPEUTIC,1
AT,APHASIA,1
AT,ARRHYTHMIA,1
AT,ARTHRITIS,1
AT,ARTICULAR CALCIFICATION,1
AT,ASTIGMATISM,1
AT,ATRIAL ENLARGEMENT,1
AT,ATRIOVENTRICULAR BLOCK COMPLETE,1
AT,ATRIOVENTRICULAR BLOCK FIRST DEGREE,1
AT,ATYPICAL PNEUMONIA,1
AT,BASAL CELL CARCINOMA,1
AT,BENIGN HYDATIDIFORM MOLE,1
AT,BLOOD CALCIUM INCREASED,1
AT,BLOOD GLUCOSE INCREASED,1
AT,BLOOD POTASSIUM INCREASED,1
AT,BLOOD PRESSURE DECREASED,1
AT,BLOOD PRESSURE SYSTOLIC INCREASED,1
AT,BLOOD UREA INCREASED,1
AT,BRONCHITIS,1
AT,BUNDLE BRANCH BLOCK RIGHT,1
AT,BURNING SENSATION,1
AT,CARBOHYDRATE ANTIGEN 15-3 INCREASED,1
AT,CARCINOEMBRYONIC ANTIGEN INCREASED,1
AT,CARDIAC ARREST,1
AT,CARDIAC DISORDER,1
AT,CARDIAC FAILURE CHRONIC,1
AT,CARDIAC FAILURE CONGESTIVE,1
AT,CAROTID ARTERIOSCLEROSIS,1
AT,CAROTID ARTERY STENOSIS,1
AT,CATARACT,1
AT,CEREBRAL HAEMORRHAGE,1
AT,CEREBRAL ISCHAEMIA,1
AT,CHILLS,1
AT,CHOLECYSTITIS,1
AT,CHOLELITHIASIS,1
AT,CIRCULATORY COLLAPSE,1
AT,CLAVICLE FRACTURE,1
AT,COAGULOPATHY,1
AT,COLD SWEAT,1
AT,COLITIS,1
AT,COLITIS ISCHAEMIC,1
AT,COLON ADENOMA,1
AT,COMPUTERISED TOMOGRAM HEAD ABNORMAL,1
AT,CONJUNCTIVAL DISORDER,1
AT,CONTRAINDICATED PRODUCT ADMINISTERED,1
AT,CORONARY ARTERY OCCLUSION,1
AT,CYTOMEGALOVIRUS INFECTION,1
AT,DACRYOCYSTITIS,1
AT,DEAFNESS,1
AT,DECREASED APPETITE,1
AT,DEHYDRATION,1
AT,DELIRIUM,1
AT,DERMATITIS BULLOUS,1
AT,DEVICE ISSUE,1
AT,DIABETES MELLITUS,1
AT,DIABETES MELLITUS INADEQUATE CONTROL,1
AT,DISORIENTATION,1
AT,DIVERTICULITIS,1
AT,DIZZINESS,1
AT,DRUG ERUPTION,1
AT,DRUG LEVEL DECREASED,1
AT,DRUG-DISEASE INTERACTION,1
AT,DYSAESTHESIA,1
AT,DYSARTHRIA,1
AT,DYSGEUSIA,1
AT,DYSKINESIA,1
AT,DYSPHAGIA,1
AT,DYSPLASIA,1
AT,ELECTROCARDIOGRAM PQ INTERVAL PROLONGED,1
AT,ELECTROCARDIOGRAM QRS COMPLEX PROLONGED,1
AT,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,1
AT,EMBOLISM,1
AT,FEAR,1
AT,FEBRILE INFECTION,1
AT,FEELING COLD,1
AT,FEMUR FRACTURE,1
AT,FLUID RETENTION,1
AT,FUNGAL INFECTION,1
AT,FURUNCLE,1
AT,GASTRIC CYST,1
AT,GASTRIC MUCOSA ERYTHEMA,1
AT,GASTRITIS,1
AT,GASTROENTERITIS SALMONELLA,1
AT,GASTROINTESTINAL DISORDER,1
AT,GASTROINTESTINAL INFECTION,1
AT,HAEMATEMESIS,1
AT,HAEMATOCRIT DECREASED,1
AT,HAEMATURIA,1
AT,HAEMOPTYSIS,1
AT,HAEMORRHAGE,1
AT,HEAD INJURY,1
AT,HEADACHE,1
AT,HEPATIC CIRRHOSIS,1
AT,HEPATIC ENCEPHALOPATHY,1
AT,HEPATIC HAEMORRHAGE,1
AT,HEPATIC STEATOSIS,1
AT,HEPATITIS B,1
AT,HEPATOCELLULAR CARCINOMA,1
AT,HOT FLUSH,1
AT,HYDRONEPHROSIS,1
AT,HYPERKINESIA,1
AT,HYPERMETROPIA,1
AT,HYPOGEUSIA,1
AT,HYPOGLYCAEMIA,1
AT,HYPOMAGNESAEMIA,1
AT,HYPONATRAEMIA,1
AT,HYPOXIA,1
AT,INFLUENZA,1
AT,INFUSION RELATED REACTION,1
AT,INTENTIONAL UNDERDOSE,1
AT,INTERNAL HAEMORRHAGE,1
AT,INTERSTITIAL LUNG DISEASE,1
AT,INTERVERTEBRAL DISC PROTRUSION,1
AT,ISCHAEMIC STROKE,1
AT,JAUNDICE,1
AT,JOINT EFFUSION,1
AT,JOINT SWELLING,1
AT,LEUKOENCEPHALOPATHY,1
AT,LEUKOPENIA,1
AT,LIPASE INCREASED,1
AT,LIVER FUNCTION TEST INCREASED,1
AT,LOSS OF CONSCIOUSNESS,1
AT,LUMBAR VERTEBRAL FRACTURE,1
AT,LYMPHANGIOSIS CARCINOMATOSA,1
AT,MALIGNANT NEOPLASM PROGRESSION,1
AT,MALLORY-WEISS SYNDROME,1
AT,MATERNAL EXPOSURE DURING PREGNANCY,1
AT,METABOLIC SYNDROME,1
AT,METASTASES TO BREAST,1
AT,MOBILITY DECREASED,1
AT,MUSCULAR WEAKNESS,1
AT,MUSCULOSKELETAL PAIN,1
AT,MYELOFIBROSIS,1
AT,MYOCARDIAL NECROSIS MARKER INCREASED,1
AT,NECROSIS,1
AT,NEUROPATHY PERIPHERAL,1
AT,NEUTROPHIL COUNT DECREASED,1
AT,NIGHT SWEATS,1
AT,NOCTURNAL DYSPNOEA,1
AT,ODYNOPHAGIA,1
AT,OEDEMA,1
AT,ON AND OFF PHENOMENON,1
AT,OPTIC ISCHAEMIC NEUROPATHY,1
AT,ORAL DISORDER,1
AT,OSTEOPOROTIC FRACTURE,1
AT,OTITIS MEDIA VIRAL,1
AT,PAIN,1
AT,PAIN IN EXTREMITY,1
AT,PALLOR,1
AT,PALPITATIONS,1
AT,PANCREATIC CARCINOMA,1
AT,PANCREATIC ENZYMES INCREASED,1
AT,PANNICULITIS,1
AT,PAPILLARY THYROID CANCER,1
AT,PARAPLEGIA,1
AT,PERIORBITAL HAEMATOMA,1
AT,PERIPHERAL ARTERIAL OCCLUSIVE DISEASE,1
AT,PHLEBITIS,1
AT,PLATELET COUNT DECREASED,1
AT,PLEURAL EFFUSION,1
AT,PLEURISY,1
AT,PNEUMOCYSTIS JIROVECII PNEUMONIA,1
AT,POST PROCEDURAL HAEMATOMA,1
AT,POST PROCEDURAL HAEMORRHAGE,1
AT,PRODUCT FORMULATION ISSUE,1
AT,PULMONARY EMBOLISM,1
AT,PULMONARY HAEMORRHAGE,1
AT,PULMONARY OEDEMA,1
AT,PULSE ABSENT,1
AT,RECTAL ABSCESS,1
AT,RED BLOOD CELL COUNT DECREASED,1
AT,RED CELL DISTRIBUTION WIDTH INCREASED,1
AT,REFUSAL OF TREATMENT BY PATIENT,1
AT,RENAL CANCER RECURRENT,1
AT,RENAL CELL CARCINOMA,1
AT,RENAL COLIC,1
AT,RENAL CYST,1
AT,RESPIRATORY DEPRESSION,1
AT,RESTLESS LEGS SYNDROME,1
AT,RESTLESSNESS,1
AT,RETINAL ANOMALY CONGENITAL,1
AT,RETINOPATHY HYPERTENSIVE,1
AT,ROAD TRAFFIC ACCIDENT,1
AT,SHOCK,1
AT,SICK SINUS SYNDROME,1
AT,SJOGREN^S SYNDROME,1
AT,SLEEP DISORDER,1
AT,SOMNOLENCE,1
AT,SPINAL CORD OPERATION,1
AT,SPINAL PAIN,1
AT,SPLENOMEGALY,1
AT,SPUTUM DISCOLOURED,1
AT,STAPHYLOCOCCAL INFECTION,1
AT,STOMATITIS,1
AT,SUDDEN DEATH,1
AT,SUICIDAL IDEATION,1
AT,TUBERCULOUS PLEURISY,1
AT,UPPER RESPIRATORY TRACT INFECTION,1
AT,URETEROLITHIASIS,1
AT,URINARY RETENTION,1
AT,URINARY TRACT PAIN,1
AT,VENTRICULAR ARRHYTHMIA,1
AT,VENTRICULAR FIBRILLATION,1
AT,VENTRICULAR HYPOKINESIA,1
AT,VITH NERVE PARESIS,1
AT,WHITE BLOOD CELL COUNT DECREASED,1
AT,WITHDRAWAL ARRHYTHMIA,1
BB,DEATH,1
BB,PNEUMONIA,1
BY,NEPHROPATHY,7
BY,CALCULUS URINARY,1
BY,DERMATITIS BULLOUS,1
BY,DRY MOUTH,1
BY,INSOMNIA,1
BY,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,1
BY,OEDEMA,1
BY,PYELONEPHRITIS ACUTE,1
BY,RENAL FAILURE ACUTE,1
BY,THIRST,1
BY,URINARY RETENTION,1
BE,ACUTE KIDNEY INJURY,17
BE,RENAL FAILURE,15
BE,RHABDOMYOLYSIS,14
BE,DIARRHOEA,11
BE,CONFUSIONAL STATE,10
BE,CARDIAC FAILURE,8
BE,DECREASED APPETITE,8
BE,HEPATIC FAILURE,8
BE,DEHYDRATION,7
BE,DYSPNOEA,7
BE,FALL,7
BE,NAUSEA,7
BE,VOMITING,7
BE,ANAEMIA,6
BE,PULMONARY EMBOLISM,6
BE,URINARY TRACT INFECTION,6
BE,WEIGHT DECREASED,6
BE,EMBOLISM,5
BE,ENCEPHALOPATHY,5
BE,FATIGUE,5
BE,HEADACHE,5
BE,HYPERKALAEMIA,5
BE,PNEUMONIA,5
BE,RENAL FAILURE ACUTE,5
BE,RENAL TUBULAR NECROSIS,5
BE,SOMNOLENCE,5
BE,DISEASE PROGRESSION,4
BE,DRUG-INDUCED LIVER INJURY,4
BE,DYSPHAGIA,4
BE,HEPATITIS TOXIC,4
BE,HEPATOCELLULAR INJURY,4
BE,MALAISE,4
BE,MYOCLONUS,4
BE,NEUTROPENIA,4
BE,OLIGURIA,4
BE,PYREXIA,4
BE,TOXICITY TO VARIOUS AGENTS,4
BE,TRANSIENT ISCHAEMIC ATTACK,4
BE,ASTHENIA,3
BE,ATRIAL FIBRILLATION,3
BE,BACK PAIN,3
BE,BLOOD BILIRUBIN INCREASED,3
BE,CENTRAL NERVOUS SYSTEM LESION,3
BE,DEATH,3
BE,FEBRILE NEUTROPENIA,3
BE,GENERAL PHYSICAL HEALTH DETERIORATION,3
BE,HEPATIC ENCEPHALOPATHY,3
BE,HYPERTENSION,3
BE,HYPOKALAEMIA,3
BE,INTERSTITIAL LUNG DISEASE,3
BE,JAUNDICE,3
BE,MYOCARDIAL INFARCTION,3
BE,NEPHROTIC SYNDROME,3
BE,PLEURAL EFFUSION,3
BE,SEPTIC SHOCK,3
BE,VENTRICULAR TACHYCARDIA,3
BE,ABDOMINAL PAIN,2
BE,ACUTE PULMONARY OEDEMA,2
BE,AMAUROSIS,2
BE,ANGIOEDEMA,2
BE,ARTHRALGIA,2
BE,ASCITES,2
BE,BILIARY TRACT INFECTION,2
BE,BLOOD CREATINE PHOSPHOKINASE MB INCREASED,2
BE,BRADYCARDIA,2
BE,CANCER PAIN,2
BE,CARDIAC ARREST,2
BE,CARDIAC FAILURE CONGESTIVE,2
BE,CARDIOMYOPATHY,2
BE,CEREBROVASCULAR ACCIDENT,2
BE,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,2
BE,CONGENITAL CARDIOVASCULAR ANOMALY,2
BE,DEPRESSION,2
BE,EJECTION FRACTION DECREASED,2
BE,ELECTROCARDIOGRAM QT PROLONGED,2
BE,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,2
BE,ESCHERICHIA URINARY TRACT INFECTION,2
BE,EXTRASYSTOLES,2
BE,FACIAL BONES FRACTURE,2
BE,GAMMA-GLUTAMYLTRANSFERASE INCREASED,2
BE,GASTROENTERITIS,2
BE,GASTROINTESTINAL DISORDER,2
BE,GUILLAIN-BARRE SYNDROME,2
BE,HAEMATOCHEZIA,2
BE,HAEMATOMA,2
BE,HEPATITIS,2
BE,HEPATITIS ACUTE,2
BE,HYPOCHROMIC ANAEMIA,2
BE,HYPOGLYCAEMIA,2
BE,INFLAMMATION,2
BE,INFLUENZA LIKE ILLNESS,2
BE,INTERNATIONAL NORMALISED RATIO INCREASED,2
BE,MUSCULAR WEAKNESS,2
BE,MYALGIA,2
BE,OEDEMA,2
BE,OSTEONECROSIS OF JAW,2
BE,PAIN IN EXTREMITY,2
BE,PARAESTHESIA,2
BE,PERICARDIAL EFFUSION,2
BE,PLATELET COUNT DECREASED,2
BE,POLYARTHRITIS,2
BE,POLYNEUROPATHY,2
BE,PROTEINURIA,2
BE,PRURITUS,2
BE,RENAL IMPAIRMENT,2
BE,RESPIRATORY FAILURE,2
BE,RESTLESS LEGS SYNDROME,2
BE,SKIN ULCER,2
BE,STOMA SITE HYPERGRANULATION,2
BE,SUBCUTANEOUS ABSCESS,2
BE,SYNCOPE,2
BE,TORSADE DE POINTES,2
BE,TRANSAMINASES INCREASED,2
BE,TREATMENT FAILURE,2
BE,TROPONIN INCREASED,2
BE,ABDOMINAL PAIN UPPER,1
BE,ACCIDENTAL EXPOSURE TO PRODUCT,1
BE,ACETABULUM FRACTURE,1
BE,ACUTE CORONARY SYNDROME,1
BE,ACUTE HEPATIC FAILURE,1
BE,ACUTE MYELOID LEUKAEMIA,1
BE,ACUTE MYOCARDIAL INFARCTION,1
BE,AFFECTIVE DISORDER,1
BE,ALANINE AMINOTRANSFERASE ABNORMAL,1
BE,ALANINE AMINOTRANSFERASE INCREASED,1
BE,ALVEOLAR OSTEITIS,1
BE,AMYLASE INCREASED,1
BE,AMYLOIDOSIS SENILE,1
BE,ANXIETY,1
BE,APHTHOUS STOMATITIS,1
BE,APPARENT DEATH,1
BE,ARTERIAL THROMBOSIS,1
BE,ASPARTATE AMINOTRANSFERASE ABNORMAL,1
BE,ASPARTATE AMINOTRANSFERASE INCREASED,1
BE,ATELECTASIS,1
BE,ATRIAL FLUTTER,1
BE,BILIRUBIN CONJUGATED INCREASED,1
BE,BLEPHARITIS,1
BE,BLOOD BILIRUBIN UNCONJUGATED INCREASED,1
BE,BLOOD CREATINE PHOSPHOKINASE ABNORMAL,1
BE,BLOOD CREATININE INCREASED,1
BE,BLOOD GLUCOSE ABNORMAL,1
BE,BLOOD PRESSURE INCREASED,1
BE,BRADYARRHYTHMIA,1
BE,BRADYPHRENIA,1
BE,BRAIN NEOPLASM,1
BE,BRONCHITIS,1
BE,BRONCHOSPASM PARADOXICAL,1
BE,C-REACTIVE PROTEIN INCREASED,1
BE,CALCIPHYLAXIS,1
BE,CALCULUS URETERIC,1
BE,CARCINOEMBRYONIC ANTIGEN INCREASED,1
BE,CARDIAC DEATH,1
BE,CARDIOVASCULAR DISORDER,1
BE,CARPAL TUNNEL SYNDROME,1
BE,CATARACT,1
BE,CEREBRAL INFARCTION,1
BE,CHEST PAIN,1
BE,CHOLANGIOCARCINOMA,1
BE,CHROMATURIA,1
BE,CHRONIC KIDNEY DISEASE,1
BE,CLOSTRIDIUM DIFFICILE INFECTION,1
BE,COGNITIVE DISORDER,1
BE,COLITIS,1
BE,COMA,1
BE,COMMUNICATION DISORDER,1
BE,CONCOMITANT DISEASE PROGRESSION,1
BE,CONDITION AGGRAVATED,1
BE,CONSTIPATION,1
BE,CONTRAINDICATED PRODUCT ADMINISTERED,1
BE,CONTUSION,1
BE,DEEP BRAIN STIMULATION,1
BE,DEEP VEIN THROMBOSIS,1
BE,DERMATITIS CONTACT,1
BE,DEVICE DISLOCATION,1
BE,DIABETES MELLITUS,1
BE,DIFFUSE ALOPECIA,1
BE,DIPLOPIA,1
BE,DISEASE RECURRENCE,1
BE,DIZZINESS,1
BE,DRUG ABUSE,1
BE,DRUG ADMINISTRATION ERROR,1
BE,DRUG DOSE OMISSION,1
BE,DRUG ERUPTION,1
BE,DRUG HYPERSENSITIVITY,1
BE,DRUG INEFFECTIVE,1
BE,DRUG INTOLERANCE,1
BE,DYSKINESIA,1
BE,DYSLIPIDAEMIA,1
BE,EAR INFECTION,1
BE,ECCHYMOSIS,1
BE,ECZEMA,1
BE,ELECTROCARDIOGRAM ABNORMAL,1
BE,EMBEDDED DEVICE,1
BE,END STAGE RENAL DISEASE,1
BE,ENTEROBACTER INFECTION,1
BE,EOSINOPHILIA,1
BE,EPISTAXIS,1
BE,ERYTHEMA,1
BE,ESCHERICHIA SEPSIS,1
BE,EXCESSIVE GRANULATION TISSUE,1
BE,EXPOSED BONE IN JAW,1
BE,FACE OEDEMA,1
BE,FAECES PALE,1
BE,FEELING ABNORMAL,1
BE,FEMORAL NECK FRACTURE,1
BE,FIBROSIS,1
BE,FIBULA FRACTURE,1
BE,FLUSHING,1
BE,FOOD INTOLERANCE,1
BE,GAIT DISTURBANCE,1
BE,GASTROOESOPHAGEAL REFLUX DISEASE,1
BE,GENITAL LESION,1
BE,GINGIVAL DISCOLOURATION,1
BE,GINGIVITIS,1
BE,GOUT,1
BE,HAEMODIALYSIS,1
BE,HAEMOGLOBIN DECREASED,1
BE,HAEMOPTYSIS,1
BE,HAEMORRHAGE,1
BE,HAEMORRHAGIC ANAEMIA,1
BE,HAEMORRHAGIC EROSIVE GASTRITIS,1
BE,HAEMOTHORAX,1
BE,HALLUCINATION,1
BE,HALLUCINATION_ VISUAL,1
BE,HEMIPARESIS,1
BE,HEMIPLEGIA,1
BE,HEPATIC NECROSIS,1
BE,HEPATIC STEATOSIS,1
BE,HEPATOCELLULAR CARCINOMA,1
BE,HEPATOTOXICITY,1
BE,HERPES ZOSTER,1
BE,HIDRADENITIS,1
BE,HYPERAESTHESIA,1
BE,HYPERHIDROSIS,1
BE,HYPERSENSITIVITY,1
BE,HYPERSENSITIVITY VASCULITIS,1
BE,HYPOCALCAEMIA,1
BE,HYPONATRAEMIA,1
BE,HYPOPROTEINAEMIA,1
BE,HYPOTENSION,1
BE,HYPOVENTILATION,1
BE,HYPOVOLAEMIC SHOCK,1
BE,HYPOXIA,1
BE,IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME ASSOCIATED TUBERCULOSIS,1
BE,IMPAIRED HEALING,1
BE,INCORRECT ROUTE OF DRUG ADMINISTRATION,1
BE,INFECTED SKIN ULCER,1
BE,INFLAMMATORY MARKER INCREASED,1
BE,INJURY,1
BE,INSOMNIA,1
BE,INTENTIONAL PRODUCT MISUSE,1
BE,INTENTIONAL PRODUCT USE ISSUE,1
BE,INTERVERTEBRAL DISC PROTRUSION,1
BE,INTESTINAL HAEMORRHAGE,1
BE,INTESTINAL OBSTRUCTION,1
BE,INTRADUCTAL PAPILLARY-MUCINOUS CARCINOMA OF PANCREAS,1
BE,ISCHAEMIC STROKE,1
BE,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,1
BE,LEFT ATRIAL DILATATION,1
BE,LEFT VENTRICULAR DYSFUNCTION,1
BE,LIVER DISORDER,1
BE,LIVER FUNCTION TEST ABNORMAL,1
BE,LOCALISED OEDEMA,1
BE,LUMBAR VERTEBRAL FRACTURE,1
BE,LUPUS NEPHRITIS,1
BE,LYMPHANGIOSIS CARCINOMATOSA,1
BE,LYMPHOPENIA,1
BE,MALNUTRITION,1
BE,MEDICAL DEVICE SITE REACTION,1
BE,METASTASES TO BONE,1
BE,MICTURITION DISORDER,1
BE,MIDDLE INSOMNIA,1
BE,MITRAL VALVE INCOMPETENCE,1
BE,MOBILITY DECREASED,1
BE,MOUTH ULCERATION,1
BE,MUCOSAL INFLAMMATION,1
BE,MULTIPLE ORGAN DYSFUNCTION SYNDROME,1
BE,MUSCLE HAEMORRHAGE,1
BE,MUSCLE RUPTURE,1
BE,MYDRIASIS,1
BE,MYOCARDIAL ISCHAEMIA,1
BE,NASOPHARYNGITIS,1
BE,NEPHRITIS,1
BE,NEPHROPATHY,1
BE,NEPHROPATHY TOXIC,1
BE,NEURALGIA,1
BE,NONINFECTIVE GINGIVITIS,1
BE,OCCUPATIONAL EXPOSURE TO PRODUCT,1
BE,OEDEMA MOUTH,1
BE,OESOPHAGEAL CANDIDIASIS,1
BE,OESOPHAGITIS,1
BE,ON AND OFF PHENOMENON,1
BE,OPTIC ISCHAEMIC NEUROPATHY,1
BE,OSTEOMYELITIS,1
BE,OTITIS MEDIA,1
BE,OVERDOSE,1
BE,PAIN,1
BE,PAIN IN JAW,1
BE,PANCREATIC CARCINOMA,1
BE,PANCREATITIS,1
BE,PANCREATITIS ACUTE,1
BE,PANCREATITIS CHRONIC,1
BE,PANCYTOPENIA,1
BE,PAPULE,1
BE,PARANOIA,1
BE,PEMPHIGUS,1
BE,PERINEPHRIC COLLECTION,1
BE,PERIPHERAL ARTERY THROMBOSIS,1
BE,PERIPHERAL EMBOLISM,1
BE,PLATELET COUNT INCREASED,1
BE,POLLAKIURIA,1
BE,POST PROCEDURAL HAEMATURIA,1
BE,POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME,1
BE,PRESCRIBED UNDERDOSE,1
BE,PROTEUS TEST POSITIVE,1
BE,PSORIASIS,1
BE,PSORIATIC ARTHROPATHY,1
BE,PULMONARY ALVEOLAR HAEMORRHAGE,1
BE,PULMONARY CONGESTION,1
BE,PULMONARY GRANULOMA,1
BE,PULMONARY HYPERTENSION,1
BE,PULMONARY SEPSIS,1
BE,PURULENT DISCHARGE,1
BE,PYELONEPHRITIS ACUTE,1
BE,RADIATION ASSOCIATED HAEMORRHAGE,1
BE,RADIATION SKIN INJURY,1
BE,RALES,1
BE,RASH,1
BE,RENAL CYST INFECTION,1
BE,RENAL PAIN,1
BE,RENAL TRANSPLANT,1
BE,RENAL TUBULAR DISORDER,1
BE,RESPIRATORY ARREST,1
BE,RETROPERITONEAL HAEMORRHAGE,1
BE,RIB FRACTURE,1
BE,SCLEROSING ENCAPSULATING PERITONITIS,1
BE,SEPSIS,1
BE,SINUSITIS,1
BE,SKIN EXFOLIATION,1
BE,SKIN SWELLING,1
BE,SPINAL COMPRESSION FRACTURE,1
BE,SPINAL OSTEOARTHRITIS,1
BE,STAPHYLOCOCCAL INFECTION,1
BE,STAPHYLOCOCCAL SEPSIS,1
BE,STOMA SITE OEDEMA,1
BE,STOMAL HERNIA,1
BE,STOMATITIS,1
BE,STRESS,1
BE,SUDDEN DEATH,1
BE,SUPRAVENTRICULAR TACHYCARDIA,1
BE,SYNOVITIS,1
BE,TENDERNESS,1
BE,TENDON RUPTURE,1
BE,THERAPY CHANGE,1
BE,THROMBOSIS IN DEVICE,1
BE,TOBACCO USER,1
BE,TRANSAMINASES ABNORMAL,1
BE,TRANSITIONAL CELL CARCINOMA,1
BE,TRANSPLANT DYSFUNCTION,1
BE,TRAUMATIC INTRACRANIAL HAEMORRHAGE,1
BE,TRICUSPID VALVE INCOMPETENCE,1
BE,TROPONIN T INCREASED,1
BE,UNDERDOSE,1
BE,URINE SODIUM ABNORMAL,1
BE,URTICARIA,1
BE,VIRAL INFECTION,1
BE,VITAMIN D DEFICIENCY,1
BE,WEIGHT INCREASED,1
BE,WHEEZING,1
BE,WHITE BLOOD CELL COUNT DECREASED,1
BE,WOUND DEHISCENCE,1
BE,WOUND SECRETION,1
BE,YELLOW SKIN,1
BM,DEEP VEIN THROMBOSIS,1
BM,DRUG INEFFECTIVE,1
BA,HYPONATRAEMIA,4
BA,WATER INTOXICATION,4
BA,URINARY INCONTINENCE,2
BA,ASTHENIA,1
BA,MUSCLE SPASMS,1
BA,PSYCHOMOTOR SKILLS IMPAIRED,1
BA,RECTAL HAEMORRHAGE,1
BA,THROMBOCYTOPENIA,1
BA,VOMITING,1
BR,BLOOD GLUCOSE INCREASED,6
BR,DIARRHOEA,6
BR,DYSPNOEA,6
BR,HYPERTENSION,6
BR,ARTHRALGIA,5
BR,DRUG INEFFECTIVE,5
BR,MALAISE,5
BR,BLOOD PRESSURE INCREASED,4
BR,CARDIAC FAILURE,4
BR,WEIGHT INCREASED,4
BR,BLOOD CHOLESTEROL INCREASED,3
BR,CATARACT,3
BR,COUGH,3
BR,DIABETES MELLITUS,3
BR,FATIGUE,3
BR,HEADACHE,3
BR,INFLUENZA,3
BR,METASTASES TO LIVER,3
BR,NAUSEA,3
BR,ABDOMINAL PAIN,2
BR,ANAPHYLACTIC SHOCK,2
BR,ANXIETY,2
BR,ASTHENIA,2
BR,C-REACTIVE PROTEIN INCREASED,2
BR,CARDIAC DISORDER,2
BR,COLD SWEAT,2
BR,CORONARY ARTERY OCCLUSION,2
BR,DECREASED APPETITE,2
BR,DEMENTIA ALZHEIMER^S TYPE,2
BR,DEPRESSION,2
BR,DEVICE MALFUNCTION,2
BR,DISEASE PROGRESSION,2
BR,DRUG DOSE OMISSION,2
BR,ENTEROCOLITIS,2
BR,ERYTHEMA,2
BR,FALL,2
BR,GAIT DISTURBANCE,2
BR,HAEMATOMA,2
BR,HYPOGLYCAEMIA,2
BR,INTENTIONAL PRODUCT MISUSE,2
BR,INTRAOCULAR PRESSURE INCREASED,2
BR,LEUKOCYTOSIS,2
BR,OROPHARYNGEAL PAIN,2
BR,PAIN IN EXTREMITY,2
BR,PANCREATIC ENZYMES INCREASED,2
BR,PANCREATITIS HAEMORRHAGIC,2
BR,PANCREATITIS NECROTISING,2
BR,PETECHIAE,2
BR,PNEUMONIA,2
BR,PULMONARY CONGESTION,2
BR,RASH,2
BR,RHEUMATOID ARTHRITIS,2
BR,THROMBOSIS,2
BR,THYROID CANCER,2
BR,VISION BLURRED,2
BR,VISUAL IMPAIRMENT,2
BR,WRONG TECHNIQUE IN DRUG USAGE PROCESS,2
BR,ABASIA,1
BR,ACUTE RESPIRATORY FAILURE,1
BR,AGEUSIA,1
BR,AKINESIA,1
BR,AMNESIA,1
BR,ANAEMIA,1
BR,ANGULAR CHEILITIS,1
BR,APATHY,1
BR,APHONIA,1
BR,APHTHOUS STOMATITIS,1
BR,ARRHYTHMIA,1
BR,ARTHRITIS,1
BR,ATRIAL FIBRILLATION,1
BR,ATROPHY,1
BR,BLISTER,1
BR,BLOOD CALCIUM DECREASED,1
BR,BLOOD CHOLESTEROL ABNORMAL,1
BR,BLOOD GLUCOSE FLUCTUATION,1
BR,BLOOD PRESSURE ABNORMAL,1
BR,BLOOD PRESSURE INADEQUATELY CONTROLLED,1
BR,BLOOD TEST ABNORMAL,1
BR,BLOOD URIC ACID INCREASED,1
BR,BLOOD URINE PRESENT,1
BR,BRADYARRHYTHMIA,1
BR,BRAIN NEOPLASM BENIGN,1
BR,BREAST CANCER,1
BR,BRONCHITIS,1
BR,BRONCHOSPASM,1
BR,CARDIAC FAILURE CONGESTIVE,1
BR,CARDIAC OPERATION,1
BR,CAROTID ARTERY DISEASE,1
BR,CATHETER PLACEMENT,1
BR,CEREBRAL ISCHAEMIA,1
BR,CEREBROVASCULAR ACCIDENT,1
BR,CHEST PAIN,1
BR,CHOLELITHIASIS,1
BR,CHROMATURIA,1
BR,COAGULOPATHY,1
BR,CONDITION AGGRAVATED,1
BR,CONFUSIONAL STATE,1
BR,CONSTIPATION,1
BR,CREPITATIONS,1
BR,DECREASED IMMUNE RESPONSIVENESS,1
BR,DIABETIC EYE DISEASE,1
BR,DIABETIC METABOLIC DECOMPENSATION,1
BR,DIVERTICULITIS,1
BR,DIZZINESS,1
BR,DIZZINESS POSTURAL,1
BR,DRUG ADMINISTRATION ERROR,1
BR,DRUG HYPERSENSITIVITY,1
BR,DRUG-INDUCED LIVER INJURY,1
BR,DRY EYE,1
BR,DRY MOUTH,1
BR,DRY THROAT,1
BR,DUODENAL ULCER,1
BR,DYSGRAPHIA,1
BR,DYSPEPSIA,1
BR,ENLARGED UVULA,1
BR,ERYSIPELAS,1
BR,EXOSTOSIS,1
BR,EXPIRED PRODUCT ADMINISTERED,1
BR,EYE INFLAMMATION,1
BR,EYE PAIN,1
BR,EYELID OEDEMA,1
BR,FEELING ABNORMAL,1
BR,FEMUR FRACTURE,1
BR,FLATULENCE,1
BR,FORMICATION,1
BR,GASTROINTESTINAL CARCINOMA,1
BR,GASTROINTESTINAL HAEMORRHAGE,1
BR,GASTROINTESTINAL INFECTION,1
BR,GLAUCOMA,1
BR,GLOSSODYNIA,1
BR,GLUCOSE TOLERANCE IMPAIRED,1
BR,GLYCOSYLATED HAEMOGLOBIN INCREASED,1
BR,HAEMODYNAMIC INSTABILITY,1
BR,HAEMOGLOBIN DECREASED,1
BR,HAEMORRHOIDS,1
BR,HEART RATE DECREASED,1
BR,HEART RATE IRREGULAR,1
BR,HYPERHIDROSIS,1
BR,HYPERTENSIVE CRISIS,1
BR,HYPERTRIGLYCERIDAEMIA,1
BR,HYPOKINESIA,1
BR,IIIRD NERVE PARALYSIS,1
BR,IMMUNODEFICIENCY,1
BR,IMPATIENCE,1
BR,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,1
BR,INCORRECT DOSE ADMINISTERED,1
BR,INFARCTION,1
BR,INFECTION,1
BR,INFLAMMATION,1
BR,INJECTION SITE ERYTHEMA,1
BR,INSOMNIA,1
BR,INTENTIONAL DRUG MISUSE,1
BR,INTESTINAL HAEMORRHAGE,1
BR,KNEE ARTHROPLASTY,1
BR,LACERATION,1
BR,LETHARGY,1
BR,LIMB DISCOMFORT,1
BR,LIVER DISORDER,1
BR,LOWER RESPIRATORY TRACT INFLAMMATION,1
BR,MACULE,1
BR,MATERNAL EXPOSURE DURING PREGNANCY,1
BR,MENORRHAGIA,1
BR,MENTAL IMPAIRMENT,1
BR,METABOLIC SYNDROME,1
BR,MICTURITION URGENCY,1
BR,MOUTH INJURY,1
BR,MUSCULOSKELETAL PAIN,1
BR,MYALGIA,1
BR,MYELOPATHY,1
BR,MYOCARDIAL INFARCTION,1
BR,NASAL CONGESTION,1
BR,NASAL POLYPS,1
BR,NASOPHARYNGITIS,1
BR,NECK PAIN,1
BR,NEOPLASM RECURRENCE,1
BR,NEUTROPENIA,1
BR,NORMAL NEWBORN,1
BR,OBESITY SURGERY,1
BR,OCULAR DISCOMFORT,1
BR,OEDEMA PERIPHERAL,1
BR,ORAL DISCOMFORT,1
BR,ORAL PAIN,1
BR,OSTEOARTHRITIS,1
BR,OSTEOPOROSIS,1
BR,PARATHYROID DISORDER,1
BR,PATELLA FRACTURE,1
BR,PERIPHERAL ARTERY OCCLUSION,1
BR,PERIPHERAL ARTERY THROMBOSIS,1
BR,PERIPHERAL NERVE INFECTION,1
BR,PLEURAL EFFUSION,1
BR,PROSTATE INFECTION,1
BR,PROTEIN TOTAL DECREASED,1
BR,PRURITUS,1
BR,PULMONARY FIBROSIS,1
BR,PULPITIS DENTAL,1
BR,RENAL CELL CARCINOMA,1
BR,RENAL COLIC,1
BR,RENAL IMPAIRMENT,1
BR,RETCHING,1
BR,RETINAL OEDEMA,1
BR,RHINITIS,1
BR,ROAD TRAFFIC ACCIDENT,1
BR,SERUM FERRITIN INCREASED,1
BR,SHOCK HAEMORRHAGIC,1
BR,SKIN DISCOLOURATION,1
BR,SOMNOLENCE,1
BR,SPEECH DISORDER,1
BR,SPINAL PAIN,1
BR,SUBCUTANEOUS HAEMATOMA,1
BR,TACHYCARDIA,1
BR,TENDON INJURY,1
BR,THERAPEUTIC RESPONSE DELAYED,1
BR,THROAT IRRITATION,1
BR,THYROID MASS,1
BR,TOOTHACHE,1
BR,URINE ANALYSIS ABNORMAL,1
BR,UTERINE LEIOMYOMA,1
BR,VARICOSE VEIN RUPTURED,1
BR,VENOUS OCCLUSION,1
BR,VITRECTOMY,1
BR,WEIGHT DECREASED,1
BR,WOUND,1
BR,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,1
BG,DRY SKIN,3
BG,AGITATION,2
BG,ANXIETY,2
BG,ASTHENIA,2
BG,ATAXIA,2
BG,COLORECTAL CANCER,2
BG,CONFUSIONAL STATE,2
BG,GAIT DISTURBANCE,2
BG,MEMORY IMPAIRMENT,2
BG,NAUSEA,2
BG,NEUROTOXICITY,2
BG,PALLOR,2
BG,PATHOLOGICAL FRACTURE,2
BG,TOXICITY TO VARIOUS AGENTS,2
BG,ABNORMAL BEHAVIOUR,1
BG,ACUTE MYOCARDIAL INFARCTION,1
BG,ANTIPSYCHOTIC DRUG LEVEL ABOVE THERAPEUTIC,1
BG,APHASIA,1
BG,APNOEIC ATTACK,1
BG,BODY MASS INDEX DECREASED,1
BG,CARDIAC ARREST,1
BG,CEREBROVASCULAR ACCIDENT,1
BG,CHRONIC GASTRITIS,1
BG,COMA,1
BG,CONVULSION,1
BG,DRUG DOSE OMISSION,1
BG,HEMIPARESIS,1
BG,HYPOREFLEXIA,1
BG,HYPOTONIA,1
BG,MUCOSAL DRYNESS,1
BG,POISONING DELIBERATE,1
BG,RESPIRATORY ARREST,1
BG,RESPIRATORY DEPRESSION,1
BG,RESTLESSNESS,1
BG,SOMNOLENCE,1
BG,SUICIDE ATTEMPT,1
BG,TREMOR,1
BG,VASCULAR STENT THROMBOSIS,1
BG,WEIGHT DECREASED,1
CA,RHEUMATOID ARTHRITIS,48
CA,FATIGUE,37
CA,CONDITION AGGRAVATED,33
CA,JOINT SWELLING,32
CA,NASOPHARYNGITIS,31
CA,DRUG INEFFECTIVE,30
CA,ARTHRALGIA,28
CA,DYSPNOEA,26
CA,PAIN,26
CA,HYPOGLYCAEMIA,25
CA,OSTEOARTHRITIS,25
CA,DIARRHOEA,24
CA,FALL,24
CA,METABOLIC ACIDOSIS,24
CA,ASTHENIA,23
CA,SPINAL COLUMN STENOSIS,21
CA,TREATMENT FAILURE,21
CA,BLOOD PRESSURE INCREASED,20
CA,NAUSEA,20
CA,COUGH,19
CA,HEADACHE,18
CA,CONTUSION,16
CA,PYREXIA,16
CA,VOMITING PROJECTILE,16
CA,WEIGHT DECREASED,16
CA,ABDOMINAL PAIN,15
CA,HYPOTENSION,15
CA,PAIN IN EXTREMITY,15
CA,SUICIDAL IDEATION,15
CA,VOMITING,15
CA,DEHYDRATION,14
CA,LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES,14
CA,MALAISE,14
CA,SINUSITIS,14
CA,ARTHRITIS,13
CA,BLOOD CREATININE INCREASED,13
CA,CHEST PAIN,13
CA,PNEUMONIA,13
CA,WEIGHT INCREASED,13
CA,INJECTION SITE BRUISING,12
CA,GRIP STRENGTH DECREASED,11
CA,INJECTION SITE ERYTHEMA,11
CA,INJECTION SITE PRURITUS,11
CA,INJECTION SITE RASH,11
CA,INJECTION SITE REACTION,11
CA,INJECTION SITE SWELLING,11
CA,PERIPHERAL SWELLING,11
CA,CARDIAC FAILURE CONGESTIVE,10
CA,CEREBROVASCULAR ACCIDENT,10
CA,INFUSION RELATED REACTION,10
CA,TENDERNESS,10
CA,BLOOD PRESSURE FLUCTUATION,9
CA,DIZZINESS,9
CA,HAEMOGLOBIN DECREASED,9
CA,INFLUENZA,9
CA,ROTATOR CUFF REPAIR,9
CA,URINARY TRACT INFECTION,9
CA,ACTIVITIES OF DAILY LIVING IMPAIRED,8
CA,ASTHMA,8
CA,BACK PAIN,8
CA,BODY TEMPERATURE DECREASED,8
CA,CORONARY ARTERY OCCLUSION,8
CA,HEART RATE DECREASED,8
CA,MYOCARDIAL INFARCTION,8
CA,OXYGEN SATURATION DECREASED,8
CA,ABDOMINAL PAIN UPPER,7
CA,BLOOD GLUCOSE INCREASED,7
CA,BLOOD PRESSURE SYSTOLIC INCREASED,7
CA,BRONCHITIS,7
CA,CELLULITIS,7
CA,CHEST DISCOMFORT,7
CA,DYSPEPSIA,7
CA,ACUTE KIDNEY INJURY,6
CA,ANAEMIA,6
CA,ANGINA PECTORIS,6
CA,DEATH,6
CA,HYPERTENSION,6
CA,LOSS OF CONSCIOUSNESS,6
CA,LOWER RESPIRATORY TRACT INFECTION,6
CA,MUSCULAR WEAKNESS,6
CA,MYALGIA,6
CA,OEDEMA PERIPHERAL,6
CA,PRURITUS,6
CA,RASH,6
CA,SEPSIS,6
CA,VIRAL INFECTION,6
CA,ACUTE MYOCARDIAL INFARCTION,5
CA,ARTHROPATHY,5
CA,ATRIAL FIBRILLATION,5
CA,BLOOD CHOLESTEROL INCREASED,5
CA,BLOOD PRESSURE DECREASED,5
CA,CARDIAC FAILURE,5
CA,CONFUSIONAL STATE,5
CA,DECREASED APPETITE,5
CA,DRUG HYPERSENSITIVITY,5
CA,EYE SWELLING,5
CA,FLUID RETENTION,5
CA,HEART RATE INCREASED,5
CA,HERPES ZOSTER,5
CA,HYPERSENSITIVITY,5
CA,HYPOAESTHESIA,5
CA,INJECTION SITE PAIN,5
CA,LUNG INFECTION,5
CA,MALIGNANT NEOPLASM PROGRESSION,5
CA,MUSCULOSKELETAL PAIN,5
CA,NEURALGIA,5
CA,PRODUCT USE ISSUE,5
CA,ABDOMINAL DISCOMFORT,4
CA,ANGIOEDEMA,4
CA,BALANCE DISORDER,4
CA,BLISTER,4
CA,BLOOD PRESSURE DIASTOLIC INCREASED,4
CA,CARDIAC ARREST,4
CA,CATARACT,4
CA,CHILLS,4
CA,COLITIS,4
CA,CYST,4
CA,DEEP VEIN THROMBOSIS,4
CA,DUODENAL ULCER,4
CA,DYSPHAGIA,4
CA,DYSURIA,4
CA,FEELING ABNORMAL,4
CA,FLANK PAIN,4
CA,GASTROINTESTINAL HAEMORRHAGE,4
CA,HAEMATEMESIS,4
CA,HAEMATOCHEZIA,4
CA,HAEMOGLOBIN ABNORMAL,4
CA,HEPATIC CIRRHOSIS,4
CA,HERNIA,4
CA,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,4
CA,INTERNATIONAL NORMALISED RATIO INCREASED,4
CA,INTESTINAL OBSTRUCTION,4
CA,LACRIMATION INCREASED,4
CA,PANCREATITIS,4
CA,RESPIRATORY TRACT CONGESTION,4
CA,SKIN EXFOLIATION,4
CA,SNEEZING,4
CA,UPPER RESPIRATORY TRACT INFECTION,4
CA,WHEEZING,4
CA,ABDOMINAL DISTENSION,3
CA,ANKLE FRACTURE,3
CA,ARRHYTHMIA,3
CA,ARTERIOSCLEROSIS CORONARY ARTERY,3
CA,BLOOD IMMUNOGLOBULIN E INCREASED,3
CA,BLOOD PRESSURE DIASTOLIC DECREASED,3
CA,BRADYCARDIA,3
CA,CONSTIPATION,3
CA,CORONARY ARTERY DISEASE,3
CA,DEPRESSION,3
CA,DEVICE INTERACTION,3
CA,DIABETES MELLITUS,3
CA,DISCOMFORT,3
CA,DRUG-INDUCED LIVER INJURY,3
CA,EAR INFECTION,3
CA,ECZEMA,3
CA,EPISTAXIS,3
CA,EYE ALLERGY,3
CA,EYE PRURITUS,3
CA,FEELING COLD,3
CA,GASTROINTESTINAL DISORDER,3
CA,GENERAL PHYSICAL HEALTH DETERIORATION,3
CA,JOINT INJURY,3
CA,JOINT STIFFNESS,3
CA,LOCALISED INFECTION,3
CA,METASTASES TO LIVER,3
CA,MOBILITY DECREASED,3
CA,MUSCULOSKELETAL STIFFNESS,3
CA,PALPITATIONS,3
CA,PLEURAL EFFUSION,3
CA,POOR PERIPHERAL CIRCULATION,3
CA,PRODUCT QUALITY ISSUE,3
CA,PSORIASIS,3
CA,PULMONARY OEDEMA,3
CA,RENAL FAILURE,3
CA,RENAL FAILURE ACUTE,3
CA,RENAL IMPAIRMENT,3
CA,RIB FRACTURE,3
CA,SKIN LESION,3
CA,SOMNOLENCE,3
CA,SYNCOPE,3
CA,THROAT IRRITATION,3
CA,TRANSIENT ISCHAEMIC ATTACK,3
CA,VISION BLURRED,3
CA,WHITE BLOOD CELL COUNT DECREASED,3
CA,ABDOMINAL ADHESIONS,2
CA,ABDOMINAL PAIN LOWER,2
CA,ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED,2
CA,ACUTE CORONARY SYNDROME,2
CA,ADVERSE EVENT,2
CA,ALOPECIA,2
CA,AMNESIA,2
CA,AORTIC ANEURYSM,2
CA,APHASIA,2
CA,ARTERIAL OCCLUSIVE DISEASE,2
CA,ARTHRITIS BACTERIAL,2
CA,BACTERIAL INFECTION,2
CA,BILE DUCT OBSTRUCTION,2
CA,BLOOD CREATINE PHOSPHOKINASE ABNORMAL,2
CA,BLOOD GROWTH HORMONE INCREASED,2
CA,BLOOD LACTIC ACID INCREASED,2
CA,BLOOD MAGNESIUM DECREASED,2
CA,BLOOD PRESSURE SYSTOLIC DECREASED,2
CA,BONE PAIN,2
CA,BREAST CANCER,2
CA,CARDIAC DISORDER,2
CA,CHOLELITHIASIS,2
CA,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,2
CA,COLON CANCER,2
CA,COMPARTMENT SYNDROME,2
CA,CORONARY ARTERY BYPASS,2
CA,CREATININE RENAL CLEARANCE DECREASED,2
CA,CROHN^S DISEASE,2
CA,CYSTITIS,2
CA,CYSTITIS KLEBSIELLA,2
CA,DEAFNESS,2
CA,DEMENTIA,2
CA,DIVERTICULAR PERFORATION,2
CA,DRUG EFFECT INCOMPLETE,2
CA,DRUG INTOLERANCE,2
CA,EXTRASYSTOLES,2
CA,EYE PAIN,2
CA,FAECES DISCOLOURED,2
CA,FIBRIN D DIMER INCREASED,2
CA,FIBROMYALGIA,2
CA,FLATULENCE,2
CA,FLUSHING,2
CA,FREQUENT BOWEL MOVEMENTS,2
CA,GAIT DISTURBANCE,2
CA,GANGRENE,2
CA,GASTRIC DISORDER,2
CA,GOUT,2
CA,HAEMATOMA,2
CA,HEART RATE IRREGULAR,2
CA,HEPATIC ENZYME INCREASED,2
CA,HEPATITIS ACUTE,2
CA,HIP FRACTURE,2
CA,HIP SURGERY,2
CA,HOSPITALISATION,2
CA,HYPERHIDROSIS,2
CA,HYPERSOMNIA,2
CA,HYPOXIA,2
CA,ILEUS,2
CA,INFECTION,2
CA,INJECTION SITE HAEMORRHAGE,2
CA,INSOMNIA,2
CA,JAUNDICE,2
CA,KNEE ARTHROPLASTY,2
CA,LABYRINTHITIS,2
CA,LACERATION,2
CA,LIMB INJURY,2
CA,LIPASE INCREASED,2
CA,LIVER DISORDER,2
CA,LOWER LIMB FRACTURE,2
CA,MASS,2
CA,MEDICATION ERROR,2
CA,MELAENA,2
CA,MEMORY IMPAIRMENT,2
CA,MUSCLE RUPTURE,2
CA,MYOPATHY,2
CA,NECK PAIN,2
CA,NEEDLE ISSUE,2
CA,NEOPLASM,2
CA,NEUROENDOCRINE TUMOUR,2
CA,NEUROPATHY PERIPHERAL,2
CA,ORAL HERPES,2
CA,OROPHARYNGEAL PAIN,2
CA,PANCREATIC CARCINOMA,2
CA,PARAESTHESIA,2
CA,PERICARDIAL EFFUSION,2
CA,PERIPHERAL ISCHAEMIA,2
CA,POLLAKIURIA,2
CA,POLYP,2
CA,POST PROCEDURAL COMPLICATION,2
CA,PRODUCT SUBSTITUTION ISSUE,2
CA,PRODUCT USE IN UNAPPROVED INDICATION,2
CA,PRODUCTIVE COUGH,2
CA,PRURITUS GENERALISED,2
CA,RECTAL HAEMORRHAGE,2
CA,RESPIRATORY FAILURE,2
CA,RESPIRATORY RATE INCREASED,2
CA,RHINORRHOEA,2
CA,ROAD TRAFFIC ACCIDENT,2
CA,SCAB,2
CA,SECRETION DISCHARGE,2
CA,SINUS CONGESTION,2
CA,SINUS TACHYCARDIA,2
CA,SKIN ULCER,2
CA,SPEECH DISORDER,2
CA,SPUTUM DISCOLOURED,2
CA,SWELLING,2
CA,THERAPEUTIC RESPONSE DECREASED,2
CA,THERAPY NON-RESPONDER,2
CA,TRANSFUSION-RELATED CIRCULATORY OVERLOAD,2
CA,TUBULOINTERSTITIAL NEPHRITIS,2
CA,TYPE 2 DIABETES MELLITUS,2
CA,UPPER LIMB FRACTURE,2
CA,URTICARIA,2
CA,VENTRICULAR FIBRILLATION,2
CA,VERTIGO,2
CA,VIITH NERVE PARALYSIS,2
CA,VIRAL UPPER RESPIRATORY TRACT INFECTION,2
CA,VISUAL ACUITY REDUCED,2
CA,VISUAL IMPAIRMENT,2
CA,WEIGHT BEARING DIFFICULTY,2
CA,ABASIA,1
CA,ABDOMINAL HERNIA,1
CA,ABNORMAL FAECES,1
CA,ACCOMMODATION DISORDER,1
CA,ACUTE HEPATIC FAILURE,1
CA,ACUTE PULMONARY OEDEMA,1
CA,ADENOCARCINOMA PANCREAS,1
CA,ADVERSE DRUG REACTION,1
CA,ADVERSE REACTION,1
CA,AGITATION,1
CA,ALANINE AMINOTRANSFERASE INCREASED,1
CA,ANAL INCONTINENCE,1
CA,ANASTOMOTIC ULCER,1
CA,ANGINA UNSTABLE,1
CA,ANTI A ANTIBODY,1
CA,ANTI-ERYTHROPOIETIN ANTIBODY POSITIVE,1
CA,ANTICOAGULATION DRUG LEVEL BELOW THERAPEUTIC,1
CA,ANXIETY,1
CA,AORTIC VALVE REPLACEMENT,1
CA,APHONIA,1
CA,APLASIA PURE RED CELL,1
CA,APPENDICITIS,1
CA,APPENDICITIS PERFORATED,1
CA,ARTHRITIS INFECTIVE,1
CA,ASCITES,1
CA,ASPARTATE AMINOTRANSFERASE INCREASED,1
CA,ATRIOVENTRICULAR BLOCK,1
CA,ATRIOVENTRICULAR BLOCK COMPLETE,1
CA,AZOTAEMIA,1
CA,BACK INJURY,1
CA,BLADDER CANCER,1
CA,BLADDER CATHETER PERMANENT,1
CA,BLADDER DISORDER,1
CA,BLINDNESS,1
CA,BLOOD ALKALINE PHOSPHATASE INCREASED,1
CA,BLOOD CALCIUM DECREASED,1
CA,BLOOD CREATININE ABNORMAL,1
CA,BLOOD GLUCOSE ABNORMAL,1
CA,BLOOD GLUCOSE DECREASED,1
CA,BLOOD GLUCOSE FLUCTUATION,1
CA,BLOOD GROWTH HORMONE DECREASED,1
CA,BLOOD POTASSIUM DECREASED,1
CA,BLOOD POTASSIUM INCREASED,1
CA,BLOOD SODIUM DECREASED,1
CA,BLOOD THYROID STIMULATING HORMONE INCREASED,1
CA,BLOOD TRIGLYCERIDES INCREASED,1
CA,BLOOD URINE PRESENT,1
CA,BODY TEMPERATURE INCREASED,1
CA,BRAIN STEM HAEMORRHAGE,1
CA,BRONCHIECTASIS,1
CA,BUNDLE BRANCH BLOCK RIGHT,1
CA,BURSITIS,1
CA,CARBON MONOXIDE DIFFUSING CAPACITY DECREASED,1
CA,CARDIAC INFECTION,1
CA,CARDIAC MURMUR,1
CA,CARDIAC OPERATION,1
CA,CARDIOMEGALY,1
CA,CARDIOVASCULAR DISORDER,1
CA,CATARACT OPERATION COMPLICATION,1
CA,CHEMOTHERAPY,1
CA,CHOKING,1
CA,CHOKING SENSATION,1
CA,CHOLECYSTITIS INFECTIVE,1
CA,CHRONIC KIDNEY DISEASE,1
CA,CIRCUMCISION,1
CA,CLOSTRIDIUM DIFFICILE INFECTION,1
CA,COAGULOPATHY,1
CA,COLITIS ULCERATIVE,1
CA,CONJUNCTIVAL DEPOSIT,1
CA,CONTRAINDICATED PRODUCT ADMINISTERED,1
CA,CORONARY ANGIOPLASTY,1
CA,CORONARY ARTERIAL STENT INSERTION,1
CA,CORTISOL ABNORMAL,1
CA,CREPITATIONS,1
CA,CRYING,1
CA,CYST REMOVAL,1
CA,DECREASED ACTIVITY,1
CA,DECREASED INTEREST,1
CA,DECUBITUS ULCER,1
CA,DENTAL PROSTHESIS PLACEMENT,1
CA,DEPRESSED MOOD,1
CA,DERMAL CYST,1
CA,DERMATITIS INFECTED,1
CA,DEVICE RELATED INFECTION,1
CA,DISEASE PROGRESSION,1
CA,DRUG ADMINISTRATION ERROR,1
CA,DRUG DOSE OMISSION,1
CA,DRUG EFFECT DECREASED,1
CA,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,1
CA,DRY SKIN,1
CA,DUCHENNE MUSCULAR DYSTROPHY,1
CA,DUODENAL STENOSIS,1
CA,DYSARTHRIA,1
CA,DYSGEUSIA,1
CA,DYSKINESIA,1
CA,DYSPHONIA,1
CA,DYSPHORIA,1
CA,DYSPNOEA EXERTIONAL,1
CA,DYSSTASIA,1
CA,EAR INFECTION FUNGAL,1
CA,EAR PAIN,1
CA,ECCHYMOSIS,1
CA,EMBOLISM VENOUS,1
CA,ENCEPHALOPATHY,1
CA,ERYTHEMA,1
CA,EXCESSIVE CERUMEN PRODUCTION,1
CA,EYE DISCHARGE,1
CA,EYE INFECTION,1
CA,EYE INFECTION VIRAL,1
CA,EYE OPERATION COMPLICATION,1
CA,FACIAL NERVE DISORDER,1
CA,FACIAL PAIN,1
CA,FAILURE TO THRIVE,1
CA,FEBRILE NEUTROPENIA,1
CA,FEEDING DISORDER,1
CA,FEELING HOT,1
CA,FIBROADENOMA OF BREAST,1
CA,FIBULA FRACTURE,1
CA,FLUID OVERLOAD,1
CA,FOOT DEFORMITY,1
CA,FRACTURE,1
CA,FRUSTRATION,1
CA,GASTRIC HAEMORRHAGE,1
CA,GASTROENTERITIS,1
CA,GASTROINTESTINAL INFECTION,1
CA,GASTROINTESTINAL PAIN,1
CA,GASTROINTESTINAL WALL THICKENING,1
CA,GASTROOESOPHAGEAL REFLUX DISEASE,1
CA,GENERALISED ERYTHEMA,1
CA,GENERALISED OEDEMA,1
CA,GENITAL HERPES,1
CA,GLOMERULAR FILTRATION RATE ABNORMAL,1
CA,GLUCOSE TOLERANCE IMPAIRED,1
CA,GLYCOSYLATED HAEMOGLOBIN INCREASED,1
CA,GRANULOMATOSIS WITH POLYANGIITIS,1
CA,HAEMATURIA,1
CA,HAEMOGLOBINURIA,1
CA,HAEMOLYSIS,1
CA,HAEMORRHOIDS,1
CA,HALLUCINATION,1
CA,HALLUCINATION_ VISUAL,1
CA,HEAD DISCOMFORT,1
CA,HEAD INJURY,1
CA,HEART RATE ABNORMAL,1
CA,HEART VALVE OPERATION,1
CA,HEPATIC ENZYME ABNORMAL,1
CA,HEPATIC STEATOSIS,1
CA,HEPATOMEGALY,1
CA,HERPES VIRUS INFECTION,1
CA,HYPERGLYCAEMIA,1
CA,HYPERLIPIDAEMIA,1
CA,HYPERTONIC BLADDER,1
CA,HYPERVOLAEMIA,1
CA,HYPOKINESIA,1
CA,HYPOTHYROIDISM,1
CA,HYPOVOLAEMIC SHOCK,1
CA,IDIOPATHIC PULMONARY FIBROSIS,1
CA,IMMEDIATE POST-INJECTION REACTION,1
CA,IMMUNE SYSTEM DISORDER,1
CA,IMPAIRED HEALING,1
CA,IMPAIRED WORK ABILITY,1
CA,INFARCTION,1
CA,INFLAMMATION,1
CA,INFLAMMATORY MARKER INCREASED,1
CA,INFLUENZA LIKE ILLNESS,1
CA,INNER EAR DISORDER,1
CA,INTENTIONAL DRUG MISUSE,1
CA,INTERMITTENT CLAUDICATION,1
CA,INTERVERTEBRAL DISC PROTRUSION,1
CA,INTESTINAL ISCHAEMIA,1
CA,INTESTINAL PERFORATION,1
CA,INTESTINAL POLYP,1
CA,INTESTINAL STENOSIS,1
CA,IRITIS,1
CA,JOINT EFFUSION,1
CA,KETOSIS,1
CA,KIDNEY INFECTION,1
CA,KLEBSIELLA TEST POSITIVE,1
CA,LACTIC ACIDOSIS,1
CA,LEUKOCYTOSIS,1
CA,LEUKOPLAKIA,1
CA,LICHEN PLANUS,1
CA,LIMB OPERATION,1
CA,LIPASE ABNORMAL,1
CA,LOCAL SWELLING,1
CA,LUNG ADENOCARCINOMA STAGE IV,1
CA,LUNG DISORDER,1
CA,LUNG NEOPLASM MALIGNANT,1
CA,LUPUS-LIKE SYNDROME,1
CA,MALIGNANT MELANOMA,1
CA,MENIERE^S DISEASE,1
CA,MENINGITIS BACTERIAL,1
CA,MENISCUS INJURY,1
CA,MENTAL IMPAIRMENT,1
CA,METASTASES TO CENTRAL NERVOUS SYSTEM,1
CA,METASTASES TO LUNG,1
CA,METASTASES TO SKIN,1
CA,METASTATIC CARCINOID TUMOUR,1
CA,MIDDLE INSOMNIA,1
CA,MIGRAINE,1
CA,MOLE EXCISION,1
CA,MOVEMENT DISORDER,1
CA,MUCOSAL HAEMORRHAGE,1
CA,MULTI-ORGAN FAILURE,1
CA,MUSCLE TWITCHING,1
CA,MUSCULOSKELETAL CHEST PAIN,1
CA,MYOCARDITIS,1
CA,NASAL CONGESTION,1
CA,NASAL OBSTRUCTION,1
CA,NASAL ULCER,1
CA,NEPHROLITHIASIS,1
CA,NERVE INJURY,1
CA,NERVOUSNESS,1
CA,NEUROGENIC SHOCK,1
CA,NEUTRALISING ANTIBODIES POSITIVE,1
CA,NEUTROPENIA,1
CA,NEUTROPENIC SEPSIS,1
CA,NIGHT SWEATS,1
CA,NIGHTMARE,1
CA,NON-CARDIAC CHEST PAIN,1
CA,OBSTRUCTIVE AIRWAYS DISORDER,1
CA,OCCULT BLOOD,1
CA,OCULAR HYPERAEMIA,1
CA,OESOPHAGEAL CARCINOMA,1
CA,OESOPHAGEAL INJURY,1
CA,OESOPHAGEAL SPASM,1
CA,ORGANISING PNEUMONIA,1
CA,OVERDOSE,1
CA,PAIN OF SKIN,1
CA,PANCREAS INFECTION,1
CA,PANCREATIC MASS,1
CA,PANCREATITIS NECROTISING,1
CA,PARAESTHESIA MUCOSAL,1
CA,PARAESTHESIA ORAL,1
CA,PARANOIA,1
CA,PARASITE STOOL TEST POSITIVE,1
CA,PERICARDITIS,1
CA,PERIPHERAL COLDNESS,1
CA,PERIPHERAL EMBOLISM,1
CA,PHARYNGEAL PARAESTHESIA,1
CA,PHARYNGITIS STREPTOCOCCAL,1
CA,PHOTOSENSITIVITY REACTION,1
CA,PLANTAR ERYTHEMA,1
CA,PLATELET COUNT DECREASED,1
CA,PNEUMONIA ASPIRATION,1
CA,PNEUMONIA STAPHYLOCOCCAL,1
CA,POST HERPETIC NEURALGIA,1
CA,POST PROCEDURAL INFECTION,1
CA,POSTOPERATIVE ABSCESS,1
CA,PRESCRIBED UNDERDOSE,1
CA,PRESYNCOPE,1
CA,PRODUCT COATING ISSUE,1
CA,PRODUCT PHYSICAL ISSUE,1
CA,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,1
CA,PROSTATIC DISORDER,1
CA,PROSTATIC SPECIFIC ANTIGEN INCREASED,1
CA,PULMONARY CAVITATION,1
CA,PULMONARY EMBOLISM,1
CA,PULMONARY MASS,1
CA,QUALITY OF LIFE DECREASED,1
CA,RASH ERYTHEMATOUS,1
CA,RASH PRURITIC,1
CA,READING DISORDER,1
CA,RED BLOOD CELL COUNT DECREASED,1
CA,RENAL DISORDER,1
CA,RENAL FAILURE CHRONIC,1
CA,RENAL TUBULAR DISORDER,1
CA,RENAL TUBULAR NECROSIS,1
CA,RESPIRATORY ARREST,1
CA,RESPIRATORY DISTRESS,1
CA,RESPIRATORY RATE DECREASED,1
CA,RESPIRATORY TRACT INFECTION,1
CA,RESTLESSNESS,1
CA,RETINAL DETACHMENT,1
CA,RETINAL TEAR,1
CA,RETROPERITONEAL HAEMORRHAGE,1
CA,RHEUMATOID FACTOR POSITIVE,1
CA,RHEUMATOID NODULE,1
CA,SARCOIDOSIS,1
CA,SCAR,1
CA,SCIATICA,1
CA,SENSATION OF FOREIGN BODY,1
CA,SENSITIVITY TO WEATHER CHANGE,1
CA,SENSORY LOSS,1
CA,SEPTIC SHOCK,1
CA,SHOCK,1
CA,SINUS DISORDER,1
CA,SKIN CANCER,1
CA,SKIN DISCOLOURATION,1
CA,SKIN FISSURES,1
CA,SKIN ULCER HAEMORRHAGE,1
CA,SLEEP APNOEA SYNDROME,1
CA,SLEEP DISORDER,1
CA,SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION_ INSOMNIA TYPE,1
CA,SLEEP TERROR,1
CA,SMALL INTESTINAL OBSTRUCTION,1
CA,SPINAL COMPRESSION FRACTURE,1
CA,SPINAL FUSION SURGERY,1
CA,SPLEEN DISORDER,1
CA,SPLENOMEGALY,1
CA,SQUAMOUS CELL CARCINOMA OF SKIN,1
CA,STAPHYLOCOCCAL INFECTION,1
CA,STOMATITIS,1
CA,STRESS,1
CA,STUPOR,1
CA,SUPRAVENTRICULAR TACHYCARDIA,1
CA,SWOLLEN JOINT COUNT,1
CA,TACHYCARDIA,1
CA,TACHYPNOEA,1
CA,TEMPERATURE INTOLERANCE,1
CA,TENDON RUPTURE,1
CA,TENDONITIS,1
CA,THERAPY CESSATION,1
CA,THROAT TIGHTNESS,1
CA,THROMBOCYTOPENIA,1
CA,THROMBOSIS,1
CA,THYROID CYST,1
CA,THYROID MASS,1
CA,THYROID NEOPLASM,1
CA,TOOTH DISORDER,1
CA,TOOTH FRACTURE,1
CA,TOOTH REPAIR,1
CA,TORTICOLLIS,1
CA,TOTAL LUNG CAPACITY DECREASED,1
CA,TOXIC SHOCK SYNDROME,1
CA,TOXICITY TO VARIOUS AGENTS,1
CA,TOXICOLOGIC TEST ABNORMAL,1
CA,TRIGEMINAL NERVE DISORDER,1
CA,TYMPANIC MEMBRANE PERFORATION,1
CA,UMBILICAL HERNIA,1
CA,UPPER EXTREMITY MASS,1
CA,URINARY BLADDER HAEMORRHAGE,1
CA,URINARY RETENTION,1
CA,UROSEPSIS,1
CA,UTERINE LEIOMYOMA,1
CA,UTERINE NEOPLASM,1
CA,UTERINE OPERATION,1
CA,VASCULAR FRAGILITY,1
CA,VASCULAR OCCLUSION,1
CA,VASCULITIS,1
CA,VENTRICULAR TACHYCARDIA,1
CA,VERTIGO POSITIONAL,1
CA,VIRAL SINUSITIS,1
CA,VOLVULUS,1
CA,WHITE BLOOD CELL COUNT INCREASED,1
CA,WOUND,1
CA,WOUND SECRETION,1
KY,ABDOMINAL DISCOMFORT,1
KY,DIZZINESS,1
KY,DRUG ABUSE,1
KY,TREATMENT NONCOMPLIANCE,1
CN,ABDOMINAL DISTENSION,1
CN,BRADYCARDIA,1
CN,CHEST PAIN,1
CN,COMA,1
CN,DECREASED APPETITE,1
CN,DYSPNOEA,1
CN,GASTRIC CANCER,1
CN,HYPOKALAEMIA,1
CN,HYPOTENSION,1
CN,ISCHAEMIC STROKE,1
CN,LUNG INFECTION,1
CN,METABOLIC ALKALOSIS,1
CN,OEDEMA PERIPHERAL,1
CN,PYREXIA,1
CN,RASH,1
CN,UPPER GASTROINTESTINAL HAEMORRHAGE,1
CN,WEIGHT INCREASED,1
HR,DEHYDRATION,3
HR,ANGINA UNSTABLE,2
HR,DERMATITIS BULLOUS,2
HR,ENTEROCOLITIS,2
HR,HYPOMAGNESAEMIA,2
HR,LEUKOPENIA,2
HR,PLATELET COUNT DECREASED,2
HR,TYPE IV HYPERSENSITIVITY REACTION,2
HR,ABDOMINAL PAIN UPPER,1
HR,BLOOD BILIRUBIN INCREASED,1
HR,CHROMATURIA,1
HR,DIABETIC KETOACIDOSIS,1
HR,GANGRENE,1
HR,HAEMATURIA,1
HR,JAUNDICE,1
HR,KETOACIDOSIS,1
HR,METASTASES TO LIVER,1
HR,PALPITATIONS,1
HR,TACHYARRHYTHMIA,1
CZ,BLADDER CANCER,2
CZ,COR PULMONALE ACUTE,1
CZ,OSTEOARTHRITIS,1
CZ,PNEUMONIA,1
CZ,POST PROCEDURAL INFECTION,1
CZ,PULMONARY EMBOLISM,1
CZ,PULMONARY INFARCTION,1
CZ,STAPHYLOCOCCAL INFECTION,1
DK,NEUROPATHY PERIPHERAL,12
DK,NAUSEA,10
DK,VOMITING,10
DK,DRUG CLEARANCE DECREASED,6
DK,TOXICITY TO VARIOUS AGENTS,6
DK,LIVER DISORDER,3
DK,NEUROTOXICITY,3
DK,ANGIOEDEMA,2
DK,FATIGUE,2
DK,ABDOMINAL DISCOMFORT,1
DK,ACTIVITIES OF DAILY LIVING IMPAIRED,1
DK,ACUTE KIDNEY INJURY,1
DK,CARDIAC ARREST,1
DK,CEREBRAL HAEMORRHAGE,1
DK,CHEST PAIN,1
DK,DECREASED APPETITE,1
DK,DEPRESSION,1
DK,DIABETES MELLITUS INADEQUATE CONTROL,1
DK,DISEASE PROGRESSION,1
DK,DISSEMINATED INTRAVASCULAR COAGULATION,1
DK,DIZZINESS,1
DK,DYSPNOEA,1
DK,DYSPNOEA EXERTIONAL,1
DK,FEBRILE NEUTROPENIA,1
DK,FEELING ABNORMAL,1
DK,FEELING DRUNK,1
DK,GENERALISED OEDEMA,1
DK,HEADACHE,1
DK,HYPOPHYSITIS,1
DK,HYPOTENSION,1
DK,IMPAIRED SELF-CARE,1
DK,INSOMNIA,1
DK,LABELLED DRUG-DISEASE INTERACTION MEDICATION ERROR,1
DK,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,1
DK,LACTIC ACIDOSIS,1
DK,LOSS OF CONSCIOUSNESS,1
DK,METASTASES TO SPINE,1
DK,MULTIPLE ORGAN DYSFUNCTION SYNDROME,1
DK,NEUTROPHIL COUNT DECREASED,1
DK,PERICARDITIS,1
DK,PULMONARY EMBOLISM,1
DK,RENAL FAILURE,1
DK,TUBULOINTERSTITIAL NEPHRITIS,1
DK,VISUAL IMPAIRMENT,1
DK,WALKING DISABILITY,1
DO,ASTHENIA,2
DO,DIZZINESS,2
DO,PYREXIA,2
DO,ANAEMIA,1
DO,BLOOD GLUCOSE INCREASED,1
DO,DECREASED APPETITE,1
DO,FALL,1
DO,INJECTION SITE ABSCESS,1
DO,INJECTION SITE ERYTHEMA,1
DO,INJECTION SITE PAIN,1
DO,INJECTION SITE PUSTULE,1
DO,INJECTION SITE SWELLING,1
DO,INSOMNIA,1
DO,PROSTATIC SPECIFIC ANTIGEN INCREASED,1
DO,TREMOR,1
EG,FATIGUE,2
EG,ANAL INFECTION,1
EG,ASTHENIA,1
EG,HYPERSENSITIVITY,1
EG,JOINT STIFFNESS,1
EG,LEUKOPENIA,1
EG,LIGAMENT INJURY,1
EG,MOUTH ULCERATION,1
EG,PAIN IN EXTREMITY,1
EG,PLATELET COUNT DECREASED,1
EG,PYREXIA,1
EG,SUDDEN DEATH,1
EG,TACHYCARDIA,1
EG,WHITE BLOOD CELL COUNT DECREASED,1
FI,ANGIOEDEMA,2
FI,DELIRIUM,1
FI,DRY MOUTH,1
FI,GENERAL PHYSICAL HEALTH DETERIORATION,1
FI,HEPATOTOXICITY,1
FI,HYPOTHYROIDISM,1
FI,INSOMNIA,1
FI,MACULAR DEGENERATION,1
FI,MIGRAINE,1
FI,MYOCARDIAL INFARCTION,1
FI,MYOPATHY,1
FI,PYREXIA,1
FI,VISUAL IMPAIRMENT,1
FR,ANGIOEDEMA,22
FR,ACUTE KIDNEY INJURY,21
FR,DIARRHOEA,17
FR,RENAL FAILURE,16
FR,RENAL FAILURE ACUTE,14
FR,FALL,13
FR,PLEURAL EFFUSION,12
FR,HYPERKALAEMIA,11
FR,ANAEMIA,10
FR,CONFUSIONAL STATE,10
FR,EOSINOPHILIA,9
FR,VOMITING,9
FR,NAUSEA,8
FR,OVERDOSE,8
FR,RHABDOMYOLYSIS,8
FR,HEPATITIS,7
FR,BLOOD CREATININE INCREASED,6
FR,CARDIO-RESPIRATORY ARREST,6
FR,CELLULITIS,6
FR,HYPOGLYCAEMIA,6
FR,NEUTROPENIA,6
FR,THROMBOCYTOPENIA,6
FR,AMYOTROPHIC LATERAL SCLEROSIS,5
FR,ASTHENIA,5
FR,DECREASED APPETITE,5
FR,DEHYDRATION,5
FR,DYSPHONIA,5
FR,DYSPNOEA,5
FR,EPISTAXIS,5
FR,HYPONATRAEMIA,5
FR,METABOLIC ACIDOSIS,5
FR,PANCREATITIS ACUTE,5
FR,PYREXIA,5
FR,SPINAL COMPRESSION FRACTURE,5
FR,THROMBOTIC MICROANGIOPATHY,5
FR,TREMOR,5
FR,URINARY RETENTION,5
FR,WEIGHT DECREASED,5
FR,ABDOMINAL PAIN,4
FR,AGITATION,4
FR,BALANCE DISORDER,4
FR,CARDIAC FAILURE,4
FR,COMA,4
FR,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,4
FR,GENERAL PHYSICAL HEALTH DETERIORATION,4
FR,LUNG DISORDER,4
FR,MALAISE,4
FR,MELAENA,4
FR,MULTI-ORGAN FAILURE,4
FR,RESPIRATORY DISTRESS,4
FR,SOMNOLENCE,4
FR,ANURIA,3
FR,ASCITES,3
FR,BLOOD PRESSURE DECREASED,3
FR,C-REACTIVE PROTEIN INCREASED,3
FR,COLITIS,3
FR,DISORIENTATION,3
FR,DIZZINESS,3
FR,DYSARTHRIA,3
FR,FASCIITIS,3
FR,HAEMATOMA,3
FR,HEADACHE,3
FR,HYPERTENSION,3
FR,HYPERTONIA,3
FR,HYPOTENSION,3
FR,ISCHAEMIC STROKE,3
FR,LOSS OF CONSCIOUSNESS,3
FR,PLEURISY,3
FR,RENAL IMPAIRMENT,3
FR,SEPTIC SHOCK,3
FR,SKIN LESION,3
FR,SPEECH DISORDER,3
FR,ABDOMINAL DISTENSION,2
FR,ABNORMAL BEHAVIOUR,2
FR,ABNORMAL FAECES,2
FR,ACCIDENTAL DEATH,2
FR,ACUTE PRERENAL FAILURE,2
FR,ACUTE PULMONARY OEDEMA,2
FR,APHASIA,2
FR,CANDIDA SEPSIS,2
FR,CARDIOACTIVE DRUG LEVEL INCREASED,2
FR,CHEST PAIN,2
FR,CHOKING SENSATION,2
FR,CHOLESTASIS,2
FR,CONDITION AGGRAVATED,2
FR,DEATH,2
FR,DEMENTIA,2
FR,DEPRESSION,2
FR,DRUG INEFFECTIVE,2
FR,ELECTROCARDIOGRAM ST SEGMENT ABNORMAL,2
FR,FEBRILE BONE MARROW APLASIA,2
FR,GASTROINTESTINAL HAEMORRHAGE,2
FR,GLOMERULAR FILTRATION RATE INCREASED,2
FR,HEMIPLEGIA,2
FR,HEPATOCELLULAR INJURY,2
FR,HOIGNE^S SYNDROME,2
FR,HYPERGLYCAEMIA,2
FR,HYPOCALCAEMIA,2
FR,HYPOMAGNESAEMIA,2
FR,HYPOVOLAEMIC SHOCK,2
FR,HYPOXIA,2
FR,INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION,2
FR,INTERNATIONAL NORMALISED RATIO INCREASED,2
FR,INTERSTITIAL LUNG DISEASE,2
FR,LACTIC ACIDOSIS,2
FR,LEUKOCYTOCLASTIC VASCULITIS,2
FR,LEUKOPENIA,2
FR,LIP OEDEMA,2
FR,ORTHOSTATIC HYPOTENSION,2
FR,OXYGEN SATURATION DECREASED,2
FR,PALPITATIONS,2
FR,PANCREATITIS,2
FR,PANCYTOPENIA,2
FR,PARTIAL SEIZURES,2
FR,PERICARDIAL HAEMORRHAGE,2
FR,PERICARDITIS,2
FR,PERIPHERAL ARTERY THROMBOSIS,2
FR,RASH,2
FR,RASH PUSTULAR,2
FR,RENAL TUBULAR NECROSIS,2
FR,SEIZURE,2
FR,SKIN NECROSIS,2
FR,STAPHYLOCOCCAL SEPSIS,2
FR,SYNCOPE,2
FR,SYSTEMIC INFLAMMATORY RESPONSE SYNDROME,2
FR,TACHYCARDIA,2
FR,TETANY,2
FR,THROMBOSIS,2
FR,TONGUE DRY,2
FR,TOXICITY TO VARIOUS AGENTS,2
FR,URTICARIA,2
FR,VENOUS THROMBOSIS,2
FR,WEIGHT INCREASED,2
FR,ABSCESS,1
FR,ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED,1
FR,ACUTE CORONARY SYNDROME,1
FR,ACUTE MYELOID LEUKAEMIA,1
FR,ACUTE RESPIRATORY DISTRESS SYNDROME,1
FR,AGE-RELATED MACULAR DEGENERATION,1
FR,AGEUSIA,1
FR,ALANINE AMINOTRANSFERASE INCREASED,1
FR,ANAEMIA MACROCYTIC,1
FR,ANGINA PECTORIS,1
FR,ANXIETY,1
FR,APATHY,1
FR,ARRHYTHMIA,1
FR,ARTERIOGRAM CORONARY,1
FR,ARTHRITIS,1
FR,ARTHRITIS BACTERIAL,1
FR,ASPARTATE AMINOTRANSFERASE INCREASED,1
FR,AZOTAEMIA,1
FR,BACK PAIN,1
FR,BLISTER,1
FR,BLOOD CHLORIDE DECREASED,1
FR,BLOOD IRON DECREASED,1
FR,BLOOD OSMOLARITY DECREASED,1
FR,BLOOD POTASSIUM INCREASED,1
FR,BLOOD PRESSURE INCREASED,1
FR,BLOOD THYROID STIMULATING HORMONE DECREASED,1
FR,BLOOD UREA INCREASED,1
FR,BLOOD URIC ACID INCREASED,1
FR,BRADYCARDIA,1
FR,BRADYPNOEA,1
FR,BRAIN INJURY,1
FR,BRONCHITIS,1
FR,BUNDLE BRANCH BLOCK LEFT,1
FR,CARDIAC MURMUR,1
FR,CARDIAC TAMPONADE,1
FR,CARDIOGENIC SHOCK,1
FR,CAROTID SINUS SYNDROME,1
FR,CEREBELLAR HAEMATOMA,1
FR,CEREBRAL ATROPHY,1
FR,CEREBROVASCULAR ACCIDENT,1
FR,CHEST DISCOMFORT,1
FR,CHILLS,1
FR,CHOLANGITIS,1
FR,CHOLECYSTITIS,1
FR,CHOLECYSTITIS INFECTIVE,1
FR,CHOLELITHIASIS,1
FR,CHOLELITHIASIS OBSTRUCTIVE,1
FR,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,1
FR,CLOSTRIDIUM DIFFICILE COLITIS,1
FR,CONSTIPATION,1
FR,CONVULSION,1
FR,COUGH,1
FR,CREATININE RENAL CLEARANCE DECREASED,1
FR,CYSTITIS HAEMORRHAGIC,1
FR,CYTOMEGALOVIRUS INFECTION,1
FR,CYTOMEGALOVIRUS TEST POSITIVE,1
FR,DETACHMENT OF RETINAL PIGMENT EPITHELIUM,1
FR,DISEASE PROGRESSION,1
FR,DIVERTICULITIS,1
FR,DIVERTICULUM INTESTINAL,1
FR,DRUG ERUPTION,1
FR,DRUG INTOLERANCE,1
FR,DUODENOGASTRIC REFLUX,1
FR,DYSPHAGIA,1
FR,DYSPNOEA EXERTIONAL,1
FR,ECZEMA,1
FR,ELECTROCARDIOGRAM REPOLARISATION ABNORMALITY,1
FR,ENCEPHALOPATHY,1
FR,ENTEROBACTER SEPSIS,1
FR,EPSTEIN-BARR VIRUS TEST POSITIVE,1
FR,ERYTHEMA,1
FR,ERYTHEMA MULTIFORME,1
FR,ESCHAR,1
FR,ESCHERICHIA INFECTION,1
FR,EXTREMITY NECROSIS,1
FR,FACE INJURY,1
FR,FACE OEDEMA,1
FR,FATIGUE,1
FR,FEELING ABNORMAL,1
FR,FOOD AVERSION,1
FR,FOOD INTOLERANCE,1
FR,FUNGAL INFECTION,1
FR,GAIT DISTURBANCE,1
FR,GAMMA-GLUTAMYLTRANSFERASE INCREASED,1
FR,GASTRITIS,1
FR,GASTROENTERITIS,1
FR,GLYCOSYLATED HAEMOGLOBIN INCREASED,1
FR,GOITRE,1
FR,GUILLAIN-BARRE SYNDROME,1
FR,HAEMARTHROSIS,1
FR,HAEMATEMESIS,1
FR,HAEMATURIA,1
FR,HAEMODIALYSIS,1
FR,HAEMOLYTIC ANAEMIA,1
FR,HAEMOPTYSIS,1
FR,HAEMORRHAGE,1
FR,HAEMORRHAGIC STROKE,1
FR,HAEMORRHOIDS,1
FR,HAEMOTHORAX,1
FR,HALLUCINATION_ VISUAL,1
FR,HEAD INJURY,1
FR,HEPATIC ENCEPHALOPATHY,1
FR,HEPATIC ENZYME INCREASED,1
FR,HEPATIC FAILURE,1
FR,HEPATITIS FULMINANT,1
FR,HEPATOCELLULAR CARCINOMA,1
FR,HERNIA,1
FR,HERNIAL EVENTRATION,1
FR,HERPES ZOSTER,1
FR,HIATUS HERNIA,1
FR,HYPERAESTHESIA,1
FR,HYPERAMMONAEMIA,1
FR,HYPERBILIRUBINAEMIA,1
FR,HYPERCALCAEMIA,1
FR,HYPERHOMOCYSTEINAEMIA,1
FR,HYPERSENSITIVITY,1
FR,HYPOALBUMINAEMIA,1
FR,HYPOVOLAEMIA,1
FR,ILEUS,1
FR,INFLAMMATION,1
FR,INFUSION SITE ABSCESS,1
FR,INGUINAL HERNIA,1
FR,INTRA-ABDOMINAL HAEMATOMA,1
FR,IRON DEFICIENCY ANAEMIA,1
FR,JOINT DISLOCATION,1
FR,JUGULAR VEIN THROMBOSIS,1
FR,KERATITIS,1
FR,KETOACIDOSIS,1
FR,LEUKOCYTURIA,1
FR,LOCALISED OEDEMA,1
FR,LUNG INFECTION,1
FR,METASTASES TO GASTROINTESTINAL TRACT,1
FR,METASTASES TO LIVER,1
FR,METASTASES TO LUNG,1
FR,MIOSIS,1
FR,MUCOSAL INFLAMMATION,1
FR,MUSCLE HAEMORRHAGE,1
FR,MUSCLE SPASMS,1
FR,MYELODYSPLASTIC SYNDROME,1
FR,MYOCARDIAL INFARCTION,1
FR,NEOPLASM PROGRESSION,1
FR,NERVE COMPRESSION,1
FR,NERVOUS SYSTEM DISORDER,1
FR,NORMOCHROMIC NORMOCYTIC ANAEMIA,1
FR,OEDEMA,1
FR,OEDEMA MOUTH,1
FR,OEDEMA PERIPHERAL,1
FR,OESOPHAGITIS,1
FR,OESOPHAGITIS HAEMORRHAGIC,1
FR,ORAL CANDIDIASIS,1
FR,OSTEITIS,1
FR,PACKED RED BLOOD CELL TRANSFUSION,1
FR,PAIN,1
FR,PANCREATIC CARCINOMA,1
FR,PANCREATIC NECROSIS,1
FR,PANCREATITIS CHRONIC,1
FR,PANIC ATTACK,1
FR,PARAESTHESIA,1
FR,PARAPARESIS,1
FR,PERIPHERAL ARTERIAL OCCLUSIVE DISEASE,1
FR,PERIPHERAL ARTERY ANEURYSM,1
FR,PLATELET COUNT DECREASED,1
FR,PNEUMONIA,1
FR,PNEUMONIA ASPIRATION,1
FR,PNEUMONIA KLEBSIELLA,1
FR,PNEUMOTHORAX,1
FR,POLLAKIURIA,1
FR,POTENTIATING DRUG INTERACTION,1
FR,PRERENAL FAILURE,1
FR,PRESYNCOPE,1
FR,PROTEINURIA,1
FR,PROTHROMBIN TIME PROLONGED,1
FR,PRURITUS,1
FR,PULMONARY EMBOLISM,1
FR,PULMONARY FIBROSIS,1
FR,PURPURA,1
FR,RALES,1
FR,RASH MACULAR,1
FR,RASH MACULO-PAPULAR,1
FR,RASH PRURITIC,1
FR,RECTAL HAEMORRHAGE,1
FR,RED BLOOD CELL COUNT DECREASED,1
FR,RENAL FAILURE CHRONIC,1
FR,RENAL FUNCTION TEST ABNORMAL,1
FR,RENAL TUBULAR DISORDER,1
FR,RESPIRATORY ARREST,1
FR,RESPIRATORY TRACT INFECTION,1
FR,RETINAL DETACHMENT,1
FR,RETINAL HAEMORRHAGE,1
FR,RIB FRACTURE,1
FR,RIGHT VENTRICULAR FAILURE,1
FR,SEROTONIN SYNDROME,1
FR,SHOCK HAEMORRHAGIC,1
FR,SINUS BRADYCARDIA,1
FR,SINUS DISORDER,1
FR,SINUS TACHYCARDIA,1
FR,SKIN DISORDER,1
FR,SKIN ODOUR ABNORMAL,1
FR,SKIN ULCER,1
FR,SPLENIC RUPTURE,1
FR,SQUAMOUS CELL CARCINOMA,1
FR,STAPHYLOCOCCAL ABSCESS,1
FR,SUBCUTANEOUS ABSCESS,1
FR,SUBDURAL HAEMATOMA,1
FR,SUBRETINAL HAEMATOMA,1
FR,SUFFOCATION FEELING,1
FR,SUSPECTED TRANSMISSION OF AN INFECTIOUS AGENT VIA PRODUCT,1
FR,TENDON RUPTURE,1
FR,THROMBOPHLEBITIS SUPERFICIAL,1
FR,THYROXINE INCREASED,1
FR,TONGUE OEDEMA,1
FR,TOOTH ABSCESS,1
FR,TOXIC SKIN ERUPTION,1
FR,TRANSAMINASES ABNORMAL,1
FR,TRANSFUSION,1
FR,TUBULOINTERSTITIAL NEPHRITIS,1
FR,TUMOUR LYSIS SYNDROME,1
FR,UMBILICAL HERNIA,1
FR,UNDERDOSE,1
FR,URINARY TRACT INFECTION,1
FR,URINARY TRACT OBSTRUCTION,1
FR,VENTRICULAR FIBRILLATION,1
FR,VENTRICULAR TACHYCARDIA,1
FR,VERTIGO,1
FR,VISUAL ACUITY REDUCED,1
FR,WOUND,1
FR,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,1
DE,DIARRHOEA,28
DE,FALL,28
DE,DYSPNOEA,22
DE,LOSS OF CONSCIOUSNESS,22
DE,PNEUMONIA,22
DE,ANAEMIA,21
DE,GENERAL PHYSICAL HEALTH DETERIORATION,20
DE,SYNCOPE,19
DE,ACUTE KIDNEY INJURY,18
DE,ASTHENIA,17
DE,NAUSEA,17
DE,RASH,17
DE,RESTLESSNESS,17
DE,PANCYTOPENIA,16
DE,ATRIAL FIBRILLATION,15
DE,DIZZINESS,15
DE,FATIGUE,15
DE,HYPOKALAEMIA,15
DE,RENAL FAILURE,15
DE,DYSARTHRIA,14
DE,HYPONATRAEMIA,13
DE,HYPOTENSION,12
DE,LEFT VENTRICULAR HYPERTROPHY,12
DE,PRESCRIBED UNDERDOSE,12
DE,BRONCHITIS,11
DE,FACIAL NERVE DISORDER,11
DE,MYOCLONUS,11
DE,CARDIAC FAILURE,10
DE,CIRCULATORY COLLAPSE,10
DE,DEHYDRATION,10
DE,VOMITING,10
DE,INFECTION,9
DE,PANCREATITIS,9
DE,PULMONARY EMBOLISM,9
DE,ANGIOEDEMA,8
DE,ARRHYTHMIA,8
DE,BLOOD CREATININE INCREASED,8
DE,CEREBRAL INFARCTION,8
DE,CEREBROVASCULAR ACCIDENT,8
DE,CONSTIPATION,8
DE,HYPERTENSION,8
DE,LUNG INFECTION,8
DE,PYREXIA,8
DE,ABDOMINAL PAIN,7
DE,ACIDOSIS,7
DE,ARTHRALGIA,7
DE,DEEP VEIN THROMBOSIS,7
DE,HYPERKALAEMIA,7
DE,MALAISE,7
DE,PAIN,7
DE,SOMNOLENCE,7
DE,WEIGHT DECREASED,7
DE,BLOOD PRESSURE INCREASED,6
DE,DECREASED APPETITE,6
DE,DYSPHAGIA,6
DE,GENERALISED TONIC-CLONIC SEIZURE,6
DE,LEUKOPENIA,6
DE,PAIN IN EXTREMITY,6
DE,PALPITATIONS,6
DE,PRURITUS,6
DE,SEPSIS,6
DE,SLEEP DISORDER,6
DE,URINARY TRACT INFECTION,6
DE,VISUAL IMPAIRMENT,6
DE,ABDOMINAL PAIN UPPER,5
DE,ASCITES,5
DE,ASPARTATE AMINOTRANSFERASE INCREASED,5
DE,BRADYCARDIA,5
DE,CARDIOVASCULAR DISORDER,5
DE,CEREBRAL HAEMORRHAGE,5
DE,GAMMA-GLUTAMYLTRANSFERASE INCREASED,5
DE,GASTRIC ULCER,5
DE,HEADACHE,5
DE,HYPERHIDROSIS,5
DE,HYPERTENSIVE CRISIS,5
DE,HYPOGLYCAEMIA,5
DE,MOOD ALTERED,5
DE,MYOCARDIAL INFARCTION,5
DE,NASOPHARYNGITIS,5
DE,SLEEP APNOEA SYNDROME,5
DE,THROMBOCYTOPENIA,5
DE,TREMOR,5
DE,ALANINE AMINOTRANSFERASE INCREASED,4
DE,APHASIA,4
DE,ARTHROPATHY,4
DE,BLOOD GLUCOSE INCREASED,4
DE,CHEST DISCOMFORT,4
DE,CHILLS,4
DE,CONCUSSION,4
DE,CONFUSIONAL STATE,4
DE,COUGH,4
DE,DELIRIUM,4
DE,DRUG INEFFECTIVE,4
DE,DRUG-INDUCED LIVER INJURY,4
DE,DYSPNOEA EXERTIONAL,4
DE,EPILEPSY,4
DE,EPISTAXIS,4
DE,ERYTHEMA,4
DE,GAIT DISTURBANCE,4
DE,GASTROINTESTINAL INFLAMMATION,4
DE,HAEMARTHROSIS,4
DE,HAEMOGLOBIN DECREASED,4
DE,HAEMORRHAGIC ANAEMIA,4
DE,IMPAIRED HEALING,4
DE,INFLAMMATION,4
DE,MUSCULOSKELETAL STIFFNESS,4
DE,OEDEMA PERIPHERAL,4
DE,OSTEONECROSIS OF JAW,4
DE,OVERDOSE,4
DE,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,4
DE,SKIN ULCER,4
DE,SNORING,4
DE,SUICIDE ATTEMPT,4
DE,URINARY RETENTION,4
DE,WEIGHT INCREASED,4
DE,ABDOMINAL DISCOMFORT,3
DE,ACCIDENT,3
DE,ACUTE CORONARY SYNDROME,3
DE,AGITATION,3
DE,ATRIOVENTRICULAR BLOCK,3
DE,ATRIOVENTRICULAR BLOCK SECOND DEGREE,3
DE,BACK PAIN,3
DE,BLOOD BILIRUBIN INCREASED,3
DE,BLOOD PRESSURE FLUCTUATION,3
DE,CARDIOVASCULAR INSUFFICIENCY,3
DE,CAROTID ARTERY OCCLUSION,3
DE,CHEST PAIN,3
DE,CHROMATURIA,3
DE,COMPLETED SUICIDE,3
DE,CONDITION AGGRAVATED,3
DE,CONVULSION,3
DE,CYSTITIS,3
DE,DEATH,3
DE,DRUG PRESCRIBING ERROR,3
DE,DRUG TOLERANCE DECREASED,3
DE,DYSPHONIA,3
DE,DYSURIA,3
DE,FEELING ABNORMAL,3
DE,FEMUR FRACTURE,3
DE,FUNGAL INFECTION,3
DE,GASTROINTESTINAL DISORDER,3
DE,GASTROINTESTINAL HAEMORRHAGE,3
DE,GENERALISED OEDEMA,3
DE,GLOMERULAR FILTRATION RATE DECREASED,3
DE,HAEMATEMESIS,3
DE,HAEMATURIA,3
DE,HAEMORRHAGE,3
DE,HEMIPARESIS,3
DE,HEPATIC ENZYME INCREASED,3
DE,INTERVERTEBRAL DISC PROTRUSION,3
DE,IRON OVERLOAD,3
DE,ISCHAEMIC STROKE,3
DE,JAUNDICE,3
DE,JOINT SWELLING,3
DE,MALIGNANT NEOPLASM PROGRESSION,3
DE,MELAENA,3
DE,METABOLIC ACIDOSIS,3
DE,METASTASES TO LUNG,3
DE,MUSCLE SPASMS,3
DE,MUSCULOSKELETAL PAIN,3
DE,MYELODYSPLASTIC SYNDROME,3
DE,MYOPATHY,3
DE,NIGHT SWEATS,3
DE,NON-HODGKIN^S LYMPHOMA,3
DE,NON-HODGKIN^S LYMPHOMA RECURRENT,3
DE,OCULAR HYPERAEMIA,3
DE,OSTEOARTHRITIS,3
DE,PARAESTHESIA,3
DE,PERITONITIS,3
DE,PLEURAL EFFUSION,3
DE,PNEUMONIA BACTERIAL,3
DE,PRODUCTIVE COUGH,3
DE,PROSTATE CANCER,3
DE,RENAL CYST,3
DE,RENAL FUNCTION TEST ABNORMAL,3
DE,RESPIRATION ABNORMAL,3
DE,RESPIRATORY TRACT INFECTION,3
DE,SEIZURE,3
DE,SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS,3
DE,SWELLING FACE,3
DE,SWOLLEN TONGUE,3
DE,TACHYCARDIA,3
DE,TENDON RUPTURE,3
DE,THYROID MASS,3
DE,TOXICITY TO VARIOUS AGENTS,3
DE,VERTIGO,3
DE,WHITE BLOOD CELL COUNT INCREASED,3
DE,ABSCESS,2
DE,ACCIDENTAL EXPOSURE TO PRODUCT,2
DE,ACUTE HEPATIC FAILURE,2
DE,ACUTE MYOCARDIAL INFARCTION,2
DE,AGGRESSION,2
DE,ALOPECIA,2
DE,AMYLASE INCREASED,2
DE,ANAPHYLACTIC SHOCK,2
DE,ANGINA PECTORIS,2
DE,ASPIRATION,2
DE,ATYPICAL PNEUMONIA,2
DE,AUTOIMMUNE HEPATITIS,2
DE,BLOOD ALKALINE PHOSPHATASE INCREASED,2
DE,BLOOD GLUCOSE DECREASED,2
DE,BLOOD LACTATE DEHYDROGENASE INCREASED,2
DE,BLOOD PRESSURE DIASTOLIC DECREASED,2
DE,BLOOD UREA INCREASED,2
DE,BLOOD URINE PRESENT,2
DE,BONE LOSS,2
DE,BREAST CANCER,2
DE,BRONCHOPNEUMONIA,2
DE,CARDIAC ARREST,2
DE,CARDIAC DISORDER,2
DE,CARDIAC FAILURE ACUTE,2
DE,CAROTID ARTERY STENOSIS,2
DE,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,2
DE,COMMUNICATION DISORDER,2
DE,CONJUNCTIVAL HAEMORRHAGE,2
DE,CREATININE RENAL CLEARANCE DECREASED,2
DE,CROHN^S DISEASE,2
DE,DELUSION,2
DE,DEPRESSED LEVEL OF CONSCIOUSNESS,2
DE,DIABETES MELLITUS,2
DE,DISTURBANCE IN ATTENTION,2
DE,DUODENAL ULCER,2
DE,DYSGEUSIA,2
DE,EAR DISORDER,2
DE,EAR PAIN,2
DE,EMBOLISM,2
DE,ERUCTATION,2
DE,ERYSIPELAS,2
DE,EXTRASYSTOLES,2
DE,EYE HAEMORRHAGE,2
DE,EYE PAIN,2
DE,FEMALE GENITAL TRACT FISTULA,2
DE,FLATULENCE,2
DE,GASTROINTESTINAL INFECTION,2
DE,GASTROOESOPHAGEAL REFLUX DISEASE,2
DE,HAEMATOCHEZIA,2
DE,HAEMATOMA,2
DE,HEART RATE DECREASED,2
DE,HELICOBACTER GASTRITIS,2
DE,HEPATIC CIRRHOSIS,2
DE,HEPATIC STEATOSIS,2
DE,HUMERUS FRACTURE,2
DE,HYDRONEPHROSIS,2
DE,HYPERGLYCAEMIA,2
DE,HYPERSENSITIVITY VASCULITIS,2
DE,ILEUS,2
DE,IMMOBILE,2
DE,INCORRECT DOSE ADMINISTERED,2
DE,INFLAMMATORY MARKER INCREASED,2
DE,INSOMNIA,2
DE,INTENTIONAL OVERDOSE,2
DE,INTESTINAL ISCHAEMIA,2
DE,INTESTINAL STENOSIS,2
DE,INTRAOCULAR PRESSURE INCREASED,2
DE,INTRAVENTRICULAR HAEMORRHAGE,2
DE,ISCHAEMIC CEREBRAL INFARCTION,2
DE,JOINT INJURY,2
DE,LIP SWELLING,2
DE,LIPASE INCREASED,2
DE,LOWER GASTROINTESTINAL HAEMORRHAGE,2
DE,MANIA,2
DE,MENINGITIS,2
DE,MENTAL DISORDER,2
DE,METASTASES TO BONE,2
DE,MOBILITY DECREASED,2
DE,MUCOUS STOOLS,2
DE,MYALGIA,2
DE,NEUTROPENIA,2
DE,NON-CARDIAC CHEST PAIN,2
DE,OEDEMA,2
DE,OESOPHAGEAL DISCOMFORT,2
DE,OESOPHAGITIS,2
DE,OTITIS MEDIA,2
DE,PALLOR,2
DE,PANCREATIC DISORDER,2
DE,PANCREATITIS ACUTE,2
DE,PANIC ATTACK,2
DE,PARONYCHIA,2
DE,PLASMA CELL MYELOMA,2
DE,PLATELET COUNT DECREASED,2
DE,PLATELET COUNT INCREASED,2
DE,POLYNEUROPATHY,2
DE,POLYSEROSITIS,2
DE,PSORIASIS,2
DE,PULMONARY MASS,2
DE,PULMONARY OEDEMA,2
DE,RECTAL STENOSIS,2
DE,RENAL CANCER,2
DE,RENAL COLIC,2
DE,RENAL IMPAIRMENT,2
DE,RESPIRATORY FAILURE,2
DE,RHABDOMYOLYSIS,2
DE,RHEUMATIC DISORDER,2
DE,RHEUMATOID NODULE,2
DE,RIB FRACTURE,2
DE,SEPTIC SHOCK,2
DE,SHOCK,2
DE,SKIN EXFOLIATION,2
DE,SPEECH DISORDER,2
DE,SPONDYLOLISTHESIS,2
DE,SQUAMOUS CELL CARCINOMA OF SKIN,2
DE,SUBARACHNOID HAEMORRHAGE,2
DE,SUBDURAL HAEMATOMA,2
DE,TACHYPNOEA,2
DE,THORACIC VERTEBRAL FRACTURE,2
DE,THROMBOSIS,2
DE,TRANSIENT ISCHAEMIC ATTACK,2
DE,TYPE 2 DIABETES MELLITUS,2
DE,UPPER RESPIRATORY TRACT INFECTION,2
DE,URINARY TRACT OBSTRUCTION,2
DE,UROSEPSIS,2
DE,URTICARIA,2
DE,VENTRICULAR EXTRASYSTOLES,2
DE,VISION BLURRED,2
DE,VISUAL ACUITY REDUCED,2
DE,VISUAL FIELD DEFECT,2
DE,VITILIGO,2
DE,ABASIA,1
DE,ABDOMINAL HERNIA,1
DE,ABDOMINAL PAIN LOWER,1
DE,ABSCESS LIMB,1
DE,ACCIDENTAL OVERDOSE,1
DE,ACTINIC KERATOSIS,1
DE,ACTINOMYCOSIS,1
DE,ACTIVITIES OF DAILY LIVING IMPAIRED,1
DE,ACUTE PRERENAL FAILURE,1
DE,ACUTE RESPIRATORY FAILURE,1
DE,ACUTE STRESS DISORDER,1
DE,ADVERSE EVENT,1
DE,AGEUSIA,1
DE,ALVEOLITIS,1
DE,ANAEMIA MACROCYTIC,1
DE,ANAEMIA OF MALIGNANT DISEASE,1
DE,ANAL ABSCESS,1
DE,ANAL FISTULA,1
DE,ANAL HAEMORRHAGE,1
DE,ANAL INFLAMMATION,1
DE,ANAL STENOSIS,1
DE,ANASTOMOTIC COMPLICATION,1
DE,ANEURYSM RUPTURED,1
DE,ANOSMIA,1
DE,ANTIBODY TEST POSITIVE,1
DE,ANXIETY,1
DE,AORTIC ANEURYSM,1
DE,AORTIC VALVE STENOSIS,1
DE,APATHY,1
DE,APHAGIA,1
DE,APHTHOUS STOMATITIS,1
DE,APPLICATION SITE ERYTHEMA,1
DE,APPLICATION SITE PAIN,1
DE,APPLICATION SITE PRURITUS,1
DE,APRAXIA,1
DE,ARTERIAL HAEMORRHAGE,1
DE,ARTERIAL OCCLUSIVE DISEASE,1
DE,ARTERIAL STENOSIS,1
DE,ARTERIOSCLEROSIS CORONARY ARTERY,1
DE,ARTERIOSPASM CORONARY,1
DE,ARTHROPOD STING,1
DE,ASTHMA,1
DE,ATRIOVENTRICULAR BLOCK COMPLETE,1
DE,AVERSION,1
DE,B-CELL LYMPHOMA RECURRENT,1
DE,BACTERIAL DISEASE CARRIER,1
DE,BACTERIAL SEPSIS,1
DE,BACTERIURIA,1
DE,BASAL CELL CARCINOMA,1
DE,BASAL GANGLIA HAEMORRHAGE,1
DE,BASOPHIL COUNT INCREASED,1
DE,BENIGN NEOPLASM,1
DE,BENIGN PROSTATIC HYPERPLASIA,1
DE,BILIARY DILATATION,1
DE,BILIRUBIN CONJUGATED INCREASED,1
DE,BIOPSY TRACHEA,1
DE,BIOPSY VAGINA,1
DE,BIPOLAR DISORDER,1
DE,BLADDER CANCER,1
DE,BLADDER TRANSITIONAL CELL CARCINOMA,1
DE,BLOOD ALBUMIN DECREASED,1
DE,BLOOD CALCIUM DECREASED,1
DE,BLOOD CHOLESTEROL INCREASED,1
DE,BLOOD CREATINE PHOSPHOKINASE INCREASED,1
DE,BLOOD CREATININE DECREASED,1
DE,BLOOD POTASSIUM INCREASED,1
DE,BLOOD PRESSURE DECREASED,1
DE,BLOOD SODIUM DECREASED,1
DE,BODY TEMPERATURE INCREASED,1
DE,BRAIN DEATH,1
DE,BRAIN NEOPLASM,1
DE,BREAST CANCER STAGE II,1
DE,BREAST PAIN,1
DE,BRONCHITIS BACTERIAL,1
DE,BURNING SENSATION,1
DE,C-REACTIVE PROTEIN INCREASED,1
DE,CACHEXIA,1
DE,CALCULUS URETERIC,1
DE,CARDIAC FLUTTER,1
DE,CARDIAC VALVE DISEASE,1
DE,CARDIOGENIC SHOCK,1
DE,CARDIOMYOPATHY,1
DE,CARPAL TUNNEL SYNDROME,1
DE,CATHETERISATION CARDIAC,1
DE,CELLULITIS ORBITAL,1
DE,CEREBRAL ARTERY OCCLUSION,1
DE,CEREBRAL ISCHAEMIA,1
DE,CEREBRAL SARCOIDOSIS,1
DE,CERVICAL VERTEBRAL FRACTURE,1
DE,CHEILITIS,1
DE,CHOLECYSTITIS,1
DE,CHOLELITHIASIS,1
DE,CHRONIC MYELOID LEUKAEMIA,1
DE,CHRONIC MYELOMONOCYTIC LEUKAEMIA,1
DE,CLOSTRIDIUM DIFFICILE COLITIS,1
DE,CLOSTRIDIUM DIFFICILE INFECTION,1
DE,COGNITIVE DISORDER,1
DE,COLITIS,1
DE,COLITIS ULCERATIVE,1
DE,COLON ADENOMA,1
DE,COLON CANCER,1
DE,COMPARTMENT SYNDROME,1
DE,CONJUNCTIVITIS,1
DE,CONTUSION,1
DE,CORONARY ARTERIAL STENT INSERTION,1
DE,CORONARY ARTERY DISEASE,1
DE,CYANOSIS,1
DE,CYSTITIS NONINFECTIVE,1
DE,DEAFNESS,1
DE,DEFAECATION URGENCY,1
DE,DEMENTIA,1
DE,DEMYELINATION,1
DE,DEPRESSION,1
DE,DERMAL CYST,1
DE,DERMATITIS,1
DE,DERMATITIS ALLERGIC,1
DE,DERMATITIS ATOPIC,1
DE,DERMATITIS BULLOUS,1
DE,DIABETES MELLITUS INADEQUATE CONTROL,1
DE,DIABETIC ULCER,1
DE,DISCOMFORT,1
DE,DISORIENTATION,1
DE,DIVERTICULITIS,1
DE,DIVERTICULUM,1
DE,DRUG ADMINISTRATION ERROR,1
DE,DRUG EFFECT DECREASED,1
DE,DRUG ERUPTION,1
DE,DRUG WITHDRAWAL SYNDROME,1
DE,DRY MOUTH,1
DE,DUODENAL PERFORATION,1
DE,DUODENAL ULCER HAEMORRHAGE,1
DE,DUODENITIS,1
DE,DYSGRAPHIA,1
DE,DYSPEPSIA,1
DE,EAR TUBE INSERTION,1
DE,ECZEMA,1
DE,EJECTION FRACTION ABNORMAL,1
DE,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,1
DE,EMBOLIC STROKE,1
DE,ENCEPHALITIS,1
DE,ENCEPHALOPATHY,1
DE,ENDOCARDITIS,1
DE,ENDOSCOPY UPPER GASTROINTESTINAL TRACT,1
DE,ENERGY INCREASED,1
DE,ENTEROCOCCAL INFECTION,1
DE,EPSTEIN-BARR VIRUS INFECTION,1
DE,ESCHERICHIA INFECTION,1
DE,ESCHERICHIA URINARY TRACT INFECTION,1
DE,EXERCISE TOLERANCE DECREASED,1
DE,EYE INFLAMMATION,1
DE,EYE IRRITATION,1
DE,EYE PRURITUS,1
DE,EYE SWELLING,1
DE,FACE INJURY,1
DE,FACET JOINT SYNDROME,1
DE,FACIAL PARESIS,1
DE,FAECAL CALPROTECTIN INCREASED,1
DE,FAECES PALE,1
DE,FEAR,1
DE,FEBRILE INFECTION,1
DE,FEBRILE NEUTROPENIA,1
DE,FLANK PAIN,1
DE,FLUID INTAKE REDUCED,1
DE,FLUSHING,1
DE,FOOD AVERSION,1
DE,FOOT DEFORMITY,1
DE,FOOT FRACTURE,1
DE,FORCED EXPIRATORY VOLUME DECREASED,1
DE,FOREIGN BODY,1
DE,FRACTURE,1
DE,FREQUENT BOWEL MOVEMENTS,1
DE,FUNGAL OESOPHAGITIS,1
DE,GALLBLADDER DISORDER,1
DE,GASTRIC PERFORATION,1
DE,GASTRIC ULCER HAEMORRHAGE,1
DE,GASTRITIS,1
DE,GASTRITIS EROSIVE,1
DE,GASTROENTERITIS,1
DE,GASTROINTESTINAL MUCOSAL DISORDER,1
DE,GASTROINTESTINAL NECROSIS,1
DE,GASTROINTESTINAL STOMA COMPLICATION,1
DE,GASTROINTESTINAL WALL THICKENING,1
DE,GENE MUTATION,1
DE,GENERAL PHYSICAL CONDITION ABNORMAL,1
DE,GINGIVITIS,1
DE,GLAUCOMA,1
DE,GLOMERULAR FILTRATION RATE INCREASED,1
DE,GLOSSITIS,1
DE,GLYCOSURIA,1
DE,GLYCOSYLATED HAEMOGLOBIN INCREASED,1
DE,GOUT,1
DE,GRANULOMA,1
DE,HAEMATOTOXICITY,1
DE,HAEMODYNAMIC INSTABILITY,1
DE,HAEMORRHAGE INTRACRANIAL,1
DE,HAEMORRHAGIC PNEUMONIA,1
DE,HAEMORRHAGIC STROKE,1
DE,HAEMORRHOIDAL HAEMORRHAGE,1
DE,HAEMORRHOIDS,1
DE,HALLUCINATION,1
DE,HAND DEFORMITY,1
DE,HAPTOGLOBIN DECREASED,1
DE,HEAD BANGING,1
DE,HEAD DISCOMFORT,1
DE,HEAD INJURY,1
DE,HEART VALVE INCOMPETENCE,1
DE,HEPATIC ADENOMA,1
DE,HEPATIC CYST,1
DE,HEPATIC FAILURE,1
DE,HEPATIC FIBROSIS,1
DE,HEPATITIS,1
DE,HEPATITIS CHOLESTATIC,1
DE,HEPATOMEGALY,1
DE,HEPATORENAL SYNDROME,1
DE,HERNIA OBSTRUCTIVE,1
DE,HERPES ZOSTER,1
DE,HOMICIDAL IDEATION,1
DE,HYDROCELE,1
DE,HYDROCEPHALUS,1
DE,HYDROCHOLECYSTIS,1
DE,HYPERCORTICOIDISM,1
DE,HYPERKINESIA,1
DE,HYPERSENSITIVITY,1
DE,HYPOACUSIS,1
DE,HYPOAESTHESIA,1
DE,HYPOALBUMINAEMIA,1
DE,HYPOKINESIA,1
DE,HYPOPITUITARISM,1
DE,HYPOTHERMIA,1
DE,IMPAIRED QUALITY OF LIFE,1
DE,INCISIONAL HERNIA,1
DE,INCORRECT DOSAGE ADMINISTERED,1
DE,INCORRECT ROUTE OF DRUG ADMINISTRATION,1
DE,INFECTIOUS PLEURAL EFFUSION,1
DE,INFECTIVE EXACERBATION OF CHRONIC OBSTRUCTIVE AIRWAYS DISEASE,1
DE,INFLUENZA LIKE ILLNESS,1
DE,INJECTION SITE ABSCESS,1
DE,INJECTION SITE HAEMATOMA,1
DE,INJURY,1
DE,INTENTIONAL PRODUCT USE ISSUE,1
DE,INTERNATIONAL NORMALISED RATIO INCREASED,1
DE,INTERSTITIAL LUNG DISEASE,1
DE,INTESTINAL PERFORATION,1
DE,INTESTINAL POLYP,1
DE,INTRACARDIAC THROMBUS,1
DE,INTRACRANIAL VENOUS SINUS THROMBOSIS,1
DE,INTRADUCTAL PAPILLARY MUCINOUS NEOPLASM,1
DE,IRITIS,1
DE,IRON DEFICIENCY,1
DE,KETOACIDOSIS,1
DE,KNEE DEFORMITY,1
DE,LACERATION,1
DE,LEFT VENTRICULAR DYSFUNCTION,1
DE,LEIOMYOMA,1
DE,LEUKOCYTOSIS,1
DE,LEUKOCYTURIA,1
DE,LICHEN SCLEROSUS,1
DE,LIMB DISCOMFORT,1
DE,LIMB OPERATION,1
DE,LIVER ABSCESS,1
DE,LIVER DISORDER,1
DE,LIVER FUNCTION TEST ABNORMAL,1
DE,LIVER FUNCTION TEST INCREASED,1
DE,LIVER INJURY,1
DE,LOCALISED INTRAABDOMINAL FLUID COLLECTION,1
DE,LOWER LIMB FRACTURE,1
DE,LUMBAR SPINAL STENOSIS,1
DE,LYMPHOCYTE PERCENTAGE DECREASED,1
DE,MAJOR DEPRESSION,1
DE,MALIGNANT NEOPLASM OF UNKNOWN PRIMARY SITE,1
DE,MEAN CELL HAEMOGLOBIN CONCENTRATION INCREASED,1
DE,MEDICATION ERROR,1
DE,MENINGEAL DISORDER,1
DE,MENISCAL DEGENERATION,1
DE,MESENTERIC ARTERY THROMBOSIS,1
DE,METABOLIC DISORDER,1
DE,METASTASIS,1
DE,METEOROPATHY,1
DE,MITRAL VALVE INCOMPETENCE,1
DE,MONOCYTE PERCENTAGE INCREASED,1
DE,MUCOSAL INFLAMMATION,1
DE,MULTIPLE ORGAN DYSFUNCTION SYNDROME,1
DE,MULTIPLE SCLEROSIS RELAPSE,1
DE,MUSCLE HAEMORRHAGE,1
DE,MUSCULAR WEAKNESS,1
DE,MUSCULOSKELETAL DISCOMFORT,1
DE,MYCOBACTERIUM TUBERCULOSIS COMPLEX TEST POSITIVE,1
DE,MYOCARDITIS,1
DE,MYOGLOBIN BLOOD INCREASED,1
DE,MYOSITIS,1
DE,NAIL DISORDER,1
DE,NERVOUSNESS,1
DE,NEUROENDOCRINE CARCINOMA,1
DE,NEUROPATHIC ULCER,1
DE,NEUTROPENIC COLITIS,1
DE,NEUTROPENIC INFECTION,1
DE,NEUTROPHIL COUNT INCREASED,1
DE,NIGHTMARE,1
DE,NON-SMALL CELL LUNG CANCER STAGE IIIB,1
DE,OBSESSIVE RUMINATION,1
DE,OESOPHAGEAL ADENOCARCINOMA,1
DE,OESOPHAGITIS ULCERATIVE,1
DE,OLIGURIA,1
DE,ORAL CANDIDIASIS,1
DE,ORAL DISORDER,1
DE,ORTHOSTATIC HYPERTENSION,1
DE,OSTEITIS,1
DE,OSTEOMYELITIS CHRONIC,1
DE,OSTEONECROSIS,1
DE,OSTEOSCLEROSIS,1
DE,OVARIAN ADENOMA,1
DE,PAIN IN JAW,1
DE,PANCREATIC CARCINOMA,1
DE,PANCREATIC CARCINOMA METASTATIC,1
DE,PANCREATIC CARCINOMA STAGE II,1
DE,PANCREATIC CYST,1
DE,PARAESTHESIA EAR,1
DE,PARALYSIS,1
DE,PARANOIA,1
DE,PARATHYROIDECTOMY,1
DE,PARESIS,1
DE,PARKINSONIAN GAIT,1
DE,PARKINSON^S DISEASE,1
DE,PARTIAL SEIZURES,1
DE,PEAK EXPIRATORY FLOW RATE DECREASED,1
DE,PENILE OEDEMA,1
DE,PERICARDIAL EFFUSION,1
DE,PERICARDITIS,1
DE,PERINEPHRIC ABSCESS,1
DE,PERIPHERAL ARTERIAL OCCLUSIVE DISEASE,1
DE,PERIPHERAL ARTERY STENOSIS,1
DE,PERIPHERAL COLDNESS,1
DE,PERIPHERAL SENSORY NEUROPATHY,1
DE,PERIPHERAL SWELLING,1
DE,PERIPHERAL VASCULAR DISORDER,1
DE,PERITONEAL ADHESIONS,1
DE,PERITONITIS BACTERIAL,1
DE,PHYSICAL DISABILITY,1
DE,PITUITARY TUMOUR BENIGN,1
DE,PITUITARY TUMOUR RECURRENT,1
DE,PITUITARY-DEPENDENT CUSHING^S SYNDROME,1
DE,PNEUMONIA ASPIRATION,1
DE,PNEUMONIA KLEBSIELLA,1
DE,POLLAKIURIA,1
DE,POLYDIPSIA,1
DE,POLYPECTOMY,1
DE,POLYURIA,1
DE,POST PROCEDURAL SEPSIS,1
DE,POSTOPERATIVE RESPIRATORY FAILURE,1
DE,POSTRENAL FAILURE,1
DE,PRECANCEROUS SKIN LESION,1
DE,PRESYNCOPE,1
DE,PROCEDURAL COMPLICATION,1
DE,PRODUCT QUALITY ISSUE,1
DE,PRODUCT USE IN UNAPPROVED INDICATION,1
DE,PRODUCT USE ISSUE,1
DE,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,1
DE,PROSTATE CANCER METASTATIC,1
DE,PROSTATIC DISORDER,1
DE,PROTEIN TOTAL DECREASED,1
DE,PROTHROMBIN TIME PROLONGED,1
DE,PROTHROMBIN TIME SHORTENED,1
DE,PSEUDARTHROSIS,1
DE,PSOAS ABSCESS,1
DE,PSORIATIC ARTHROPATHY,1
DE,PULMONARY ARTERIAL HYPERTENSION,1
DE,PULMONARY FIBROSIS,1
DE,PUSTULAR PSORIASIS,1
DE,PYLORIC STENOSIS,1
DE,RADICULOPATHY,1
DE,RADIUS FRACTURE,1
DE,RASH GENERALISED,1
DE,RECTAL ABSCESS,1
DE,RED BLOOD CELL SEDIMENTATION RATE ABNORMAL,1
DE,RENAL CYST HAEMORRHAGE,1
DE,RENAL FAILURE ACUTE,1
DE,RESPIRATORY DISORDER,1
DE,RESPIRATORY DISTRESS,1
DE,RESTRICTIVE CARDIOMYOPATHY,1
DE,RETINAL VEIN THROMBOSIS,1
DE,RETROPERITONEAL HAEMATOMA,1
DE,RHEUMATOID ARTHRITIS,1
DE,RHEUMATOID LUNG,1
DE,ROAD TRAFFIC ACCIDENT,1
DE,ROSACEA,1
DE,SALIVA ALTERED,1
DE,SARCOIDOSIS,1
DE,SCREAMING,1
DE,SERUM FERRITIN INCREASED,1
DE,SINUS TACHYCARDIA,1
DE,SINUSITIS,1
DE,SKIN CANCER,1
DE,SKIN DISORDER,1
DE,SKIN INJURY,1
DE,SKIN REACTION,1
DE,SKIN SWELLING,1
DE,SKIN TOXICITY,1
DE,SPINAL FRACTURE,1
DE,SPINAL OSTEOARTHRITIS,1
DE,SPLENIC RUPTURE,1
DE,SPLENOMEGALY,1
DE,SPUR CELL ANAEMIA,1
DE,SQUAMOUS CELL CARCINOMA,1
DE,STENT PLACEMENT,1
DE,STRESS CARDIOMYOPATHY,1
DE,STUPOR,1
DE,SUBILEUS,1
DE,SUBSTANCE ABUSE,1
DE,SUDDEN DEATH,1
DE,SUDDEN HEARING LOSS,1
DE,SUICIDAL IDEATION,1
DE,SWELLING,1
DE,SYSTEMIC LUPUS ERYTHEMATOSUS,1
DE,TENDON PAIN,1
DE,TENSION,1
DE,TERMINAL STATE,1
DE,THROMBOPHLEBITIS,1
DE,THROMBOSIS IN DEVICE,1
DE,THYROID CANCER,1
DE,THYROID FUNCTION TEST ABNORMAL,1
DE,TINNITUS,1
DE,TOXIC EPIDERMAL NECROLYSIS,1
DE,TRACHEAL OEDEMA,1
DE,TRANSFUSION,1
DE,TRANSPLANT DYSFUNCTION,1
DE,TRANSPLANT FAILURE,1
DE,TRAUMATIC HAEMATOMA,1
DE,TRI-IODOTHYRONINE DECREASED,1
DE,TROPONIN INCREASED,1
DE,ULCER,1
DE,ULCERATIVE KERATITIS,1
DE,UPPER RESPIRATORY FUNGAL INFECTION,1
DE,URETERIC HAEMORRHAGE,1
DE,URETHRITIS NONINFECTIVE,1
DE,URINARY HESITATION,1
DE,UVEITIS,1
DE,VASCULITIS CEREBRAL,1
DE,VENOUS HAEMORRHAGE,1
DE,VENOUS OCCLUSION,1
DE,VENOUS THROMBOSIS,1
DE,VENTRICULAR ARRHYTHMIA,1
DE,VENTRICULAR FIBRILLATION,1
DE,VITAL CAPACITY DECREASED,1
DE,VITH NERVE PARALYSIS,1
DE,VOCAL CORD PARALYSIS,1
DE,WHEEZING,1
DE,WHITE MATTER LESION,1
DE,WOUND,1
DE,WOUND SECRETION,1
DE,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,1
GH,JAUNDICE,1
GR,DYSPNOEA,2
GR,HYPERKALAEMIA,2
GR,OEDEMA PERIPHERAL,2
GR,PROTEINURIA,2
GR,RENAL IMPAIRMENT,2
GR,ACUTE MYOCARDIAL INFARCTION,1
GR,AGEUSIA,1
GR,ANURIA,1
GR,BLOOD POTASSIUM INCREASED,1
GR,BLOOD PRESSURE SYSTOLIC DECREASED,1
GR,BLOOD SODIUM DECREASED,1
GR,BLOOD UREA INCREASED,1
GR,BUTTERFLY RASH,1
GR,CARDIAC ARREST,1
GR,CARDIAC FAILURE CONGESTIVE,1
GR,CEREBRAL ISCHAEMIA,1
GR,CONDITION AGGRAVATED,1
GR,CONTRAINDICATED DRUG ADMINISTERED,1
GR,DYSPNOEA EXERTIONAL,1
GR,EXOSTOSIS OF JAW,1
GR,EXPOSED BONE IN JAW,1
GR,FISTULA,1
GR,GAIT DISTURBANCE,1
GR,GLOMERULAR FILTRATION RATE DECREASED,1
GR,GLOMERULONEPHRITIS,1
GR,HAEMATURIA,1
GR,HEPATIC ENZYME INCREASED,1
GR,HYPERCALCAEMIA,1
GR,HYPOTENSION,1
GR,LOW CARDIAC OUTPUT SYNDROME,1
GR,LUPUS NEPHRITIS,1
GR,METABOLIC ACIDOSIS,1
GR,OSTEONECROSIS OF JAW,1
GR,PALPITATIONS,1
GR,RENAL ARTERY STENOSIS,1
GR,RENAL FAILURE,1
GR,TACHYARRHYTHMIA,1
GR,URINE OUTPUT DECREASED,1
GR,WEIGHT INCREASED,1
GU,DIARRHOEA,1
GU,RASH,1
GT,MALAISE,1
GT,PARALYSIS,1
HK,OVERDOSE,10
HK,SHOCK,10
HK,HYPOTENSION,4
HK,CARDIOTOXICITY,3
HK,TOXICITY TO VARIOUS AGENTS,2
HK,ABDOMINAL DISTENSION,1
HK,ABORTION MISSED,1
HK,APLASIA PURE RED CELL,1
HK,CARDIAC ARREST,1
HK,CEREBRAL ARTERY THROMBOSIS,1
HK,CEREBRAL INFARCTION,1
HK,CEREBROVASCULAR ACCIDENT,1
HK,CIRCULATORY COLLAPSE,1
HK,DEEP VEIN THROMBOSIS,1
HK,DEHYDRATION,1
HK,DIZZINESS,1
HK,DYSPNOEA,1
HK,EXPOSURE DURING PREGNANCY,1
HK,HAEMATURIA,1
HK,HEMIPLEGIA,1
HK,HEPARIN-INDUCED THROMBOCYTOPENIA,1
HK,INTENTIONAL OVERDOSE,1
HK,LUNG CONSOLIDATION,1
HK,MYOCARDIAL ISCHAEMIA,1
HK,NAUSEA,1
HK,OEDEMA PERIPHERAL,1
HK,ORTHOPNOEA,1
HK,PERIPHERAL SWELLING,1
HK,SOMNOLENCE,1
HK,URINARY RETENTION,1
HK,VOMITING,1
HU,ACUTE MYOCARDIAL INFARCTION,3
HU,BLOOD CREATINE PHOSPHOKINASE INCREASED,3
HU,BLOOD PRESSURE INCREASED,3
HU,CHEST PAIN,3
HU,HYPERHIDROSIS,3
HU,VENTRICULAR FIBRILLATION,3
HU,ALOPECIA,1
HU,CARDIAC FAILURE,1
HU,CARDIOMEGALY,1
HU,COLON CANCER METASTATIC,1
HU,DIARRHOEA,1
HU,DRY MOUTH,1
HU,EPILEPSY,1
HU,ERYTHEMA MULTIFORME,1
HU,HAEMORRHAGE,1
HU,HIATUS HERNIA,1
HU,HYPERKERATOSIS,1
HU,HYPOAESTHESIA,1
HU,ILIAC ARTERY OCCLUSION,1
HU,MALAISE,1
HU,MYALGIA,1
HU,PAIN IN EXTREMITY,1
HU,PULMONARY CONGESTION,1
HU,PYREXIA,1
HU,RASH,1
HU,RASH GENERALISED,1
HU,SEPSIS,1
HU,SUNBURN,1
HU,VOMITING,1
IN,RENAL IMPAIRMENT,2
IN,ABDOMINAL PAIN,1
IN,ACUTE KIDNEY INJURY,1
IN,BLADDER CANCER,1
IN,BLOOD PRESSURE FLUCTUATION,1
IN,BLOOD URINE PRESENT,1
IN,CHRONIC KIDNEY DISEASE,1
IN,CONCOMITANT DISEASE PROGRESSION,1
IN,DIABETES MELLITUS,1
IN,DRUG INEFFECTIVE,1
IN,DYSPNOEA,1
IN,FLANK PAIN,1
IN,HAEMATOCHEZIA,1
IN,INTERSTITIAL LUNG DISEASE,1
IN,LEFT VENTRICULAR FAILURE,1
IN,MYOCARDIAL ISCHAEMIA,1
IN,NAUSEA,1
IN,OVERLAP SYNDROME,1
IN,PROTEINURIA,1
IN,RENAL FAILURE ACUTE,1
IN,RENAL FAILURE CHRONIC,1
IN,RESPIRATORY DISTRESS,1
IN,STAPHYLOCOCCAL INFECTION,1
IN,URINARY TRACT INFECTION,1
IN,URINE OUTPUT DECREASED,1
IN,VENTRICULAR HYPOKINESIA,1
IR,DYSARTHRIA,1
IR,DYSPHAGIA,1
IR,FEAR OF DISEASE,1
IR,HYPOTENSION,1
IQ,CEREBRAL HAEMORRHAGE,1
IQ,CEREBROVASCULAR ACCIDENT,1
IQ,CHOKING SENSATION,1
IQ,HYPERTENSION,1
IQ,INFLUENZA,1
IQ,NERVOUSNESS,1
IQ,OROPHARYNGEAL PAIN,1
IE,TOXICITY TO VARIOUS AGENTS,10
IE,DECREASED APPETITE,9
IE,DIARRHOEA,8
IE,NEUROMYOPATHY,8
IE,ACUTE KIDNEY INJURY,7
IE,FALL,7
IE,DEATH,5
IE,MUSCULAR WEAKNESS,4
IE,CHEST DISCOMFORT,3
IE,DEPRESSED MOOD,3
IE,DUODENAL ULCER PERFORATION,3
IE,DYSPNOEA,3
IE,GASTRITIS,3
IE,INTESTINAL DIAPHRAGM DISEASE,3
IE,IRON DEFICIENCY ANAEMIA,3
IE,MYOCARDIAL INFARCTION,3
IE,ANXIETY,2
IE,CHEST PAIN,2
IE,DEHYDRATION,2
IE,DUODENITIS,2
IE,INTENTIONAL OVERDOSE,2
IE,INTESTINAL PERFORATION,2
IE,IRRITABILITY,2
IE,OESOPHAGITIS,2
IE,PANIC ATTACK,2
IE,STATUS EPILEPTICUS,2
IE,ABDOMINAL PAIN LOWER,1
IE,ALANINE AMINOTRANSFERASE INCREASED,1
IE,ANURIA,1
IE,ASPIRATION JOINT,1
IE,AXONAL NEUROPATHY,1
IE,BALANCE DISORDER,1
IE,BLOOD ALKALINE PHOSPHATASE INCREASED,1
IE,BLOOD CREATINE PHOSPHOKINASE INCREASED,1
IE,BLOOD CREATININE INCREASED,1
IE,BLOOD POTASSIUM INCREASED,1
IE,BLOOD PRESSURE INADEQUATELY CONTROLLED,1
IE,BLOOD UREA INCREASED,1
IE,BLOOD URIC ACID INCREASED,1
IE,BLOOD URINE PRESENT,1
IE,BUNDLE BRANCH BLOCK RIGHT,1
IE,C-REACTIVE PROTEIN INCREASED,1
IE,CARDIAC ARREST,1
IE,CARDIAC DISORDER,1
IE,CEREBRAL DISORDER,1
IE,CEREBRAL HAEMORRHAGE,1
IE,CEREBRAL ISCHAEMIA,1
IE,CHRONIC LYMPHOCYTIC LEUKAEMIA,1
IE,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,1
IE,CLUMSINESS,1
IE,COUGH,1
IE,CRYING,1
IE,CYANOSIS,1
IE,DIAPHRAGMATIC DISORDER,1
IE,DIZZINESS,1
IE,DRUG INEFFECTIVE,1
IE,DYSPEPSIA,1
IE,DYSPNOEA EXERTIONAL,1
IE,FATIGUE,1
IE,FLUSHING,1
IE,GAMMA-GLUTAMYLTRANSFERASE INCREASED,1
IE,GASTROINTESTINAL CANCER METASTATIC,1
IE,GLYCOSYLATED HAEMOGLOBIN DECREASED,1
IE,HAEMOGLOBIN DECREASED,1
IE,HELICOBACTER INFECTION,1
IE,HOSPITALISATION,1
IE,HYPERTENSION,1
IE,HYPERTENSIVE ENCEPHALOPATHY,1
IE,HYPOTONIA,1
IE,ILEAL STENOSIS,1
IE,INCREASED VISCOSITY OF BRONCHIAL SECRETION,1
IE,INFLAMMATORY BOWEL DISEASE,1
IE,INJURY,1
IE,INTESTINAL OBSTRUCTION,1
IE,JAUNDICE CHOLESTATIC,1
IE,JAUNDICE HEPATOCELLULAR,1
IE,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,1
IE,LOWER RESPIRATORY TRACT INFECTION,1
IE,LYMPHOCYTOSIS,1
IE,MALAISE,1
IE,MICTURITION URGENCY,1
IE,MOTOR DYSFUNCTION,1
IE,MULTIPLE SCLEROSIS RELAPSE,1
IE,MUSCLE SPASMS,1
IE,MYOPATHY,1
IE,NASAL CONGESTION,1
IE,NASOPHARYNGITIS,1
IE,NAUSEA,1
IE,NON-CARDIAC CHEST PAIN,1
IE,OEDEMA PERIPHERAL,1
IE,PALPITATIONS,1
IE,PENILE SQUAMOUS CELL CARCINOMA,1
IE,PERIPHERAL SWELLING,1
IE,PLATELET COUNT DECREASED,1
IE,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,1
IE,PULMONARY EMBOLISM,1
IE,PYREXIA,1
IE,RENAL FAILURE,1
IE,RENAL FAILURE ACUTE,1
IE,RESPIRATORY DISORDER,1
IE,RESPIRATORY FAILURE,1
IE,RESPIRATORY SYNCYTIAL VIRUS TEST POSITIVE,1
IE,RHONCHI,1
IE,SECOND PRIMARY MALIGNANCY,1
IE,SEPSIS,1
IE,SQUAMOUS CELL CARCINOMA,1
IE,TROPONIN T INCREASED,1
IE,URINARY INCONTINENCE,1
IE,URINE KETONE BODY,1
IE,VASCULITIS CEREBRAL,1
IE,WEIGHT DECREASED,1
IL,TOXICITY TO VARIOUS AGENTS,3
IL,MUCOSAL INFLAMMATION,2
IL,PANCYTOPENIA,2
IL,GASTROINTESTINAL HAEMORRHAGE,1
IL,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,1
IT,SYNCOPE,22
IT,DRUG ABUSE,18
IT,VOMITING,16
IT,SOPOR,14
IT,HYPOTENSION,11
IT,LOSS OF CONSCIOUSNESS,11
IT,MACROGLOSSIA,11
IT,MALAISE,11
IT,ANAEMIA,10
IT,DRUG INEFFECTIVE,10
IT,DYSPNOEA,9
IT,PALPITATIONS,9
IT,RENAL FAILURE ACUTE,9
IT,ACUTE KIDNEY INJURY,8
IT,ASTHENIA,7
IT,ATRIOVENTRICULAR BLOCK SECOND DEGREE,7
IT,BRADYCARDIA,7
IT,PRESYNCOPE,7
IT,RASH,7
IT,TOXICITY TO VARIOUS AGENTS,7
IT,COUGH,6
IT,HYPERKALAEMIA,6
IT,HYPERTENSIVE CRISIS,6
IT,HYPOGLYCAEMIC COMA,6
IT,HYPONATRAEMIA,6
IT,LIP OEDEMA,6
IT,NAUSEA,6
IT,CEREBRAL HAEMORRHAGE,5
IT,DIARRHOEA,5
IT,DISORIENTATION,5
IT,ERYTHEMA,5
IT,GAIT DISTURBANCE,5
IT,HAEMATURIA,5
IT,HEADACHE,5
IT,INTERNATIONAL NORMALISED RATIO INCREASED,5
IT,NEUTROPENIA,5
IT,PELVIC FRACTURE,5
IT,APHASIA,4
IT,BLOOD CREATININE INCREASED,4
IT,BRADYKINESIA,4
IT,BRADYPHRENIA,4
IT,DEHYDRATION,4
IT,HAEMOPTYSIS,4
IT,HEAD INJURY,4
IT,HYPERSENSITIVITY,4
IT,HYPERTENSION,4
IT,MYOCLONUS,4
IT,OVERDOSE,4
IT,PRURITUS,4
IT,THROMBOCYTOPENIA,4
IT,TONGUE OEDEMA,4
IT,ACCIDENTAL EXPOSURE TO PRODUCT,3
IT,APNOEA,3
IT,ATRIAL FIBRILLATION,3
IT,BLOOD PRESSURE INCREASED,3
IT,COMA,3
IT,CONFUSIONAL STATE,3
IT,DEPRESSED LEVEL OF CONSCIOUSNESS,3
IT,ENTEROCOLITIS HAEMORRHAGIC,3
IT,FACE OEDEMA,3
IT,HYPERHIDROSIS,3
IT,HYPOGLYCAEMIA,3
IT,INTENTIONAL PRODUCT MISUSE,3
IT,INTENTIONAL SELF-INJURY,3
IT,LARYNGOSPASM,3
IT,MELAENA,3
IT,OEDEMA PERIPHERAL,3
IT,PERIORBITAL OEDEMA,3
IT,PNEUMONIA,3
IT,RENAL FAILURE CHRONIC,3
IT,TOXIC EPIDERMAL NECROLYSIS,3
IT,VERTIGO,3
IT,ABDOMINAL PAIN,2
IT,ACUTE RESPIRATORY FAILURE,2
IT,ANGIOEDEMA,2
IT,BUNDLE BRANCH BLOCK LEFT,2
IT,CARDIAC FAILURE,2
IT,CARDIO-RESPIRATORY ARREST,2
IT,CEREBRAL ISCHAEMIA,2
IT,DECREASED APPETITE,2
IT,DIVERTICULITIS,2
IT,DRUG HYPERSENSITIVITY,2
IT,DYSARTHRIA,2
IT,ECTROPION,2
IT,EPISTAXIS,2
IT,FATIGUE,2
IT,GASTROENTERITIS,2
IT,GASTROINTESTINAL HAEMORRHAGE,2
IT,HAEMORRHAGE,2
IT,HYPOKINESIA,2
IT,INTERSTITIAL LUNG DISEASE,2
IT,LANGUAGE DISORDER,2
IT,ORTHOSTATIC HYPOTENSION,2
IT,PALATAL OEDEMA,2
IT,PRODUCT USE ISSUE,2
IT,PRURITUS GENERALISED,2
IT,PSYCHOMOTOR HYPERACTIVITY,2
IT,PYREXIA,2
IT,RECTAL HAEMORRHAGE,2
IT,SKIN REACTION,2
IT,SOMNOLENCE,2
IT,SUBDURAL HAEMORRHAGE,2
IT,TREATMENT FAILURE,2
IT,URINARY RETENTION,2
IT,ABDOMINAL ABSCESS,1
IT,ABDOMINAL PAIN UPPER,1
IT,ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED,1
IT,ACUTE MONOCYTIC LEUKAEMIA,1
IT,ACUTE MYELOID LEUKAEMIA,1
IT,ACUTE MYOCARDIAL INFARCTION,1
IT,ADVERSE DRUG REACTION,1
IT,ADVERSE EVENT,1
IT,ANORECTAL CELLULITIS,1
IT,ANTICONVULSANT DRUG LEVEL INCREASED,1
IT,ANXIETY,1
IT,AORTIC ANEURYSM,1
IT,ATRIOVENTRICULAR BLOCK,1
IT,BACK PAIN,1
IT,BALANCE DISORDER,1
IT,BIFASCICULAR BLOCK,1
IT,BLOOD ALKALINE PHOSPHATASE INCREASED,1
IT,BLOOD PRESSURE DECREASED,1
IT,BRAIN NEOPLASM,1
IT,BRONCHOSPASM,1
IT,BUNDLE BRANCH BLOCK RIGHT,1
IT,CEREBROSPINAL FLUID LEAKAGE,1
IT,CHEST PAIN,1
IT,CHOLELITHIASIS,1
IT,CIRCULATORY COLLAPSE,1
IT,COMA HEPATIC,1
IT,COMPLICATIONS OF TRANSPLANTED HEART,1
IT,CONDUCTION DISORDER,1
IT,CONGENITAL THROMBOCYTE DISORDER,1
IT,CONSTIPATION,1
IT,CYTOMEGALOVIRUS INFECTION,1
IT,DEPRESSION,1
IT,DERMATITIS EXFOLIATIVE,1
IT,DIABETES MELLITUS,1
IT,DIARRHOEA HAEMORRHAGIC,1
IT,DIPLOPIA,1
IT,DISEASE PROGRESSION,1
IT,DISSEMINATED INTRAVASCULAR COAGULATION,1
IT,DISTURBANCE IN ATTENTION,1
IT,DIVERTICULAR PERFORATION,1
IT,DIZZINESS,1
IT,DRUG ADMINISTRATION ERROR,1
IT,DRUG ERUPTION,1
IT,DRUG-INDUCED LIVER INJURY,1
IT,DUODENAL ULCER,1
IT,DYSENTERY,1
IT,DYSLIPIDAEMIA,1
IT,DYSPHAGIA,1
IT,ECCHYMOSIS,1
IT,EJECTION FRACTION DECREASED,1
IT,ENTERITIS,1
IT,ENTEROCOLITIS INFECTIOUS,1
IT,ENTEROCUTANEOUS FISTULA,1
IT,EROSIVE DUODENITIS,1
IT,ERYTHEMA MULTIFORME,1
IT,EXCESSIVE CERUMEN PRODUCTION,1
IT,FAECES DISCOLOURED,1
IT,FISTULA,1
IT,FLANK PAIN,1
IT,FLUSHING,1
IT,FOCAL SEGMENTAL GLOMERULOSCLEROSIS,1
IT,FRACTURED SACRUM,1
IT,GAMMA-GLUTAMYLTRANSFERASE INCREASED,1
IT,GASTRIC ULCER PERFORATION,1
IT,HAEMATEMESIS,1
IT,HAEMOGLOBIN DECREASED,1
IT,HAEMORRHAGE INTRACRANIAL,1
IT,HAEMORRHAGIC DISORDER,1
IT,HEMIPLEGIA,1
IT,HEPATIC HAEMATOMA,1
IT,HEPATITIS TOXIC,1
IT,HOT FLUSH,1
IT,HYPOACUSIS,1
IT,HYPOCOAGULABLE STATE,1
IT,HYPOKALAEMIA,1
IT,HYPONATRAEMIC SYNDROME,1
IT,HYPOTONIA,1
IT,ILEUS PARALYTIC,1
IT,INCORRECT ROUTE OF DRUG ADMINISTRATION,1
IT,INFECTION,1
IT,INFLUENZA,1
IT,INTERMITTENT CLAUDICATION,1
IT,INTESTINAL FIBROSIS,1
IT,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,1
IT,LARYNGEAL OEDEMA,1
IT,LEFT VENTRICULAR HYPERTROPHY,1
IT,LETHARGY,1
IT,LEUKOPENIA,1
IT,LOCALISED OEDEMA,1
IT,MEDICATION ERROR,1
IT,MOTOR DYSFUNCTION,1
IT,MULTI-ORGAN FAILURE,1
IT,MUSCLE HAEMORRHAGE,1
IT,MUSCULAR WEAKNESS,1
IT,NAIL DISORDER,1
IT,NECROTISING FASCIITIS,1
IT,OCCULT BLOOD POSITIVE,1
IT,OLIGURIA,1
IT,OSTEONECROSIS,1
IT,PAIN,1
IT,PAIN IN EXTREMITY,1
IT,PANCREATITIS ACUTE,1
IT,PARAESTHESIA,1
IT,PERICARDIAL EFFUSION,1
IT,PERIPHERAL ARTERY OCCLUSION,1
IT,PERIPHERAL ISCHAEMIA,1
IT,PHARYNGEAL OEDEMA,1
IT,PLEURISY,1
IT,PNEUMOCYSTIS JIROVECII INFECTION,1
IT,PNEUMONITIS,1
IT,PRODUCT MEASURED POTENCY ISSUE,1
IT,PROSTATOMEGALY,1
IT,PROTEINURIA,1
IT,PULMONARY TUBERCULOSIS,1
IT,RASH GENERALISED,1
IT,RENAL ARTERY STENOSIS,1
IT,RENAL FAILURE,1
IT,RENAL IMPAIRMENT,1
IT,RESPIRATORY FAILURE,1
IT,ROSAI-DORFMAN SYNDROME,1
IT,SEIZURE,1
IT,SINUS BRADYCARDIA,1
IT,SKIN HYPERPIGMENTATION,1
IT,SKIN TOXICITY,1
IT,STOMATITIS,1
IT,STRANGURY,1
IT,SUBDURAL HAEMATOMA,1
IT,SUBILEUS,1
IT,SUICIDAL BEHAVIOUR,1
IT,SUICIDE ATTEMPT,1
IT,SUPRAPUBIC PAIN,1
IT,TACHYARRHYTHMIA,1
IT,TACHYCARDIA,1
IT,TORSADE DE POINTES,1
IT,TRANSAMINASES INCREASED,1
IT,TRANSFUSION,1
IT,TREMOR,1
IT,UNRESPONSIVE TO STIMULI,1
IT,XEROSIS,1
JP,ACUTE KIDNEY INJURY,14
JP,RENAL IMPAIRMENT,12
JP,PROTEINURIA,10
JP,GASTROENTERITIS,5
JP,ABDOMINAL DISCOMFORT,4
JP,CHEST DISCOMFORT,4
JP,ANAEMIA,3
JP,BLOOD ALBUMIN DECREASED,3
JP,BLOOD CREATININE INCREASED,3
JP,CONDITION AGGRAVATED,3
JP,COUGH,3
JP,DRUG ERUPTION,3
JP,HEAT ILLNESS,3
JP,HYPOALBUMINAEMIA,3
JP,NAUSEA,3
JP,THROAT IRRITATION,3
JP,ANAPHYLACTIC SHOCK,2
JP,ANGINA UNSTABLE,2
JP,ANGIOEDEMA,2
JP,CEREBRAL INFARCTION,2
JP,DEHYDRATION,2
JP,DIABETES MELLITUS,2
JP,DIABETIC NEPHROPATHY,2
JP,FRACTURE,2
JP,GLOMERULAR VASCULAR DISORDER,2
JP,HAEMATOMA,2
JP,HAEMATURIA,2
JP,HYPONATRAEMIA,2
JP,INTERSTITIAL LUNG DISEASE,2
JP,NEPHROTIC SYNDROME,2
JP,OEDEMA PERIPHERAL,2
JP,PERIPHERAL SWELLING,2
JP,PNEUMONIA,2
JP,RENAL FAILURE,2
JP,URINE PROTEIN/CREATININE RATIO DECREASED,2
JP,VOMITING,2
JP,ACUTE CORONARY SYNDROME,1
JP,ANAL FISTULA,1
JP,ANGIOPLASTY,1
JP,ANURIA,1
JP,ATRIAL FIBRILLATION,1
JP,ATYPICAL FEMUR FRACTURE,1
JP,BARTTER^S SYNDROME,1
JP,BLOOD BICARBONATE DECREASED,1
JP,BLOOD CALCIUM DECREASED,1
JP,BLOOD GLUCOSE INCREASED,1
JP,BLOOD PRESSURE INCREASED,1
JP,BLOOD PRESSURE SYSTOLIC DECREASED,1
JP,BRAIN HERNIATION,1
JP,BRAIN NEOPLASM,1
JP,BRONCHITIS,1
JP,CARDIAC ABLATION,1
JP,CARDIAC FAILURE,1
JP,CARDIAC FAILURE CONGESTIVE,1
JP,CAROTID ARTERY OCCLUSION,1
JP,CATARACT,1
JP,CEREBRAL HAEMORRHAGE,1
JP,CEREBROVASCULAR ACCIDENT,1
JP,CHEST PAIN,1
JP,CIRCULATORY COLLAPSE,1
JP,COAGULATION FACTOR V LEVEL DECREASED,1
JP,CONGENITAL CYSTIC KIDNEY DISEASE,1
JP,CONSTIPATION,1
JP,CORONARY ARTERY STENOSIS,1
JP,DECREASED APPETITE,1
JP,DIARRHOEA,1
JP,DISCOMFORT,1
JP,DRUG ADMINISTRATION ERROR,1
JP,DRUG INEFFECTIVE,1
JP,EATING DISORDER,1
JP,ENDOMETRIOSIS,1
JP,ERYTHEMA MULTIFORME,1
JP,EYE DISORDER,1
JP,FAILURE TO THRIVE,1
JP,FEBRILE NEUTROPENIA,1
JP,FISTULA REPAIR,1
JP,GAIT DISTURBANCE,1
JP,GASTRIC DILATATION,1
JP,GASTRIC ULCER,1
JP,GASTRITIS BACTERIAL,1
JP,GASTRODUODENAL ULCER,1
JP,GASTROOESOPHAGEAL REFLUX DISEASE,1
JP,GLUCOSE URINE PRESENT,1
JP,GLYCOSYLATED HAEMOGLOBIN INCREASED,1
JP,HAEMOGLOBIN DECREASED,1
JP,HAEMOLYTIC ANAEMIA,1
JP,HAEMOPTYSIS,1
JP,HAEMORRHAGE,1
JP,HEMIPLEGIA,1
JP,HEPATIC FUNCTION ABNORMAL,1
JP,HERPES ZOSTER,1
JP,HYPERAMMONAEMIA,1
JP,HYPERTENSION,1
JP,HYPOCHLORAEMIA,1
JP,HYPOCOMPLEMENTAEMIA,1
JP,HYPOKALAEMIA,1
JP,HYPOPHOSPHATAEMIC RICKETS,1
JP,HYPOTENSION,1
JP,IGA NEPHROPATHY,1
JP,INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION,1
JP,INSOMNIA,1
JP,INTENTIONAL PRODUCT MISUSE,1
JP,INTRACARDIAC THROMBUS,1
JP,IRON DEFICIENCY ANAEMIA,1
JP,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,1
JP,LEUKOCYTOSIS,1
JP,MALAISE,1
JP,MATERNAL EXPOSURE DURING PREGNANCY,1
JP,OLIGURIA,1
JP,PAIN IN EXTREMITY,1
JP,PLEURAL INFECTION BACTERIAL,1
JP,PNEUMOTHORAX,1
JP,POLYMYALGIA RHEUMATICA,1
JP,PRERENAL FAILURE,1
JP,PROTEIN URINE,1
JP,PSORIASIS,1
JP,PYREXIA,1
JP,RETINAL HAEMORRHAGE,1
JP,RETINOPATHY,1
JP,THERAPEUTIC RESPONSE DECREASED,1
JP,TREATMENT NONCOMPLIANCE,1
JP,URINARY RETENTION,1
JP,WHITE BLOOD CELL COUNT INCREASED,1
KZ,CEREBRAL ARTERY THROMBOSIS,1
KZ,CEREBRAL INFARCTION,1
KZ,ISCHAEMIC STROKE,1
KR,ACUTE KIDNEY INJURY,1
KR,FULL BLOOD COUNT ABNORMAL,1
KR,HYPERGLYCAEMIA,1
KW,ASTHENIA,1
LY,ACUTE RESPIRATORY DISTRESS SYNDROME,1
LY,LOWER RESPIRATORY TRACT INFECTION,1
LY,UPPER RESPIRATORY TRACT CONGESTION,1
MX,DIZZINESS,4
MX,HYPERTENSION,3
MX,WRONG TECHNIQUE IN DRUG USAGE PROCESS,3
MX,ASPHYXIA,2
MX,BLOOD PRESSURE DECREASED,2
MX,BLOOD PRESSURE INCREASED,2
MX,CHOKING,2
MX,DRUG INEFFECTIVE,2
MX,DYSPHAGIA,2
MX,FATIGUE,2
MX,FEEDING DISORDER,2
MX,INFLUENZA,2
MX,LOSS OF CONSCIOUSNESS,2
MX,PRODUCTIVE COUGH,2
MX,SYNCOPE,2
MX,ANGINA UNSTABLE,1
MX,ASTHENIA,1
MX,BLINDNESS,1
MX,BLOOD PRESSURE FLUCTUATION,1
MX,BLOOD PRESSURE INADEQUATELY CONTROLLED,1
MX,BRONCHIAL HYPERREACTIVITY,1
MX,CAFE AU LAIT SPOTS,1
MX,CEREBRAL INFARCTION,1
MX,CONCOMITANT DISEASE AGGRAVATED,1
MX,COUGH,1
MX,DEHYDRATION,1
MX,DEMENTIA ALZHEIMER^S TYPE,1
MX,DIABETIC KETOACIDOSIS,1
MX,DIARRHOEA,1
MX,DYSPNOEA,1
MX,FEELING ABNORMAL,1
MX,GALLBLADDER DISORDER,1
MX,GASTROENTERITIS VIRAL,1
MX,HALLUCINATION,1
MX,MEMORY IMPAIRMENT,1
MX,MULTIPLE SYSTEM ATROPHY,1
MX,MUSCLE SPASMS,1
MX,MYOCARDIAL INFARCTION,1
MX,NAUSEA,1
MX,NEAR DROWNING,1
MX,OEDEMA PERIPHERAL,1
MX,PANCREATITIS NECROTISING,1
MX,PNEUMONIA,1
MX,POLLAKIURIA,1
MX,PRODUCT USE ISSUE,1
MX,PROGRESSIVE SUPRANUCLEAR PALSY,1
MX,PULMONARY CONGESTION,1
MX,PULMONARY EMBOLISM,1
MX,RASH PAPULAR,1
MX,SOFT TISSUE NEOPLASM,1
MX,STRESS,1
MX,SYSTEMIC LUPUS ERYTHEMATOSUS,1
MX,VISUAL IMPAIRMENT,1
MX,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,1
NL,DIARRHOEA,13
NL,DYSPNOEA,13
NL,FATIGUE,13
NL,ANGIOEDEMA,12
NL,METABOLIC ACIDOSIS,12
NL,MULTIPLE ORGAN DYSFUNCTION SYNDROME,12
NL,PNEUMONIA,12
NL,SEPSIS,12
NL,TOXICITY TO VARIOUS AGENTS,12
NL,DEATH,11
NL,NAUSEA,11
NL,PANCYTOPENIA,11
NL,RENAL TUBULAR NECROSIS,11
NL,CARDIAC FAILURE,10
NL,MUCOSAL INFLAMMATION,10
NL,STOMATITIS,10
NL,COUGH,9
NL,MYALGIA,9
NL,MALAISE,8
NL,CATARACT,7
NL,HOT FLUSH,7
NL,PYREXIA,7
NL,TUBULOINTERSTITIAL NEPHRITIS,7
NL,VISUAL IMPAIRMENT,7
NL,ABDOMINAL PAIN,6
NL,ALOPECIA,6
NL,ANAEMIA,6
NL,DRY EYE,6
NL,GENERAL PHYSICAL HEALTH DETERIORATION,6
NL,GOUT,6
NL,MUSCLE RUPTURE,6
NL,MYOCARDIAL INFARCTION,6
NL,OCULAR DISCOMFORT,6
NL,VOMITING,6
NL,ASTHENIA,5
NL,BACK PAIN,5
NL,CHEST PAIN,5
NL,COELIAC DISEASE,5
NL,EPISTAXIS,5
NL,GASTROINTESTINAL DISORDER,5
NL,HYPOMAGNESAEMIA,5
NL,RENAL FAILURE,5
NL,RENAL IMPAIRMENT,5
NL,ACUTE MYOCARDIAL INFARCTION,4
NL,CEREBROVASCULAR ACCIDENT,4
NL,DECREASED APPETITE,4
NL,DEHYDRATION,4
NL,DIZZINESS,4
NL,DYSPHAGIA,4
NL,EYELID OEDEMA,4
NL,FEELING COLD,4
NL,GYNAECOMASTIA,4
NL,HEADACHE,4
NL,HEART RATE DECREASED,4
NL,HYPOCALCAEMIA,4
NL,HYPOTENSION,4
NL,METASTASES TO BONE,4
NL,OEDEMA,4
NL,PAIN IN EXTREMITY,4
NL,PLEURAL EFFUSION,4
NL,POOR QUALITY SLEEP,4
NL,PRURITUS,4
NL,SPEECH DISORDER,4
NL,SWOLLEN TONGUE,4
NL,ACUTE KIDNEY INJURY,3
NL,ARTHRALGIA,3
NL,BLOOD CREATININE INCREASED,3
NL,BLOOD GLUCOSE INCREASED,3
NL,BREAST CANCER METASTATIC,3
NL,CARDIOMYOPATHY,3
NL,CHEST DISCOMFORT,3
NL,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,3
NL,CONFUSIONAL STATE,3
NL,DELIRIUM,3
NL,DEPRESSION,3
NL,DYSPHONIA,3
NL,FALL,3
NL,FLUID RETENTION,3
NL,GAIT DISTURBANCE,3
NL,GASTROENTERITIS,3
NL,HEMIPARESIS,3
NL,HIP FRACTURE,3
NL,HYPERTENSION,3
NL,INSOMNIA,3
NL,MEMORY IMPAIRMENT,3
NL,MUSCULOSKELETAL PAIN,3
NL,OEDEMA PERIPHERAL,3
NL,ORTHOSTATIC HYPOTENSION,3
NL,PAIN,3
NL,PALPITATIONS,3
NL,PARAESTHESIA,3
NL,PERIPHERAL COLDNESS,3
NL,PRODUCT USE ISSUE,3
NL,PROSTATIC SPECIFIC ANTIGEN INCREASED,3
NL,RENAL FAILURE ACUTE,3
NL,RESPIRATORY FAILURE,3
NL,STEVENS-JOHNSON SYNDROME,3
NL,URINARY TRACT INFECTION,3
NL,WEIGHT DECREASED,3
NL,ACUTE ABDOMEN,2
NL,ALANINE AMINOTRANSFERASE INCREASED,2
NL,ANURIA,2
NL,ARRHYTHMIA,2
NL,ARTHROPATHY,2
NL,ASPARTATE AMINOTRANSFERASE INCREASED,2
NL,ATRIAL FIBRILLATION,2
NL,BLOOD ALKALINE PHOSPHATASE INCREASED,2
NL,BLOOD PRESSURE FLUCTUATION,2
NL,BONE PAIN,2
NL,C-REACTIVE PROTEIN INCREASED,2
NL,CARDIAC ARREST,2
NL,CEREBRAL INFARCTION,2
NL,CONTUSION,2
NL,DISEASE PROGRESSION,2
NL,DYSKINESIA,2
NL,ELECTROLYTE IMBALANCE,2
NL,EMOTIONAL DISORDER,2
NL,FEELING ABNORMAL,2
NL,FLANK PAIN,2
NL,HAEMATOMA,2
NL,HAEMOGLOBIN DECREASED,2
NL,HAEMORRHAGIC STROKE,2
NL,HEART RATE INCREASED,2
NL,HYPERKALAEMIA,2
NL,HYPOKALAEMIA,2
NL,HYPONATRAEMIA,2
NL,IMPAIRED HEALING,2
NL,INFLUENZA LIKE ILLNESS,2
NL,INJECTION SITE ERYTHEMA,2
NL,IRON DEFICIENCY ANAEMIA,2
NL,LEUKOPENIA,2
NL,LIVER FUNCTION TEST ABNORMAL,2
NL,LOSS OF CONSCIOUSNESS,2
NL,LYMPHOMA,2
NL,MALIGNANT NEOPLASM PROGRESSION,2
NL,METASTASES TO LUNG,2
NL,MUSCLE SPASMS,2
NL,MUSCULOSKELETAL STIFFNESS,2
NL,NEUROPATHY PERIPHERAL,2
NL,NORMOCHROMIC NORMOCYTIC ANAEMIA,2
NL,OSTEOMYELITIS,2
NL,OSTEONECROSIS OF JAW,2
NL,PANCREATITIS,2
NL,PANCREATITIS ACUTE,2
NL,PLASMA CELL MYELOMA,2
NL,PRODUCT USE IN UNAPPROVED INDICATION,2
NL,PULMONARY OEDEMA,2
NL,PULMONARY SEPSIS,2
NL,PYELONEPHRITIS,2
NL,RHABDOMYOLYSIS,2
NL,RIB FRACTURE,2
NL,SECOND PRIMARY MALIGNANCY,2
NL,SLEEP ATTACKS,2
NL,STAPHYLOCOCCAL SEPSIS,2
NL,SUICIDAL IDEATION,2
NL,TERMINAL STATE,2
NL,THROMBOCYTOPENIA,2
NL,UROSEPSIS,2
NL,VERTIGO,2
NL,VIRAL INFECTION,2
NL,ABASIA,1
NL,ABDOMINAL DISCOMFORT,1
NL,ABDOMINAL DISTENSION,1
NL,ABNORMAL FAECES,1
NL,ACINETOBACTER INFECTION,1
NL,ACTIVITIES OF DAILY LIVING IMPAIRED,1
NL,ADENOIDECTOMY,1
NL,ADRENAL MASS,1
NL,ADVERSE DRUG REACTION,1
NL,AGGRESSION,1
NL,AGITATION,1
NL,AMYLASE INCREASED,1
NL,ANAPHYLACTIC REACTION,1
NL,ANEURYSM,1
NL,ANGER,1
NL,ANGINA PECTORIS,1
NL,APHASIA,1
NL,APRAXIA,1
NL,ARTERECTOMY,1
NL,ARTERIAL OCCLUSIVE DISEASE,1
NL,ARTERIOSCLEROSIS,1
NL,ASTHMA,1
NL,ATAXIA,1
NL,ATRIAL FLUTTER,1
NL,BILIRUBIN CONJUGATED INCREASED,1
NL,BLADDER CANCER,1
NL,BLADDER CATHETERISATION,1
NL,BLADDER NEOPLASM SURGERY,1
NL,BLINDNESS,1
NL,BLINDNESS UNILATERAL,1
NL,BLOOD PRESSURE DECREASED,1
NL,BLOOD UREA INCREASED,1
NL,BODY TEMPERATURE ABNORMAL,1
NL,BONE DISORDER,1
NL,BRACHIAL PLEXOPATHY,1
NL,BREAST CANCER FEMALE,1
NL,BREAST INFLAMMATION,1
NL,BURNING SENSATION MUCOSAL,1
NL,CALCULUS URETERIC,1
NL,CARDIAC ASTHMA,1
NL,CARDIAC DISORDER,1
NL,CARDIAC FAILURE CHRONIC,1
NL,CARDIAC OPERATION,1
NL,CARDIAC PACEMAKER INSERTION,1
NL,CARDIAC VALVE DISEASE,1
NL,CARDIOPULMONARY FAILURE,1
NL,CAROTID ARTERY STENOSIS,1
NL,CEREBRAL ISCHAEMIA,1
NL,CEREBROSPINAL FLUID LEAKAGE,1
NL,CHEMICAL PERITONITIS,1
NL,CHEST INJURY,1
NL,CHILLS,1
NL,CHOKING,1
NL,CHOLECYSTECTOMY,1
NL,CLOSTRIDIUM COLITIS,1
NL,COLON CANCER,1
NL,CONCOMITANT DISEASE PROGRESSION,1
NL,CONNECTIVE TISSUE INFLAMMATION,1
NL,CONSTIPATION,1
NL,CONVULSION,1
NL,CORONARY ARTERY STENOSIS,1
NL,CROHN^S DISEASE,1
NL,CRYING,1
NL,CUSHINGOID,1
NL,CYANOSIS,1
NL,DECUBITUS ULCER,1
NL,DEEP VEIN THROMBOSIS,1
NL,DEPERSONALISATION,1
NL,DEPRESSED LEVEL OF CONSCIOUSNESS,1
NL,DIABETES MELLITUS,1
NL,DIABETES MELLITUS INADEQUATE CONTROL,1
NL,DIABETIC FOOT,1
NL,DISABILITY,1
NL,DISTURBANCE IN ATTENTION,1
NL,DRUG LEVEL ABOVE THERAPEUTIC,1
NL,DRY MOUTH,1
NL,DRY SKIN,1
NL,DYSARTHRIA,1
NL,DYSPNOEA EXERTIONAL,1
NL,EAR HAEMORRHAGE,1
NL,ELECTROCARDIOGRAM QT PROLONGED,1
NL,EMBOLIC STROKE,1
NL,ENDOPHTHALMITIS,1
NL,ENTERITIS,1
NL,EPILEPSY,1
NL,ERECTILE DYSFUNCTION,1
NL,ERECTION INCREASED,1
NL,ERYTHEMA,1
NL,ESCHERICHIA URINARY TRACT INFECTION,1
NL,FAECES SOFT,1
NL,FEBRILE NEUTROPENIA,1
NL,FEMOROACETABULAR IMPINGEMENT,1
NL,FOCAL SEGMENTAL GLOMERULOSCLEROSIS,1
NL,FOLATE DEFICIENCY,1
NL,GASTRECTOMY,1
NL,GASTRITIS,1
NL,GLOMERULONEPHRITIS,1
NL,GROIN PAIN,1
NL,HAEMATOCRIT DECREASED,1
NL,HAEMATOCRIT INCREASED,1
NL,HAEMOLYTIC ANAEMIA,1
NL,HAEMORRHAGE,1
NL,HAEMORRHOIDS,1
NL,HALLUCINATION,1
NL,HALLUCINATION_ AUDITORY,1
NL,HEART RATE ABNORMAL,1
NL,HEPATITIS,1
NL,HOSPICE CARE,1
NL,HYDRONEPHROSIS,1
NL,HYPERCALCAEMIA,1
NL,HYPERHIDROSIS,1
NL,HYPERKERATOSIS,1
NL,HYPERLIPIDAEMIA,1
NL,HYPERSENSITIVITY,1
NL,HYPERSEXUALITY,1
NL,HYPERTHYROIDISM,1
NL,HYPOACUSIS,1
NL,HYPOKINESIA,1
NL,HYPOMANIA,1
NL,HYPOPARATHYROIDISM,1
NL,INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION,1
NL,INCORRECT ROUTE OF DRUG ADMINISTRATION,1
NL,INFECTED SEROMA,1
NL,INFECTION,1
NL,INFLUENZA,1
NL,INJECTION SITE HAEMATOMA,1
NL,INJECTION SITE MASS,1
NL,INJECTION SITE PAIN,1
NL,INJECTION SITE REACTION,1
NL,INJECTION SITE SWELLING,1
NL,INTERSTITIAL LUNG DISEASE,1
NL,INTERVERTEBRAL DISC OPERATION,1
NL,INTESTINAL VILLI ATROPHY,1
NL,ISCHAEMIC CEREBRAL INFARCTION,1
NL,JAW DISORDER,1
NL,JAW OPERATION,1
NL,JOINT SWELLING,1
NL,KIDNEY TRANSPLANT REJECTION,1
NL,LACTOSE INTOLERANCE,1
NL,LEFT VENTRICULAR DILATATION,1
NL,LIP SWELLING,1
NL,LOCAL SWELLING,1
NL,LOCALISED INFECTION,1
NL,LOCALISED OEDEMA,1
NL,LUNG CANCER METASTATIC,1
NL,LUNG DISORDER,1
NL,LYMPHADENECTOMY,1
NL,MAJOR DEPRESSION,1
NL,MANIA,1
NL,MASTECTOMY,1
NL,MENINGITIS,1
NL,MENTAL DISORDER,1
NL,MENTAL IMPAIRMENT,1
NL,METASTASES TO CENTRAL NERVOUS SYSTEM,1
NL,METASTASES TO PELVIS,1
NL,METASTASES TO SPINE,1
NL,METASTASIS,1
NL,METASTATIC GASTRIC CANCER,1
NL,MIGRAINE,1
NL,MOBILITY DECREASED,1
NL,MOOD SWINGS,1
NL,MOUTH SWELLING,1
NL,MOUTH ULCERATION,1
NL,MULTI-ORGAN FAILURE,1
NL,MULTIPLE SCLEROSIS,1
NL,MUSCULAR WEAKNESS,1
NL,MUSCULOSKELETAL CHEST PAIN,1
NL,MUSCULOSKELETAL DISCOMFORT,1
NL,MYOPATHY,1
NL,NASAL CONGESTION,1
NL,NASOPHARYNGITIS,1
NL,NEPHROSTOMY,1
NL,NEPHROTIC SYNDROME,1
NL,NERVE COMPRESSION,1
NL,NERVOUS SYSTEM DISORDER,1
NL,NEURALGIA,1
NL,NEUROLOGICAL SYMPTOM,1
NL,NON-HODGKIN^S LYMPHOMA,1
NL,OBESITY,1
NL,OBSESSIVE THOUGHTS,1
NL,OCULAR HYPERAEMIA,1
NL,OESOPHAGEAL DISORDER,1
NL,OESOPHAGEAL HAEMORRHAGE,1
NL,OESOPHAGITIS,1
NL,ON AND OFF PHENOMENON,1
NL,ONYCHOMYCOSIS,1
NL,OOPHORECTOMY,1
NL,OROPHARYNGEAL PAIN,1
NL,OXYGEN SATURATION DECREASED,1
NL,PALATAL SWELLING,1
NL,PARKINSON^S DISEASE,1
NL,PELVIC FRACTURE,1
NL,PENILE CURVATURE,1
NL,PERFORMANCE STATUS DECREASED,1
NL,PERIPHERAL SWELLING,1
NL,PERSONALITY CHANGE,1
NL,PERSONALITY DISORDER,1
NL,PLATELET DISORDER,1
NL,PNEUMOCYSTIS JIROVECII PNEUMONIA,1
NL,PNEUMONIA ASPIRATION,1
NL,PNEUMONIA ESCHERICHIA,1
NL,PNEUMONITIS,1
NL,POISONING,1
NL,POLYDIPSIA,1
NL,POST-TRAUMATIC PAIN,1
NL,PRERENAL FAILURE,1
NL,PRESBYACUSIS,1
NL,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,1
NL,PROSTATE CANCER,1
NL,PROSTATE CANCER METASTATIC,1
NL,PROSTATIC SPECIFIC ANTIGEN DECREASED,1
NL,PRURITUS GENERALISED,1
NL,PULMONARY EMBOLISM,1
NL,PULMONARY FIBROSIS,1
NL,PULMONARY HYPERTENSION,1
NL,PULMONARY MASS,1
NL,PULMONARY NECROSIS,1
NL,PUNCTURE SITE HAEMORRHAGE,1
NL,QUADRIPLEGIA,1
NL,RENAL CELL CARCINOMA,1
NL,RENAL FUNCTION TEST ABNORMAL,1
NL,RENAL NEOPLASM,1
NL,RESTLESS LEGS SYNDROME,1
NL,RESTRICTIVE CARDIOMYOPATHY,1
NL,RHEUMATOID ARTHRITIS,1
NL,RHINITIS,1
NL,RIGHT VENTRICULAR FAILURE,1
NL,ROAD TRAFFIC ACCIDENT,1
NL,ROTATOR CUFF SYNDROME,1
NL,SECRETION DISCHARGE,1
NL,SEIZURE,1
NL,SENSE OF OPPRESSION,1
NL,SKIN BURNING SENSATION,1
NL,SKIN DISORDER,1
NL,SKIN EXFOLIATION,1
NL,SKIN LESION,1
NL,SKIN ULCER,1
NL,SLEEP DISORDER,1
NL,SNEEZING,1
NL,SPINAL CORD INJURY,1
NL,SPINAL OSTEOARTHRITIS,1
NL,SQUAMOUS CELL CARCINOMA,1
NL,STOMA SITE DISCHARGE,1
NL,STOMA SITE ERYTHEMA,1
NL,STREPTOCOCCAL SEPSIS,1
NL,SUDDEN DEATH,1
NL,SUICIDE ATTEMPT,1
NL,SUSPECTED TRANSMISSION OF AN INFECTIOUS AGENT VIA PRODUCT,1
NL,SWELLING,1
NL,SYNCOPE,1
NL,TACHYCARDIA,1
NL,TACHYPNOEA,1
NL,TENDONITIS,1
NL,THERAPEUTIC RESPONSE CHANGED,1
NL,THROAT CANCER,1
NL,THROAT TIGHTNESS,1
NL,THROMBOSIS,1
NL,TINNITUS,1
NL,TOE AMPUTATION,1
NL,TOOTH EXTRACTION,1
NL,TOOTHACHE,1
NL,TRANSIENT ISCHAEMIC ATTACK,1
NL,TRANSITIONAL CELL CARCINOMA,1
NL,TRANSURETHRAL PROSTATECTOMY,1
NL,TREMOR,1
NL,TUMOUR COMPRESSION,1
NL,UPPER RESPIRATORY TRACT INFECTION,1
NL,URETHRAL STENOSIS,1
NL,URINARY CYSTECTOMY,1
NL,URINE OUTPUT DECREASED,1
NL,UVEITIS,1
NL,UVULECTOMY,1
NL,VASCULAR STENT RESTENOSIS,1
NL,VENOUS STENOSIS,1
NL,VERTEBRAL ARTERY OCCLUSION,1
NL,VIRAL UPPER RESPIRATORY TRACT INFECTION,1
NL,VISION BLURRED,1
NL,VISUAL ACUITY REDUCED,1
NL,VITAMIN B12 DEFICIENCY,1
NL,VITAMIN D DEFICIENCY,1
NL,WEIGHT INCREASED,1
NL,WOUND,1
NL,WOUND SEPSIS,1
NL,WRONG TECHNIQUE IN DRUG USAGE PROCESS,1
NZ,BACK PAIN,3
NZ,INSOMNIA,3
NZ,ABASIA,2
NZ,HYPOXIA,2
NZ,MUSCULAR WEAKNESS,2
NZ,SPINAL COLUMN STENOSIS,2
NZ,ABDOMINAL DISTENSION,1
NZ,ABDOMINAL PAIN,1
NZ,ACUTE KIDNEY INJURY,1
NZ,ANGINA PECTORIS,1
NZ,ARTHRALGIA,1
NZ,ATRIAL FIBRILLATION,1
NZ,BODY TEMPERATURE INCREASED,1
NZ,CHOLECYSTITIS,1
NZ,COLITIS ISCHAEMIC,1
NZ,CROHN^S DISEASE,1
NZ,FREQUENT BOWEL MOVEMENTS,1
NZ,GAIT DISTURBANCE,1
NZ,HYPERGLYCAEMIA,1
NZ,HYPOTENSION,1
NZ,MALAISE,1
NZ,PYREXIA,1
NZ,RECTAL HAEMORRHAGE,1
NZ,SYNCOPE,1
NG,HEADACHE,6
NG,DRUG INTOLERANCE,4
NG,ADVERSE DRUG REACTION,3
NG,CARDIAC ANEURYSM,2
NG,CARDIAC VENTRICULAR THROMBOSIS,2
NG,HYPOTENSION,2
NG,LEFT VENTRICULAR DYSFUNCTION,2
NG,ANORECTAL DISCOMFORT,1
NG,CHEST PAIN,1
NG,DRUG INEFFECTIVE,1
NG,DYSPEPSIA,1
NG,DYSPNOEA,1
NG,EYE DISORDER,1
NG,EYE IRRITATION,1
NG,LACRIMATION INCREASED,1
NG,NASAL DISCOMFORT,1
NG,NASAL DISORDER,1
NG,PAIN,1
NG,PALPITATIONS,1
NG,TREATMENT FAILURE,1
NG,VULVOVAGINAL BURNING SENSATION,1
NG,WHEEZING,1
NO,LACTIC ACIDOSIS,12
NO,RENAL FAILURE,9
NO,DIARRHOEA,7
NO,HAEMATEMESIS,7
NO,HYPOTHERMIA,7
NO,OSTEONECROSIS,7
NO,RECTAL HAEMORRHAGE,7
NO,VOMITING,7
NO,ABDOMINAL PAIN,6
NO,HYPOTENSION,6
NO,MALAISE,6
NO,DYSPNOEA,5
NO,NEUROENDOCRINE TUMOUR,5
NO,ACUTE KIDNEY INJURY,4
NO,ENTEROCHROMAFFIN CELL HYPERPLASIA,4
NO,HYPERGASTRINAEMIA,4
NO,OSTEITIS,4
NO,OSTEONECROSIS OF JAW,4
NO,ACUTE RESPIRATORY FAILURE,3
NO,BLOOD PRESSURE DECREASED,3
NO,CARCINOID TUMOUR OF THE STOMACH,3
NO,HYPERVENTILATION,3
NO,HYPOVENTILATION,3
NO,PNEUMOCYSTIS JIROVECII PNEUMONIA,3
NO,DIZZINESS,2
NO,HEADACHE,2
NO,HEPATIC FAILURE,2
NO,HYPERCHLORHYDRIA,2
NO,HYPOACUSIS,2
NO,MIGRAINE,2
NO,TINNITUS,2
NO,ACQUIRED EPILEPTIC APHASIA,1
NO,ACUTE CORONARY SYNDROME,1
NO,ASCITES,1
NO,ATRIAL FIBRILLATION,1
NO,AUDITORY DISORDER,1
NO,BACTERIAL TEST POSITIVE,1
NO,BLOOD GLUCOSE DECREASED,1
NO,BRONCHITIS,1
NO,CARDIOMYOPATHY,1
NO,CAROTID ARTERY OCCLUSION,1
NO,CEREBRAL ARTERY OCCLUSION,1
NO,COGNITIVE DISORDER,1
NO,DEAFNESS,1
NO,DRUG INEFFECTIVE,1
NO,GASTRIC ULCER,1
NO,GENERAL PHYSICAL HEALTH DETERIORATION,1
NO,HAEMATOCHEZIA,1
NO,HAEMODYNAMIC INSTABILITY,1
NO,HAEMORRHAGIC ANAEMIA,1
NO,HYPERKALAEMIA,1
NO,ILEUS,1
NO,INCORRECT DRUG ADMINISTRATION DURATION,1
NO,INSOMNIA,1
NO,LARGE INTESTINE PERFORATION,1
NO,MELAENA,1
NO,MIXED DEMENTIA,1
NO,PNEUMONIA,1
NO,POST PROCEDURAL HAEMORRHAGE,1
NO,PSEUDOMONAS TEST POSITIVE,1
NO,RESPIRATORY FAILURE,1
NO,SLEEP DISORDER,1
NO,SPEECH DISORDER,1
NO,STEVENS-JOHNSON SYNDROME,1
NO,SURGERY,1
NO,SYNCOPE,1
NO,TOXIC EPIDERMAL NECROLYSIS,1
OM,GENERALISED OEDEMA,11
OM,ASCITES,9
OM,PLEURAL EFFUSION,9
OM,HYPERTENSION,8
OM,ATRIAL TACHYCARDIA,3
OM,HYPOMAGNESAEMIA,3
OM,SUPRAVENTRICULAR TACHYCARDIA,3
OM,TOXICITY TO VARIOUS AGENTS,3
OM,WEIGHT INCREASED,3
OM,ABDOMINAL DISCOMFORT,1
OM,ARRHYTHMIA,1
OM,DIABETES MELLITUS,1
OM,NAUSEA,1
OM,PALPITATIONS,1
OM,VOMITING,1
PK,PERIPHERAL ISCHAEMIA,3
PK,SHOCK,3
PK,TOXIC EPIDERMAL NECROLYSIS,3
PK,ACUTE KIDNEY INJURY,2
PK,MULTIPLE ORGAN DYSFUNCTION SYNDROME,2
PK,ODYNOPHAGIA,2
PK,ABDOMINAL PAIN,1
PK,ASTERIXIS,1
PK,CELLULITIS,1
PK,CHEST PAIN,1
PK,DIARRHOEA,1
PK,DISCOMFORT,1
PK,GAIT DISTURBANCE,1
PK,HYPOAESTHESIA,1
PK,HYPOTENSION,1
PK,JAUNDICE,1
PK,LOSS OF CONSCIOUSNESS,1
PK,MYOCARDIAL INFARCTION,1
PK,PAIN IN EXTREMITY,1
PK,PNEUMONIA,1
PK,PRODUCT USE IN UNAPPROVED INDICATION,1
PK,RASH ERYTHEMATOUS,1
PK,RASH GENERALISED,1
PK,RASH PRURITIC,1
PK,RENAL IMPAIRMENT,1
PK,RESTLESSNESS,1
PK,SKIN DISCOLOURATION,1
PK,SKIN EXFOLIATION,1
PK,VOMITING,1
PA,MALAISE,4
PA,BALANCE DISORDER,3
PA,BLOOD GLUCOSE INCREASED,2
PA,CATARACT,2
PA,CHEST PAIN,2
PA,DIARRHOEA,2
PA,FATIGUE,2
PA,NASOPHARYNGITIS,2
PA,NAUSEA,2
PA,PAIN,2
PA,PTERYGIUM,2
PA,TACHYCARDIA,2
PA,VAGINAL HAEMORRHAGE,2
PA,WEIGHT DECREASED,2
PA,ABDOMINAL PAIN,1
PA,ABDOMINAL PAIN UPPER,1
PA,AGITATION,1
PA,ANAEMIA,1
PA,ANORECTAL DISCOMFORT,1
PA,ANXIETY,1
PA,ASTHENIA,1
PA,ASTHMATIC CRISIS,1
PA,BLINDNESS UNILATERAL,1
PA,BLOOD COUNT ABNORMAL,1
PA,BLOOD GLUCOSE DECREASED,1
PA,BLOOD PRESSURE INCREASED,1
PA,BRADYCARDIA,1
PA,CARDIAC ARREST,1
PA,CENTRAL NERVOUS SYSTEM LESION,1
PA,CEREBRAL ISCHAEMIA,1
PA,CEREBROVASCULAR ACCIDENT,1
PA,CHILLS,1
PA,COUGH,1
PA,DECREASED IMMUNE RESPONSIVENESS,1
PA,DENTAL CARIES,1
PA,DISORIENTATION,1
PA,DIZZINESS,1
PA,DRY SKIN,1
PA,DYSPNOEA,1
PA,EAR DISCOMFORT,1
PA,EPISTAXIS,1
PA,EXPOSURE DURING PREGNANCY,1
PA,EYE IRRITATION,1
PA,EYE PAIN,1
PA,FALL,1
PA,FEELING DRUNK,1
PA,FIBROMYALGIA,1
PA,FLATULENCE,1
PA,FLUID RETENTION,1
PA,FOETAL EXPOSURE DURING PREGNANCY,1
PA,FREQUENT BOWEL MOVEMENTS,1
PA,GLAUCOMA,1
PA,HEADACHE,1
PA,HEART RATE DECREASED,1
PA,HYPERTENSION,1
PA,HYPOACUSIS,1
PA,HYPOAESTHESIA,1
PA,HYPOPHAGIA,1
PA,HYPOPLASTIC RIGHT HEART SYNDROME,1
PA,INFLUENZA,1
PA,INJECTION SITE PAIN,1
PA,INSOMNIA,1
PA,IRRITABILITY,1
PA,IRRITABLE BOWEL SYNDROME,1
PA,LEUKOPENIA,1
PA,METABOLIC ACIDOSIS,1
PA,METASTASES TO LUNG,1
PA,MULTIPLE SCLEROSIS,1
PA,MULTIPLE SCLEROSIS RELAPSE,1
PA,MUSCULAR WEAKNESS,1
PA,MYOCARDIAL INFARCTION,1
PA,OCULAR HYPERAEMIA,1
PA,OEDEMA,1
PA,PAIN IN EXTREMITY,1
PA,PERIPHERAL VENOUS DISEASE,1
PA,PLATELET COUNT DECREASED,1
PA,PNEUMONIA,1
PA,PRESCRIBED UNDERDOSE,1
PA,PRODUCT USE IN UNAPPROVED INDICATION,1
PA,PYREXIA,1
PA,RECTAL HAEMORRHAGE,1
PA,RECTAL PROLAPSE,1
PA,RENAL FAILURE,1
PA,RESPIRATORY FAILURE,1
PA,RETINAL INJURY,1
PA,SALIVARY HYPERSECRETION,1
PA,SEIZURE,1
PA,SHORT-BOWEL SYNDROME,1
PA,SKIN ATROPHY,1
PA,SKIN DISORDER,1
PA,SKIN ULCER,1
PA,SOMNOLENCE,1
PA,SUBCUTANEOUS ABSCESS,1
PA,SYNCOPE,1
PA,TENSION HEADACHE,1
PA,THROMBOSIS,1
PA,TOOTHACHE,1
PA,UPPER GASTROINTESTINAL HAEMORRHAGE,1
PA,VIITH NERVE PARALYSIS,1
PA,VIRAL INFECTION,1
PA,VIRAL PHARYNGITIS,1
PA,VISUAL ACUITY REDUCED,1
PA,VOMITING,1
PA,WHITE BLOOD CELL COUNT DECREASED,1
PA,WOUND,1
PH,BLOOD CREATININE INCREASED,1
PH,BLOOD GLUCOSE INCREASED,1
PH,HAEMATOMA,1
PL,CHRONIC PIGMENTED PURPURA,6
PL,RHABDOMYOLYSIS,4
PL,DRUG-INDUCED LIVER INJURY,3
PL,MYOPATHY,3
PL,ACUTE MYOCARDIAL INFARCTION,2
PL,BLOOD GLUCOSE INCREASED,2
PL,BLOOD PRESSURE INCREASED,2
PL,HYPOGLYCAEMIA,2
PL,OEDEMA PERIPHERAL,2
PL,QUADRIPLEGIA,2
PL,SINUS NODE DYSFUNCTION,2
PL,UPPER RESPIRATORY TRACT INFECTION,2
PL,ABDOMINAL PAIN,1
PL,ADAMS-STOKES SYNDROME,1
PL,ADENOCARCINOMA OF COLON,1
PL,ANAEMIA,1
PL,ANGINA PECTORIS,1
PL,ARTHRALGIA,1
PL,ASCITES,1
PL,BACTERIAL SEPSIS,1
PL,BLADDER TRANSITIONAL CELL CARCINOMA,1
PL,BLOOD ALBUMIN DECREASED,1
PL,BLOOD THYROID STIMULATING HORMONE DECREASED,1
PL,BRADYCARDIA,1
PL,BRONCHITIS,1
PL,BUNDLE BRANCH BLOCK LEFT,1
PL,BURKITT^S LYMPHOMA,1
PL,CAROTID SINUS SYNDROME,1
PL,CEREBROVASCULAR ACCIDENT,1
PL,CHEST PAIN,1
PL,CHILD-PUGH-TURCOTTE SCORE INCREASED,1
PL,CHOLECYSTITIS,1
PL,CHOLELITHIASIS,1
PL,DEATH,1
PL,DECREASED APPETITE,1
PL,DIARRHOEA,1
PL,DISEASE PROGRESSION,1
PL,DIVERTICULUM INTESTINAL,1
PL,DIZZINESS,1
PL,DRUG DOSE OMISSION,1
PL,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,1
PL,DYSPNOEA,1
PL,DYSPNOEA EXERTIONAL,1
PL,EJECTION FRACTION DECREASED,1
PL,ENTERITIS,1
PL,EXERCISE TOLERANCE DECREASED,1
PL,FUNCTIONAL GASTROINTESTINAL DISORDER,1
PL,GLIOMA,1
PL,HEART RATE DECREASED,1
PL,HEPATIC FAILURE,1
PL,HYPERBILIRUBINAEMIA,1
PL,HYPOTENSION,1
PL,HYPOVOLAEMIC SHOCK,1
PL,INTERNATIONAL NORMALISED RATIO INCREASED,1
PL,ISCHAEMIC STROKE,1
PL,JAUNDICE,1
PL,LIVER INJURY,1
PL,LOCALISED OEDEMA,1
PL,LUNG DISORDER,1
PL,MALIGNANT MELANOMA,1
PL,METABOLIC DISORDER,1
PL,METASTATIC MALIGNANT MELANOMA,1
PL,MYOCARDIAL INFARCTION,1
PL,NAUSEA,1
PL,NECROBIOSIS LIPOIDICA DIABETICORUM,1
PL,NON-CARDIOGENIC PULMONARY OEDEMA,1
PL,ORTHOSTATIC HYPOTENSION,1
PL,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,1
PL,PALPITATIONS,1
PL,PERIPHERAL SWELLING,1
PL,PNEUMONIA,1
PL,POLLAKIURIA,1
PL,PULMONARY EMBOLISM,1
PL,PULMONARY OEDEMA,1
PL,SEPSIS,1
PL,SOMNOLENCE,1
PL,THROMBOPHLEBITIS SUPERFICIAL,1
PL,TROPONIN I INCREASED,1
PL,URINARY TRACT INFLAMMATION,1
PL,VERTIGO,1
PL,WEIGHT DECREASED,1
PT,PERIPHERAL ISCHAEMIA,10
PT,LACTIC ACIDOSIS,9
PT,ACUTE KIDNEY INJURY,8
PT,DIABETIC FOOT INFECTION,7
PT,DYSPNOEA,7
PT,FINGER AMPUTATION,6
PT,NAUSEA,6
PT,VOMITING,6
PT,DEATH,5
PT,ACUTE PULMONARY OEDEMA,4
PT,CHORIORETINITIS,4
PT,ERYTHEMA,4
PT,HYPOTENSION,4
PT,METABOLIC ACIDOSIS,4
PT,RENAL IMPAIRMENT,4
PT,THROMBOCYTOPENIA,4
PT,ABDOMINAL PAIN,3
PT,ACUTE MYOCARDIAL INFARCTION,3
PT,BONE MARROW TOXICITY,3
PT,CARDIAC FAILURE,3
PT,DECREASED APPETITE,3
PT,DIZZINESS,3
PT,FEBRILE NEUTROPENIA,3
PT,GASTROINTESTINAL HAEMORRHAGE,3
PT,HYPERKALAEMIA,3
PT,OROPHARYNGEAL DISCOMFORT,3
PT,PRURITUS,3
PT,RENAL INJURY,3
PT,SEPSIS,3
PT,SPEECH DISORDER,3
PT,ANAPHYLACTIC REACTION,2
PT,ANGIOEDEMA,2
PT,ASTHENIA,2
PT,BLOOD CREATININE INCREASED,2
PT,BLOOD PRESSURE INCREASED,2
PT,CANDIDURIA,2
PT,CHEST PAIN,2
PT,DRUG INEFFECTIVE,2
PT,ECCHYMOSIS,2
PT,FATIGUE,2
PT,FLUSHING,2
PT,GASTRITIS,2
PT,GENERALISED OEDEMA,2
PT,HAEMATURIA,2
PT,HAEMOPTYSIS,2
PT,HAEMORRHAGE,2
PT,HEPATIC FUNCTION ABNORMAL,2
PT,HEPATITIS TOXIC,2
PT,HYPERTENSION,2
PT,INFECTION,2
PT,LOSS OF CONSCIOUSNESS,2
PT,MELAENA,2
PT,MULTI-ORGAN FAILURE,2
PT,NEUROLOGICAL SYMPTOM,2
PT,NEUTROPENIA,2
PT,ORAL CANDIDIASIS,2
PT,OXYGEN SATURATION DECREASED,2
PT,PANCYTOPENIA,2
PT,PARAESTHESIA,2
PT,PRODUCT QUALITY ISSUE,2
PT,RESPIRATORY FAILURE,2
PT,RESPIRATORY TRACT INFECTION,2
PT,SEPTIC SHOCK,2
PT,SPLENIC RUPTURE,2
PT,TOXIC SKIN ERUPTION,2
PT,TOXICITY TO VARIOUS AGENTS,2
PT,URINARY TRACT INFECTION,2
PT,URINE OUTPUT DECREASED,2
PT,WHEEZING,2
PT,ABDOMINAL HERNIA,1
PT,ABDOMINAL PAIN UPPER,1
PT,ABNORMAL DREAMS,1
PT,ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS,1
PT,ALCOHOL INTERACTION,1
PT,ANAL INCONTINENCE,1
PT,ANAPHYLACTIC SHOCK,1
PT,ANURIA,1
PT,ARRHYTHMIA,1
PT,ARTHRALGIA,1
PT,ARTHRITIS,1
PT,BLADDER TRANSITIONAL CELL CARCINOMA,1
PT,BLOOD CREATININE ABNORMAL,1
PT,BLOOD LACTIC ACID INCREASED,1
PT,BLOOD PRESSURE ABNORMAL,1
PT,BLOOD UREA INCREASED,1
PT,BONE MARROW FAILURE,1
PT,BRADYCARDIA,1
PT,BUNDLE BRANCH BLOCK RIGHT,1
PT,CANDIDA INFECTION,1
PT,CEREBROVASCULAR ACCIDENT,1
PT,COAGULOPATHY,1
PT,CONCOMITANT DISEASE AGGRAVATED,1
PT,CONDITION AGGRAVATED,1
PT,CONJUNCTIVAL DISORDER,1
PT,CYANOSIS,1
PT,DEEP VEIN THROMBOSIS,1
PT,DEHYDRATION,1
PT,DEPRESSED LEVEL OF CONSCIOUSNESS,1
PT,DEPRESSION,1
PT,DEVICE EMBOLISATION,1
PT,DIARRHOEA,1
PT,DRUG ADMINISTRATION ERROR,1
PT,DRY EYE,1
PT,DRY MOUTH,1
PT,DYSGEUSIA,1
PT,DYSURIA,1
PT,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,1
PT,ELECTROCARDIOGRAM ST SEGMENT ELEVATION,1
PT,ELECTROLYTE IMBALANCE,1
PT,EPISTAXIS,1
PT,ESCHERICHIA URINARY TRACT INFECTION,1
PT,EYE SWELLING,1
PT,EYELID OEDEMA,1
PT,FALL,1
PT,FANCONI SYNDROME ACQUIRED,1
PT,GASTROOESOPHAGEAL REFLUX DISEASE,1
PT,GENERALISED TONIC-CLONIC SEIZURE,1
PT,GINGIVAL BLEEDING,1
PT,GLOMERULAR FILTRATION RATE DECREASED,1
PT,HAEMATOCHEZIA,1
PT,HAEMODYNAMIC INSTABILITY,1
PT,HEADACHE,1
PT,HEART RATE INCREASED,1
PT,HEPATIC ENCEPHALOPATHY,1
PT,HEPATIC FAILURE,1
PT,HEPATIC PAIN,1
PT,HYPERCAPNIA,1
PT,HYPERHIDROSIS,1
PT,HYPERLACTACIDAEMIA,1
PT,HYPERSENSITIVITY,1
PT,HYPOAESTHESIA ORAL,1
PT,HYPOGLYCAEMIA,1
PT,HYPOKALAEMIA,1
PT,HYPOTHERMIA,1
PT,HYPOVOLAEMIC SHOCK,1
PT,HYPOXIA,1
PT,INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION,1
PT,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,1
PT,INSOMNIA,1
PT,INTENTIONAL OVERDOSE,1
PT,INTENTIONAL PRODUCT USE ISSUE,1
PT,INTERNATIONAL NORMALISED RATIO INCREASED,1
PT,INTESTINAL ISCHAEMIA,1
PT,KERATITIS,1
PT,KLEBSIELLA INFECTION,1
PT,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,1
PT,LEG AMPUTATION,1
PT,LEUKOPENIA,1
PT,LIP OEDEMA,1
PT,LIPODYSTROPHY ACQUIRED,1
PT,LOWER LIMB FRACTURE,1
PT,LYMPHOPENIA,1
PT,MATERNAL EXPOSURE BEFORE PREGNANCY,1
PT,MICROANGIOPATHIC HAEMOLYTIC ANAEMIA,1
PT,MOTOR DYSFUNCTION,1
PT,MULTIMORBIDITY,1
PT,MULTIPLE SCLEROSIS RELAPSE,1
PT,MUSCULAR WEAKNESS,1
PT,MUSCULOSKELETAL PAIN,1
PT,MYOCARDIAL INFARCTION,1
PT,NEPHROANGIOSCLEROSIS,1
PT,NEPHROGENIC DIABETES INSIPIDUS,1
PT,NEPHROLITHIASIS,1
PT,NERVOUSNESS,1
PT,NORMOCHROMIC ANAEMIA,1
PT,NUCHAL RIGIDITY,1
PT,OEDEMA,1
PT,OESOPHAGEAL PAIN,1
PT,OESOPHAGEAL VARICES HAEMORRHAGE,1
PT,OPPORTUNISTIC INFECTION,1
PT,ORTHOSTATIC HYPOTENSION,1
PT,PAIN,1
PT,PERIPHERAL SWELLING,1
PT,PHYSICAL ASSAULT,1
PT,PIGMENTATION DISORDER,1
PT,PNEUMONIA,1
PT,PNEUMONIA ASPIRATION,1
PT,PNEUMONIA BACTERIAL,1
PT,PNEUMONIA LEGIONELLA,1
PT,POLYARTHRITIS,1
PT,PRODUCT SUBSTITUTION ISSUE,1
PT,PRODUCT USE IN UNAPPROVED INDICATION,1
PT,PRODUCTIVE COUGH,1
PT,PROTEINURIA,1
PT,PSEUDOMONAL BACTERAEMIA,1
PT,PSEUDOMONAS INFECTION,1
PT,PULMONARY ALVEOLAR HAEMORRHAGE,1
PT,PULMONARY CONGESTION,1
PT,PULMONARY OEDEMA,1
PT,PULMONARY VASCULITIS,1
PT,RECTAL HAEMORRHAGE,1
PT,RENAL FAILURE,1
PT,RENAL FAILURE ACUTE,1
PT,RENAL TUBULAR ACIDOSIS,1
PT,RENAL VASCULITIS,1
PT,RHABDOMYOLYSIS,1
PT,ROAD TRAFFIC ACCIDENT,1
PT,SEIZURE,1
PT,SENSORY DISTURBANCE,1
PT,SHOCK,1
PT,SHOCK HAEMORRHAGIC,1
PT,SKIN DISCOLOURATION,1
PT,SKIN EXFOLIATION,1
PT,SKIN NECROSIS,1
PT,SKIN TOXICITY,1
PT,SPINAL FRACTURE,1
PT,STOMATITIS,1
PT,SUICIDE ATTEMPT,1
PT,TACHYPNOEA,1
PT,THROMBOTIC MICROANGIOPATHY,1
PT,TRACHEOBRONCHITIS,1
PT,TRANSAMINASES INCREASED,1
PT,TREATMENT FAILURE,1
PT,TREMOR,1
PT,TUBULOINTERSTITIAL NEPHRITIS,1
PT,ULTRAFILTRATION FAILURE,1
PT,URINARY INCONTINENCE,1
PT,UROSEPSIS,1
PT,URTICARIA,1
PT,VASCULAR STENT THROMBOSIS,1
PT,VASOCONSTRICTION,1
PT,VISUAL IMPAIRMENT,1
PR,NASOPHARYNGITIS,23
PR,INJECTION SITE PAIN,16
PR,PAIN,13
PR,HEADACHE,9
PR,DIARRHOEA,7
PR,HYPERKALAEMIA,7
PR,PAIN IN EXTREMITY,7
PR,DRUG INEFFECTIVE,6
PR,URINARY TRACT INFECTION,6
PR,DIZZINESS,5
PR,FALL,5
PR,HAEMOGLOBIN DECREASED,5
PR,HYPERTENSION,5
PR,PYREXIA,5
PR,ARTHRALGIA,4
PR,ASTHMA,4
PR,BACK PAIN,4
PR,CELLULITIS,4
PR,PSORIASIS,4
PR,UNRESPONSIVE TO STIMULI,4
PR,ABDOMINAL DISCOMFORT,3
PR,ASTHENIA,3
PR,CARDIAC DISORDER,3
PR,CHEST PAIN,3
PR,CHIKUNGUNYA VIRUS INFECTION,3
PR,ERYTHEMA,3
PR,FATIGUE,3
PR,HYPERSENSITIVITY,3
PR,INJECTION SITE HAEMATOMA,3
PR,OSTEOARTHRITIS,3
PR,PALPITATIONS,3
PR,PERIPHERAL SWELLING,3
PR,PRURITUS,3
PR,RASH,3
PR,WEIGHT DECREASED,3
PR,ABDOMINAL PAIN UPPER,2
PR,ABSCESS,2
PR,ABSCESS LIMB,2
PR,ANAEMIA,2
PR,ARTHRITIS,2
PR,ARTHROPATHY,2
PR,ATRIOVENTRICULAR BLOCK,2
PR,ATRIOVENTRICULAR BLOCK COMPLETE,2
PR,BACTERIAL INFECTION,2
PR,BEDRIDDEN,2
PR,BLISTER,2
PR,BLOOD GLUCOSE INCREASED,2
PR,BLOOD PRESSURE INCREASED,2
PR,BRONCHITIS,2
PR,CEREBROVASCULAR ACCIDENT,2
PR,CONSTIPATION,2
PR,DECREASED ACTIVITY,2
PR,DECREASED APPETITE,2
PR,DEPRESSED MOOD,2
PR,DEPRESSION,2
PR,DRY SKIN,2
PR,DYSGEUSIA,2
PR,EYE SWELLING,2
PR,FACIAL PARALYSIS,2
PR,FUNGAL INFECTION,2
PR,GAIT DISTURBANCE,2
PR,HAEMODIALYSIS,2
PR,INFLAMMATION,2
PR,INJECTION SITE HAEMORRHAGE,2
PR,INJURY ASSOCIATED WITH DEVICE,2
PR,LOCALISED INFECTION,2
PR,MALAISE,2
PR,MEMORY IMPAIRMENT,2
PR,MUSCULOSKELETAL PAIN,2
PR,MYALGIA,2
PR,NAUSEA,2
PR,NECK PAIN,2
PR,ORAL PAIN,2
PR,PLATELET COUNT INCREASED,2
PR,PNEUMONIA,2
PR,PRODUCTIVE COUGH,2
PR,RASH MACULAR,2
PR,RHEUMATOID ARTHRITIS,2
PR,SLOW SPEECH,2
PR,SPINAL PAIN,2
PR,SUICIDE ATTEMPT,2
PR,SWELLING FACE,2
PR,SYNCOPE,2
PR,TACHYCARDIA,2
PR,UTERINE HAEMORRHAGE,2
PR,VISION BLURRED,2
PR,VOMITING,2
PR,WHITE BLOOD CELL COUNT INCREASED,2
PR,ABDOMINAL ABSCESS,1
PR,ABSCESS NECK,1
PR,ACUTE KIDNEY INJURY,1
PR,ACUTE RESPIRATORY DISTRESS SYNDROME,1
PR,AGEUSIA,1
PR,ALLERGIC OEDEMA,1
PR,ANAL NEOPLASM,1
PR,ANGIOEDEMA,1
PR,ANIMAL SCRATCH,1
PR,ANXIETY,1
PR,ASPIRATION PLEURAL CAVITY,1
PR,BLINDNESS,1
PR,BLOOD CHOLESTEROL INCREASED,1
PR,BLOOD CREATININE INCREASED,1
PR,BLOOD GLUCOSE ABNORMAL,1
PR,BLOOD IRON DECREASED,1
PR,BLOOD PRESSURE ABNORMAL,1
PR,BLOOD PRESSURE DECREASED,1
PR,BLOOD PRESSURE INADEQUATELY CONTROLLED,1
PR,BONE EROSION,1
PR,BONE MARROW FAILURE,1
PR,BONE NEOPLASM,1
PR,BONE PAIN,1
PR,CARDIAC ENZYMES INCREASED,1
PR,CARDIOMEGALY,1
PR,CEREBRAL INFARCTION,1
PR,CHEST DISCOMFORT,1
PR,CHOLELITHIASIS,1
PR,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,1
PR,COMA,1
PR,CONDITION AGGRAVATED,1
PR,COORDINATION ABNORMAL,1
PR,COUGH,1
PR,CYST,1
PR,DEATH,1
PR,DEHYDRATION,1
PR,DERMATITIS,1
PR,DERMATITIS ALLERGIC,1
PR,DISCOMFORT,1
PR,DIVERTICULITIS,1
PR,DRUG ADMINISTERED AT INAPPROPRIATE SITE,1
PR,DRUG EFFECT DECREASED,1
PR,DRUG EFFECT INCOMPLETE,1
PR,DRY EYE,1
PR,DYSARTHRIA,1
PR,DYSPEPSIA,1
PR,DYSPHONIA,1
PR,DYSPNOEA,1
PR,EAR INFECTION,1
PR,EAR PAIN,1
PR,END STAGE RENAL DISEASE,1
PR,EYE HAEMORRHAGE,1
PR,EYE INFLAMMATION,1
PR,EYE OPERATION,1
PR,EYELID OEDEMA,1
PR,FEELING ABNORMAL,1
PR,FEELING HOT,1
PR,FEMUR FRACTURE,1
PR,FINGER DEFORMITY,1
PR,FLATULENCE,1
PR,FUNGAL SKIN INFECTION,1
PR,GANGRENE,1
PR,GASTRITIS,1
PR,GINGIVAL ABSCESS,1
PR,GLOSSODYNIA,1
PR,HAEMATOCHEZIA,1
PR,HAEMATOMA,1
PR,HAEMOPTYSIS,1
PR,HAND FRACTURE,1
PR,HEAD INJURY,1
PR,HEPATIC STEATOSIS,1
PR,HIP FRACTURE,1
PR,HYPOAESTHESIA,1
PR,HYPOKINESIA,1
PR,HYPOTHYROIDISM,1
PR,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,1
PR,INCORRECT DOSE ADMINISTERED,1
PR,INFECTED BITES,1
PR,INFLUENZA,1
PR,INGROWN HAIR,1
PR,INJECTION SITE ERYTHEMA,1
PR,INJECTION SITE OEDEMA,1
PR,INJECTION SITE SWELLING,1
PR,INTERNAL HAEMORRHAGE,1
PR,INTERVERTEBRAL DISC PROTRUSION,1
PR,ISCHAEMIC CARDIOMYOPATHY,1
PR,KNEE ARTHROPLASTY,1
PR,LACERATION,1
PR,LIMB INJURY,1
PR,LIVER DISORDER,1
PR,LOSS OF CONSCIOUSNESS,1
PR,MENTAL STATUS CHANGES,1
PR,MOTOR DYSFUNCTION,1
PR,MOVEMENT DISORDER,1
PR,MULTI-ORGAN DISORDER,1
PR,MUSCLE SPASMS,1
PR,MUSCULAR WEAKNESS,1
PR,MUSCULOSKELETAL DISORDER,1
PR,NAIL DISORDER,1
PR,NASAL CONGESTION,1
PR,NEOPLASM MALIGNANT,1
PR,NERVOUSNESS,1
PR,NEUROPATHY PERIPHERAL,1
PR,NODAL RHYTHM,1
PR,OCULAR HYPERAEMIA,1
PR,ONYCHOMADESIS,1
PR,ORAL DISCOMFORT,1
PR,OROPHARYNGEAL PAIN,1
PR,OSTEOPENIA,1
PR,OVARIAN DISORDER,1
PR,OVERDOSE,1
PR,PAIN OF SKIN,1
PR,PANCREATIC CYST,1
PR,PARAESTHESIA ORAL,1
PR,PERIORBITAL OEDEMA,1
PR,PERIPROSTHETIC FRACTURE,1
PR,PHARYNGITIS,1
PR,PLEURAL EFFUSION,1
PR,POST PROCEDURAL INFECTION,1
PR,POSTOPERATIVE WOUND COMPLICATION,1
PR,POSTOPERATIVE WOUND INFECTION,1
PR,PROCEDURAL PAIN,1
PR,PRODUCT STORAGE ERROR,1
PR,PRURITUS ALLERGIC,1
PR,PURULENT DISCHARGE,1
PR,RASH PRURITIC,1
PR,RECTAL HAEMORRHAGE,1
PR,RED BLOOD CELL SEDIMENTATION RATE INCREASED,1
PR,RENAL FAILURE CHRONIC,1
PR,RENAL IMPAIRMENT,1
PR,RENAL MASS,1
PR,RETINOPATHY,1
PR,SCAR,1
PR,SEIZURE,1
PR,SEPTIC SHOCK,1
PR,SINUSITIS,1
PR,SKIN EXFOLIATION,1
PR,SKIN FISSURES,1
PR,SKIN LESION,1
PR,SKIN ULCER,1
PR,SOMNOLENCE,1
PR,SPINAL DISORDER,1
PR,SPONDYLITIS,1
PR,STOMA SITE DISCHARGE,1
PR,STOMA SITE ERYTHEMA,1
PR,SUBCUTANEOUS ABSCESS,1
PR,TENDON PAIN,1
PR,THROMBOPHLEBITIS,1
PR,THYROID CANCER,1
PR,THYROID MASS,1
PR,TONGUE DISORDER,1
PR,TOOTH FRACTURE,1
PR,TOOTH INFECTION,1
PR,TRACHEAL INFLAMMATION,1
PR,TRANSFUSION,1
PR,TRANSIENT ISCHAEMIC ATTACK,1
PR,TUBERCULIN TEST POSITIVE,1
PR,UNEVALUABLE EVENT,1
PR,UPPER LIMB FRACTURE,1
PR,URTICARIA,1
PR,UTERINE DISORDER,1
PR,UTERINE LEIOMYOMA,1
PR,VAGINAL HAEMORRHAGE,1
PR,VISUAL IMPAIRMENT,1
PR,WRONG TECHNIQUE IN DRUG USAGE PROCESS,1
PR,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,1
RO,PRURITUS,3
RO,DECREASED APPETITE,2
RO,HAEMATEMESIS,2
RO,HEADACHE,2
RO,NAUSEA,2
RO,AMNESIA,1
RO,ANAEMIA,1
RO,ASTHENIA,1
RO,CHRONIC KIDNEY DISEASE,1
RO,DEHYDRATION,1
RO,DELIRIUM,1
RO,DRUG DOSE OMISSION,1
RO,EPISTAXIS,1
RO,FACE OEDEMA,1
RO,LICHEN SCLEROSUS,1
RO,OEDEMA PERIPHERAL,1
RO,SECONDARY HYPERTENSION,1
RO,TREMOR,1
RU,BLOOD PRESSURE INCREASED,10
RU,CHEST PAIN,10
RU,MYOCARDIAL INFARCTION,8
RU,DYSPNOEA,6
RU,CONTUSION,5
RU,BLOOD GLUCOSE INCREASED,4
RU,PRODUCT USE ISSUE,4
RU,BLOOD PRESSURE DECREASED,3
RU,DIZZINESS,3
RU,EPISTAXIS,3
RU,GASTRITIS,3
RU,HEART RATE DECREASED,3
RU,VASCULAR STENT OCCLUSION,3
RU,ANGINA PECTORIS,2
RU,ANGINA UNSTABLE,2
RU,ASTHENIA,2
RU,DEVICE FAILURE,2
RU,DRUG INEFFECTIVE,2
RU,DYSPNOEA EXERTIONAL,2
RU,FALL,2
RU,FATIGUE,2
RU,HEADACHE,2
RU,HEART RATE INCREASED,2
RU,INSOMNIA,2
RU,ISCHAEMIC STROKE,2
RU,LOSS OF CONSCIOUSNESS,2
RU,OEDEMA,2
RU,PRODUCTIVE COUGH,2
RU,TYPE 2 DIABETES MELLITUS,2
RU,VASCULAR STENT THROMBOSIS,2
RU,WEIGHT DECREASED,2
RU,WEIGHT INCREASED,2
RU,ABDOMINAL PAIN,1
RU,ABDOMINAL PAIN UPPER,1
RU,ACUTE CORONARY SYNDROME,1
RU,ACUTE MYOCARDIAL INFARCTION,1
RU,ANAPHYLACTIC SHOCK,1
RU,ANXIETY,1
RU,ASPHYXIA,1
RU,ASTHMA,1
RU,BLEEDING TIME PROLONGED,1
RU,BLOOD CREATININE INCREASED,1
RU,BLOOD GLUCOSE DECREASED,1
RU,BLOOD GLUCOSE FLUCTUATION,1
RU,BLOOD PRESSURE ABNORMAL,1
RU,BLOOD TRIGLYCERIDES INCREASED,1
RU,BONE PAIN,1
RU,CARDIAC ARREST,1
RU,CEREBRAL HAEMORRHAGE,1
RU,CHEST DISCOMFORT,1
RU,CHOLECYSTITIS,1
RU,CHOLELITHIASIS,1
RU,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,1
RU,CORONARY ARTERY DISEASE,1
RU,CORONARY ARTERY STENOSIS,1
RU,COUGH,1
RU,CYANOSIS,1
RU,DEEP VEIN THROMBOSIS,1
RU,DERMATITIS CONTACT,1
RU,DEVICE OCCLUSION,1
RU,EAR HAEMORRHAGE,1
RU,ELECTROCARDIOGRAM ABNORMAL,1
RU,ELECTROCARDIOGRAM ST SEGMENT ELEVATION,1
RU,ENCEPHALOPATHY,1
RU,ERYTHEMA,1
RU,ESCHERICHIA SEPSIS,1
RU,FEAR,1
RU,FEELING ABNORMAL,1
RU,FOREARM FRACTURE,1
RU,GASTRIC ULCER,1
RU,GASTRODUODENITIS,1
RU,GENITAL INFECTION,1
RU,GLOMERULAR FILTRATION RATE DECREASED,1
RU,GLYCOSYLATED HAEMOGLOBIN INCREASED,1
RU,GOUT,1
RU,HAEMORRHAGE URINARY TRACT,1
RU,HIP FRACTURE,1
RU,HYPERGLYCAEMIA,1
RU,HYPERHIDROSIS,1
RU,HYPERSENSITIVITY,1
RU,HYPERTENSION,1
RU,HYPERTENSIVE CRISIS,1
RU,HYPOTENSION,1
RU,INSULIN C-PEPTIDE INCREASED,1
RU,INTERNAL HAEMORRHAGE,1
RU,INTERNATIONAL NORMALISED RATIO INCREASED,1
RU,INTERVERTEBRAL DISC PROTRUSION,1
RU,LUNG NEOPLASM MALIGNANT,1
RU,MOTOR DYSFUNCTION,1
RU,MYALGIA,1
RU,MYOCARDIAL ISCHAEMIA,1
RU,NAUSEA,1
RU,NEPHROLITHIASIS,1
RU,NERVOUSNESS,1
RU,OCULAR HYPERAEMIA,1
RU,OXYGEN SATURATION DECREASED,1
RU,PANCREATITIS CHRONIC,1
RU,PARTIAL SEIZURES,1
RU,PELVIC VENOUS THROMBOSIS,1
RU,PERINEAL CELLULITIS,1
RU,PLEURISY,1
RU,PNEUMONIA,1
RU,PROCTITIS,1
RU,PRURITUS,1
RU,PRURITUS GENITAL,1
RU,PULMONARY OEDEMA,1
RU,PYREXIA,1
RU,RALES,1
RU,RASH,1
RU,RENIN INCREASED,1
RU,RESPIRATORY ARREST,1
RU,RETINAL DETACHMENT,1
RU,RETINAL OPERATION,1
RU,SCROTAL ABSCESS,1
RU,SENSITIVITY TO WEATHER CHANGE,1
RU,SOMNOLENCE,1
RU,SPINAL CORD NEOPLASM,1
RU,SPUTUM ABNORMAL,1
RU,TACHYCARDIA,1
RU,TIBIA FRACTURE,1
RU,URETEROLITHIASIS,1
RU,VOMITING,1
RU,WHEEZING,1
RU,WRONG TECHNIQUE IN DRUG USAGE PROCESS,1
SA,NEUROLEPTIC MALIGNANT SYNDROME,9
SA,SEROTONIN SYNDROME,9
SA,NAUSEA,5
SA,HYPERGLYCAEMIA,2
SA,ALTERED STATE OF CONSCIOUSNESS,1
SA,BLOOD CREATINE PHOSPHOKINASE INCREASED,1
SA,BLOOD PRESSURE INCREASED,1
SA,BODY TEMPERATURE INCREASED,1
SA,CARDIAC FAILURE CONGESTIVE,1
SA,CEREBROVASCULAR ACCIDENT,1
SA,CLONUS,1
SA,CONFUSIONAL STATE,1
SA,DIALYSIS,1
SA,DYSPNOEA,1
SA,ERYTHEMA,1
SA,HAEMOGLOBIN DECREASED,1
SA,HEART RATE INCREASED,1
SA,HYPERHIDROSIS,1
SA,HYPERREFLEXIA,1
SA,HYPERTENSION,1
SA,HYPERTHERMIA,1
SA,LEUKOCYTOSIS,1
SA,MUSCLE RIGIDITY,1
SA,MYOCLONUS,1
SA,OEDEMA PERIPHERAL,1
SA,PAIN,1
SA,PRURITUS GENERALISED,1
SA,PYREXIA,1
SA,ROTATOR CUFF SYNDROME,1
SA,SKIN LESION,1
SA,SUDDEN CARDIAC DEATH,1
SA,TACHYCARDIA,1
RS,PULMONARY EMBOLISM,3
RS,ANAEMIA,1
RS,AZOTAEMIA,1
RS,FATIGUE,1
RS,GENERAL PHYSICAL HEALTH DETERIORATION,1
RS,HYPERTENSION,1
RS,MELAENA,1
RS,OEDEMA PERIPHERAL,1
RS,PEMPHIGUS,1
RS,PROSTATE CANCER,1
RS,TRANSAMINASES INCREASED,1
SG,HYPOTENSION,2
SG,ACUTE KIDNEY INJURY,1
SG,APPENDICITIS,1
SG,ARTHROPATHY,1
SG,ATRIAL FIBRILLATION,1
SG,BLINDNESS,1
SG,COUGH,1
SG,DEATH,1
SG,EMBOLIC STROKE,1
SG,HAEMATURIA,1
SG,HAEMOGLOBIN INCREASED,1
SG,LEIOMYOMA,1
SG,MYOCARDIAL ISCHAEMIA,1
SG,PAPILLARY THYROID CANCER,1
SG,RASH,1
SG,RESPIRATORY DEPRESSION,1
SG,RESPIRATORY TRACT INFECTION,1
SG,RETINAL HAEMORRHAGE,1
SG,SEPSIS,1
SG,SUPRAVENTRICULAR TACHYCARDIA,1
SG,TREATMENT NONCOMPLIANCE,1
SG,UNEVALUABLE EVENT,1
SG,UPPER RESPIRATORY TRACT INFECTION,1
SG,URINARY TRACT INFECTION,1
SK,BRAIN OEDEMA,1
SK,CARDIO-RESPIRATORY DISTRESS,1
SK,CEREBRAL HAEMORRHAGE,1
SK,DEEP VEIN THROMBOSIS,1
ZA,UPPER GASTROINTESTINAL HAEMORRHAGE,2
ZA,ABDOMINAL PAIN UPPER,1
ZA,ALANINE AMINOTRANSFERASE INCREASED,1
ZA,ANAEMIA,1
ZA,BLOOD PRESSURE INCREASED,1
ZA,DEPRESSION,1
ZA,DRUG INEFFECTIVE,1
ZA,DUODENITIS,1
ZA,HAEMORRHAGIC ANAEMIA,1
ZA,HOSPITALISATION,1
ZA,HYPOKALAEMIA,1
ZA,HYPONATRAEMIA,1
ZA,INTESTINAL OBSTRUCTION,1
ZA,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,1
ZA,LEG AMPUTATION,1
ZA,MELAENA,1
ZA,MYOCARDIAL INFARCTION,1
ZA,PALLOR,1
ZA,PULMONARY EMBOLISM,1
ES,ACUTE KIDNEY INJURY,10
ES,FATIGUE,8
ES,HYPOTENSION,7
ES,NAUSEA,7
ES,PYREXIA,7
ES,ASTHENIA,6
ES,HYPERKALAEMIA,6
ES,HYPERTENSION,6
ES,HYPONATRAEMIA,6
ES,VOMITING,6
ES,HYPOXIA,5
ES,COUGH,4
ES,DYSPNOEA,4
ES,FALL,4
ES,HEADACHE,4
ES,MALAISE,4
ES,CARDIAC FAILURE,3
ES,CONFUSIONAL STATE,3
ES,CONSTIPATION,3
ES,DIZZINESS,3
ES,HEPATITIS C,3
ES,NEUTROPENIA,3
ES,NON-CARDIOGENIC PULMONARY OEDEMA,3
ES,OEDEMA,3
ES,PAIN IN EXTREMITY,3
ES,PNEUMONIA,3
ES,SYNCOPE,3
ES,ABDOMINAL PAIN,2
ES,ALOPECIA,2
ES,ARRHYTHMIA,2
ES,BLADDER TRANSITIONAL CELL CARCINOMA STAGE 0,2
ES,CARDIAC ARREST,2
ES,CARDIOMYOPATHY,2
ES,CHILLS,2
ES,CHRONIC KIDNEY DISEASE,2
ES,DECREASED APPETITE,2
ES,DEPRESSION,2
ES,DIARRHOEA,2
ES,DRUG INEFFECTIVE,2
ES,DRUG-INDUCED LIVER INJURY,2
ES,FEBRILE NEUTROPENIA,2
ES,HAEMOGLOBIN DECREASED,2
ES,HYPERAMYLASAEMIA,2
ES,HYPOKALAEMIA,2
ES,HYPOTHYROIDISM,2
ES,LEFT VENTRICULAR DYSFUNCTION,2
ES,LOSS OF CONSCIOUSNESS,2
ES,OROPHARYNGEAL PAIN,2
ES,PAIN,2
ES,PANCREATITIS,2
ES,PLATELET COUNT DECREASED,2
ES,RASH,2
ES,RENAL FAILURE,2
ES,RENAL FAILURE ACUTE,2
ES,RESPIRATORY TRACT INFECTION,2
ES,RHINORRHOEA,2
ES,THROMBOCYTOPENIA,2
ES,TOXICITY TO VARIOUS AGENTS,2
ES,TRANSFUSION,2
ES,URINARY TRACT INFECTION,2
ES,VENTRICULAR FIBRILLATION,2
ES,ABDOMINAL DISCOMFORT,1
ES,ABDOMINAL PAIN UPPER,1
ES,ABDOMINAL WALL HAEMATOMA,1
ES,ACUTE MYOCARDIAL INFARCTION,1
ES,ADENOCARCINOMA PANCREAS,1
ES,ADVERSE REACTION,1
ES,AGITATION,1
ES,AKINESIA,1
ES,ALANINE AMINOTRANSFERASE INCREASED,1
ES,ALOPECIA AREATA,1
ES,AMAUROSIS,1
ES,ANAPHYLACTIC REACTION,1
ES,ANGIOPATHY,1
ES,ANTICOAGULATION DRUG LEVEL BELOW THERAPEUTIC,1
ES,AORTIC VALVE INCOMPETENCE,1
ES,ARTHRALGIA,1
ES,ASPIRATION,1
ES,BASAL CELL CARCINOMA,1
ES,BILIARY TRACT INFECTION,1
ES,BLINDNESS,1
ES,BLINDNESS TRANSIENT,1
ES,BLOOD GLUCOSE INCREASED,1
ES,BRONCHIECTASIS,1
ES,CARDIO-RESPIRATORY ARREST,1
ES,CARDIOMEGALY,1
ES,CATARACT,1
ES,CEREBELLAR SYNDROME,1
ES,CEREBROVASCULAR ACCIDENT,1
ES,CHEST PAIN,1
ES,CONDITION AGGRAVATED,1
ES,CONTUSION,1
ES,CORONARY ARTERY DISEASE,1
ES,CREUTZFELDT-JAKOB DISEASE,1
ES,CRYING,1
ES,CUTANEOUS LUPUS ERYTHEMATOSUS,1
ES,CYANOSIS,1
ES,DEATH,1
ES,DELIRIUM,1
ES,DEPRESSED MOOD,1
ES,DERMATITIS ACNEIFORM,1
ES,DIABETIC KETOACIDOSIS,1
ES,DISCOMFORT,1
ES,DISEASE PROGRESSION,1
ES,DISORIENTATION,1
ES,DYSPHAGIA,1
ES,DYSPNOEA EXERTIONAL,1
ES,EJECTION FRACTION DECREASED,1
ES,EPILEPSY,1
ES,ERYTHEMA,1
ES,ERYTHRODERMIC PSORIASIS,1
ES,EXTENSOR PLANTAR RESPONSE,1
ES,FISTULA,1
ES,FLUID RETENTION,1
ES,FRACTURE,1
ES,HAEMATOCHEZIA,1
ES,HAEMODYNAMIC INSTABILITY,1
ES,HAEMORRHAGIC DIATHESIS,1
ES,HEART RATE INCREASED,1
ES,HEART SOUNDS,1
ES,HEPATIC CANCER METASTATIC,1
ES,HEPATIC CIRRHOSIS,1
ES,HEPATOCELLULAR CARCINOMA,1
ES,HEPATOTOXICITY,1
ES,HIP FRACTURE,1
ES,HYPERREFLEXIA,1
ES,HYPERTRANSAMINASAEMIA,1
ES,HYPOAESTHESIA,1
ES,IMMUNE SYSTEM DISORDER,1
ES,INCORRECT DRUG ADMINISTRATION DURATION,1
ES,INSOMNIA,1
ES,INTRA-ABDOMINAL HAEMORRHAGE,1
ES,ISCHAEMIC STROKE,1
ES,JOINT SWELLING,1
ES,JUGULAR VEIN DISTENSION,1
ES,LACTIC ACIDOSIS,1
ES,LACUNAR INFARCTION,1
ES,LIPASE INCREASED,1
ES,LIVER FUNCTION TEST INCREASED,1
ES,LOCALISED INTRAABDOMINAL FLUID COLLECTION,1
ES,LUNG NEOPLASM,1
ES,LYMPHOPENIA,1
ES,MALE SEXUAL DYSFUNCTION,1
ES,METASTASIS,1
ES,MULTIMORBIDITY,1
ES,MUSCLE HAEMORRHAGE,1
ES,MUSCULAR WEAKNESS,1
ES,MYALGIA,1
ES,MYOCARDIAL INFARCTION,1
ES,NAIL DISORDER,1
ES,NASOPHARYNGITIS,1
ES,NEOPLASM MALIGNANT,1
ES,NEUROMYELITIS OPTICA SPECTRUM DISORDER,1
ES,NON-HODGKIN^S LYMPHOMA,1
ES,NORMOCHROMIC NORMOCYTIC ANAEMIA,1
ES,ODYNOPHAGIA,1
ES,OPTIC ISCHAEMIC NEUROPATHY,1
ES,OVERDOSE,1
ES,PALPITATIONS,1
ES,PANCREATIC CARCINOMA,1
ES,PANCREATIC DISORDER,1
ES,PANCYTOPENIA,1
ES,PAPILLARY RENAL CELL CARCINOMA,1
ES,PARAESTHESIA,1
ES,PLEURAL EFFUSION,1
ES,PLEURAL FIBROSIS,1
ES,PLEURITIC PAIN,1
ES,PSYCHOGENIC SEIZURE,1
ES,PULMONARY INFARCTION,1
ES,PUPILLARY REFLEX IMPAIRED,1
ES,RADIUS FRACTURE,1
ES,RALES,1
ES,RASH MACULO-PAPULAR,1
ES,RESPIRATORY DISORDER,1
ES,RESPIRATORY FAILURE,1
ES,RETROGRADE EJACULATION,1
ES,RHONCHI,1
ES,RICHTER^S SYNDROME,1
ES,SEBORRHOEIC DERMATITIS,1
ES,SECRETION DISCHARGE,1
ES,SENSE OF OPPRESSION,1
ES,SEPSIS,1
ES,SEPTIC SHOCK,1
ES,SEROTONIN SYNDROME,1
ES,SIGHT DISABILITY,1
ES,SINUS TACHYCARDIA,1
ES,SKIN REACTION,1
ES,SOMNOLENCE,1
ES,SPONDYLITIS,1
ES,SQUAMOUS CELL CARCINOMA,1
ES,SUDDEN DEATH,1
ES,SUPERIOR VENA CAVA SYNDROME,1
ES,SYSTEMIC INFLAMMATORY RESPONSE SYNDROME,1
ES,TACHYCARDIA,1
ES,THERMOHYPOAESTHESIA,1
ES,TRANSAMINASES INCREASED,1
ES,URINARY RETENTION,1
ES,VIRAL MUTATION IDENTIFIED,1
ES,VISION BLURRED,1
SD,BLOOD CREATININE INCREASED,1
SD,BLOOD UREA INCREASED,1
SE,ABNORMAL FAECES,6
SE,ALOPECIA,6
SE,APHASIA,6
SE,CHROMATURIA,6
SE,DRY MOUTH,6
SE,DYSPNOEA,6
SE,EAR INFECTION,6
SE,FLUSHING,6
SE,GASTROINTESTINAL MOTILITY DISORDER,6
SE,HEADACHE,6
SE,HEART RATE INCREASED,6
SE,LIP SWELLING,6
SE,MUSCULOSKELETAL DISCOMFORT,6
SE,ORAL DISCOMFORT,6
SE,RED BLOOD CELL COUNT DECREASED,6
SE,SOMATIC DELUSION,6
SE,SWOLLEN TONGUE,6
SE,URINE ODOUR ABNORMAL,6
SE,WEIGHT DECREASED,6
SE,WHITE BLOOD CELL COUNT DECREASED,6
SE,POLYNEUROPATHY,4
SE,ABDOMINAL HERNIA,1
SE,AGRANULOCYTOSIS,1
SE,ANGIOPATHY,1
SE,AORTIC DISSECTION,1
SE,CONSTIPATION,1
SE,CORNEAL PERFORATION,1
SE,DEATH,1
SE,DIARRHOEA,1
SE,DIZZINESS,1
SE,ELECTROCARDIOGRAM QT PROLONGED,1
SE,FALL,1
SE,FIBULA FRACTURE,1
SE,GENERAL SYMPTOM,1
SE,INJECTION SITE REACTION,1
SE,INTRAOCULAR PRESSURE INCREASED,1
SE,MUSCULOSKELETAL PAIN,1
SE,MUSCULOSKELETAL STIFFNESS,1
SE,PROSTATIC DISORDER,1
SE,PYREXIA,1
SE,RENAL FAILURE ACUTE,1
SE,SEASONAL ALLERGY,1
SE,VISUAL ACUITY TESTS ABNORMAL,1
CH,ACUTE KIDNEY INJURY,24
CH,NAUSEA,18
CH,CARDIAC FAILURE,14
CH,HYPERKALAEMIA,14
CH,VOMITING,14
CH,HYPOTENSION,12
CH,ASTHENIA,11
CH,GENERAL PHYSICAL HEALTH DETERIORATION,11
CH,TOXICITY TO VARIOUS AGENTS,11
CH,DIARRHOEA,10
CH,OVERDOSE,10
CH,PANCYTOPENIA,10
CH,RENAL FAILURE ACUTE,10
CH,DYSPHAGIA,9
CH,WEIGHT DECREASED,9
CH,ABDOMINAL PAIN UPPER,8
CH,ANAEMIA,8
CH,CHOLESTATIC LIVER INJURY,8
CH,DELIRIUM,8
CH,DYSPNOEA,8
CH,FALL,8
CH,FEBRILE NEUTROPENIA,8
CH,HAEMORRHAGIC ANAEMIA,8
CH,HYPONATRAEMIA,8
CH,DECREASED APPETITE,7
CH,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,7
CH,GAIT DISTURBANCE,7
CH,GASTROINTESTINAL HAEMORRHAGE,7
CH,HAEMOGLOBIN DECREASED,7
CH,MELAENA,7
CH,PAIN,7
CH,PNEUMONIA ASPIRATION,7
CH,RENAL FAILURE,7
CH,TACHYCARDIA,7
CH,BLOOD PRESSURE DECREASED,6
CH,BUNDLE BRANCH BLOCK RIGHT,6
CH,CEREBRAL HAEMORRHAGE,6
CH,DISTURBANCE IN ATTENTION,6
CH,EOSINOPHILIA,6
CH,HAEMATOMA,6
CH,HEPATOCELLULAR INJURY,6
CH,LEUKOPENIA,6
CH,LIVER INJURY,6
CH,OEDEMA PERIPHERAL,6
CH,RASH,6
CH,AGRANULOCYTOSIS,5
CH,ANGIOEDEMA,5
CH,BRADYCARDIA,5
CH,CHROMATOPSIA,5
CH,COLITIS,5
CH,CONDITION AGGRAVATED,5
CH,DIABETIC KETOACIDOSIS,5
CH,ELECTROCARDIOGRAM QT PROLONGED,5
CH,EPISTAXIS,5
CH,GASTRIC ULCER,5
CH,HAEMORRHAGIC EROSIVE GASTRITIS,5
CH,HALLUCINATION_ VISUAL,5
CH,METABOLIC ACIDOSIS,5
CH,PARAESTHESIA,5
CH,PYREXIA,5
CH,RESPIRATORY FAILURE,5
CH,SEPTIC SHOCK,5
CH,THROMBOCYTOPENIA,5
CH,TUBULOINTERSTITIAL NEPHRITIS,5
CH,VISUAL IMPAIRMENT,5
CH,ACUTE HEPATIC FAILURE,4
CH,ACUTE MYOCARDIAL INFARCTION,4
CH,APLASTIC ANAEMIA,4
CH,ARTHRALGIA,4
CH,ATRIOVENTRICULAR BLOCK SECOND DEGREE,4
CH,BASAL GANGLIA HAEMORRHAGE,4
CH,BONE MARROW FAILURE,4
CH,COMA,4
CH,DRUG ADMINISTRATION ERROR,4
CH,DRUG PRESCRIBING ERROR,4
CH,FATIGUE,4
CH,GINGIVAL BLEEDING,4
CH,HAEMORRHAGIC DIATHESIS,4
CH,HYPERHIDROSIS,4
CH,HYPERTENSION,4
CH,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,4
CH,LACTIC ACIDOSIS,4
CH,MALAISE,4
CH,RASH GENERALISED,4
CH,SUBDURAL HAEMATOMA,4
CH,THERAPEUTIC RESPONSE INCREASED,4
CH,THROMBOCYTOPENIC PURPURA,4
CH,TOXIC EPIDERMAL NECROLYSIS,4
CH,TRANSAMINASES ABNORMAL,4
CH,TRANSAMINASES INCREASED,4
CH,ABDOMINAL DISCOMFORT,3
CH,ABDOMINAL PAIN,3
CH,ANAPHYLACTIC REACTION,3
CH,APHASIA,3
CH,ATRIAL FIBRILLATION,3
CH,BALANCE DISORDER,3
CH,C-REACTIVE PROTEIN INCREASED,3
CH,CARDIAC DISORDER,3
CH,CARDIAC TAMPONADE,3
CH,CARDIOGENIC SHOCK,3
CH,CHOLESTASIS,3
CH,CONSTIPATION,3
CH,DEHYDRATION,3
CH,DIZZINESS,3
CH,DRUG INEFFECTIVE,3
CH,DUODENAL ULCER,3
CH,DYSKINESIA,3
CH,DYSPNOEA EXERTIONAL,3
CH,ECZEMA,3
CH,FAECES DISCOLOURED,3
CH,GENERALISED TONIC-CLONIC SEIZURE,3
CH,HAEMATURIA,3
CH,HEADACHE,3
CH,INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION,3
CH,INTERNATIONAL NORMALISED RATIO INCREASED,3
CH,JAUNDICE,3
CH,MULTIPLE ORGAN DYSFUNCTION SYNDROME,3
CH,MYOCARDIAL INFARCTION,3
CH,ORAL HERPES,3
CH,ORTHOSTATIC HYPOTENSION,3
CH,OSTEOPOROSIS,3
CH,PARKINSONISM,3
CH,PERICARDIAL HAEMORRHAGE,3
CH,PERICARDITIS,3
CH,PHOTOPSIA,3
CH,PNEUMONIA,3
CH,POLYNEUROPATHY,3
CH,POTENTIATING DRUG INTERACTION,3
CH,REBOUND EFFECT,3
CH,RENAL IMPAIRMENT,3
CH,SKIN TOXICITY,3
CH,SOMNOLENCE,3
CH,UPPER GASTROINTESTINAL HAEMORRHAGE,3
CH,URINARY TRACT INFECTION,3
CH,VERTIGO,3
CH,VISION BLURRED,3
CH,ABDOMINAL TENDERNESS,2
CH,ABNORMAL BEHAVIOUR,2
CH,AGGRESSION,2
CH,AGITATION,2
CH,ALANINE AMINOTRANSFERASE INCREASED,2
CH,ALTERED STATE OF CONSCIOUSNESS,2
CH,ANAL HAEMORRHAGE,2
CH,ANAPHYLACTIC SHOCK,2
CH,ANTICOAGULATION DRUG LEVEL INCREASED,2
CH,ANXIETY,2
CH,APPENDICITIS,2
CH,ARRHYTHMIA,2
CH,ARTERIOSPASM CORONARY,2
CH,ASPARTATE AMINOTRANSFERASE INCREASED,2
CH,BACTERIAL INFECTION,2
CH,BASAL CELL CARCINOMA,2
CH,BLOOD CREATININE INCREASED,2
CH,BLOOD GLUCOSE INCREASED,2
CH,BONE MARROW TOXICITY,2
CH,CARDIAC FAILURE CONGESTIVE,2
CH,CARDIOACTIVE DRUG LEVEL INCREASED,2
CH,CATARACT,2
CH,CEREBROVASCULAR ACCIDENT,2
CH,CHEST DISCOMFORT,2
CH,CONFUSIONAL STATE,2
CH,CONTRAINDICATED PRODUCT ADMINISTERED,2
CH,DEPRESSED LEVEL OF CONSCIOUSNESS,2
CH,DIABETES MELLITUS,2
CH,DISTRIBUTIVE SHOCK,2
CH,DIVERTICULITIS,2
CH,DYSPNOEA PAROXYSMAL NOCTURNAL,2
CH,ELECTROCARDIOGRAM ABNORMAL,2
CH,ENDOTRACHEAL INTUBATION,2
CH,FAECALOMA,2
CH,FEELING ABNORMAL,2
CH,FLUSHING,2
CH,GAMMA-GLUTAMYLTRANSFERASE INCREASED,2
CH,GASTRIC ULCER HAEMORRHAGE,2
CH,GASTRODUODENAL HAEMORRHAGE,2
CH,GENERALISED ERYTHEMA,2
CH,GOUT,2
CH,HAEMATOTOXICITY,2
CH,HAEMOPTYSIS,2
CH,HAEMORRHAGE,2
CH,HALLUCINATION,2
CH,HYPOCALCAEMIA,2
CH,HYPOVOLAEMIC SHOCK,2
CH,ILEUS,2
CH,ILLUSION,2
CH,INFLUENZA,2
CH,INTENTIONAL PRODUCT MISUSE,2
CH,JAUNDICE CHOLESTATIC,2
CH,LARYNGEAL OEDEMA,2
CH,LUMBAR VERTEBRAL FRACTURE,2
CH,LUNG ABSCESS,2
CH,MANIA,2
CH,MEDICATION ERROR,2
CH,MIXED LIVER INJURY,2
CH,MUCOSAL INFLAMMATION,2
CH,MYALGIA,2
CH,MYDRIASIS,2
CH,NEUTROPENIA,2
CH,NOCTURIA,2
CH,OEDEMA,2
CH,PANCREATITIS,2
CH,PLEURAL EFFUSION,2
CH,PREMATURE BABY,2
CH,PRINZMETAL ANGINA,2
CH,PRODUCT USE IN UNAPPROVED INDICATION,2
CH,PULMONARY OEDEMA,2
CH,RASH MACULO-PAPULAR,2
CH,SENSORY DISTURBANCE,2
CH,SEROTONIN SYNDROME,2
CH,SHOCK HAEMORRHAGIC,2
CH,SKIN ULCER,2
CH,SUICIDE ATTEMPT,2
CH,SYNCOPE,2
CH,TENDON DISORDER,2
CH,THORACIC VERTEBRAL FRACTURE,2
CH,VISUAL ACUITY REDUCED,2
CH,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,2
CH,ABNORMAL LOSS OF WEIGHT,1
CH,ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED,1
CH,ACUTE RESPIRATORY FAILURE,1
CH,ADNEXA UTERI CYST,1
CH,AGE-RELATED MACULAR DEGENERATION,1
CH,ALVEOLITIS ALLERGIC,1
CH,AMMONIA INCREASED,1
CH,ANAEMIA MACROCYTIC,1
CH,ANAPHYLACTOID REACTION,1
CH,ANTIDEPRESSANT DRUG LEVEL ABOVE THERAPEUTIC,1
CH,APLASIA PURE RED CELL,1
CH,APOPTOTIC COLONOPATHY,1
CH,ARRHYTHMIA SUPRAVENTRICULAR,1
CH,ARTHROPATHY,1
CH,ASTHMA,1
CH,ATAXIA,1
CH,ATRIOVENTRICULAR BLOCK COMPLETE,1
CH,AUTOIMMUNE HAEMOLYTIC ANAEMIA,1
CH,BLADDER TRANSITIONAL CELL CARCINOMA,1
CH,BLINDNESS,1
CH,BLISTER,1
CH,BLOOD CREATINE PHOSPHOKINASE INCREASED,1
CH,BLOOD ELECTROLYTES ABNORMAL,1
CH,BLOOD LACTATE DEHYDROGENASE INCREASED,1
CH,BLOOD PHOSPHORUS DECREASED,1
CH,BLOOD PRESSURE ABNORMAL,1
CH,BLOOD PRESSURE FLUCTUATION,1
CH,BLOOD PRESSURE INCREASED,1
CH,BLOOD SODIUM INCREASED,1
CH,BLOOD THYROID STIMULATING HORMONE INCREASED,1
CH,BONE DENSITY DECREASED,1
CH,BRONCHIAL SECRETION RETENTION,1
CH,BRONCHITIS,1
CH,BRONCHOSPASM,1
CH,CACHEXIA,1
CH,CARDIAC ARREST,1
CH,CARDIAC ASTHMA,1
CH,CARDIOMEGALY,1
CH,CARDIOMYOPATHY,1
CH,CEREBRAL ARTERY OCCLUSION,1
CH,CEREBRAL ATROPHY,1
CH,CEREBRAL INFARCTION,1
CH,CEREBRAL MICROHAEMORRHAGE,1
CH,CERVICAL VERTEBRAL FRACTURE,1
CH,CHARLES BONNET SYNDROME,1
CH,CHEST PAIN,1
CH,CHOKING,1
CH,CHRONIC KIDNEY DISEASE,1
CH,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,1
CH,CIRCULATORY COLLAPSE,1
CH,COAGULATION FACTOR V LEVEL DECREASED,1
CH,COMA SCALE ABNORMAL,1
CH,COMPARTMENT SYNDROME,1
CH,CONCUSSION,1
CH,CONGESTIVE CARDIOMYOPATHY,1
CH,CONJUNCTIVAL HAEMORRHAGE,1
CH,CONTUSION,1
CH,CORNEAL OEDEMA,1
CH,CORONARY ARTERY DISEASE,1
CH,CREATININE RENAL CLEARANCE DECREASED,1
CH,CUSHINGOID,1
CH,DEATH,1
CH,DECUBITUS ULCER,1
CH,DELUSION,1
CH,DEMENTIA,1
CH,DEMYELINATING POLYNEUROPATHY,1
CH,DEPRESSED MOOD,1
CH,DEVICE DISLOCATION,1
CH,DEVICE RELATED INFECTION,1
CH,DILATATION ATRIAL,1
CH,DISORIENTATION,1
CH,DISSEMINATED INTRAVASCULAR COAGULATION,1
CH,DIVERTICULUM INTESTINAL,1
CH,DIZZINESS POSTURAL,1
CH,DRUG CLEARANCE DECREASED,1
CH,DRUG ERUPTION,1
CH,DRUG HYPERSENSITIVITY,1
CH,DRUG INTOLERANCE,1
CH,DRUG USE DISORDER,1
CH,DRUG-INDUCED LIVER INJURY,1
CH,DRY SKIN,1
CH,DYSCHROMATOPSIA,1
CH,DYSPLASIA,1
CH,ECCHYMOSIS,1
CH,EJECTION FRACTION DECREASED,1
CH,EOSINOPHIL COUNT INCREASED,1
CH,EPIDERMAL NECROSIS,1
CH,EPILEPSY,1
CH,ERYSIPELAS,1
CH,EXERCISE TOLERANCE DECREASED,1
CH,EXPOSURE DURING PREGNANCY,1
CH,EXTREMITY NECROSIS,1
CH,EYE MOVEMENT DISORDER,1
CH,FEELING HOT,1
CH,FEMORAL NECK FRACTURE,1
CH,FOAMING AT MOUTH,1
CH,FOETAL EXPOSURE DURING PREGNANCY,1
CH,FOOT AMPUTATION,1
CH,FRACTURE,1
CH,GASTRITIS,1
CH,GENITAL HAEMORRHAGE,1
CH,GLOMERULAR FILTRATION RATE DECREASED,1
CH,GRAFT VERSUS HOST DISEASE,1
CH,GRIEF REACTION,1
CH,GRIMACING,1
CH,HAEMARTHROSIS,1
CH,HAEMATEMESIS,1
CH,HAEMATOCHEZIA,1
CH,HAEMODYNAMIC INSTABILITY,1
CH,HAEMOLYTIC ANAEMIA,1
CH,HAEMORRHAGE INTRACRANIAL,1
CH,HAEMORRHAGIC CEREBRAL INFARCTION,1
CH,HEAD DISCOMFORT,1
CH,HEAD INJURY,1
CH,HEARING IMPAIRED,1
CH,HEMIPLEGIA,1
CH,HEPARIN-INDUCED THROMBOCYTOPENIA,1
CH,HEPATIC CANCER,1
CH,HEPATIC ENCEPHALOPATHY,1
CH,HEPATIC ENZYME INCREASED,1
CH,HEPATITIS,1
CH,HEPATOSPLENOMEGALY,1
CH,HYPERAMMONAEMIA,1
CH,HYPERCALCAEMIA,1
CH,HYPERCAPNIA,1
CH,HYPERKERATOSIS,1
CH,HYPERREFLEXIA,1
CH,HYPERTENSIVE CRISIS,1
CH,HYPERTHYROIDISM,1
CH,HYPNAGOGIC HALLUCINATION,1
CH,HYPOALBUMINAEMIA,1
CH,HYPOCHROMIC ANAEMIA,1
CH,HYPOKALAEMIA,1
CH,INCOHERENT,1
CH,INFECTION,1
CH,INFLAMMATION,1
CH,INFUSION SITE DISCOLOURATION,1
CH,INFUSION SITE ERYTHEMA,1
CH,INFUSION SITE EXTRAVASATION,1
CH,INFUSION SITE INDURATION,1
CH,INSOMNIA,1
CH,INTENTIONAL OVERDOSE,1
CH,INTERSTITIAL LUNG DISEASE,1
CH,INTRAVENTRICULAR HAEMORRHAGE,1
CH,IRON DEFICIENCY,1
CH,ISCHAEMIC HEPATITIS,1
CH,LEFT VENTRICULAR FAILURE,1
CH,LETHARGY,1
CH,LEUKOCYTOSIS,1
CH,LIP SWELLING,1
CH,LIVER DISORDER,1
CH,LIVER FUNCTION TEST ABNORMAL,1
CH,LIVER TRANSPLANT REJECTION,1
CH,LUNG ADENOCARCINOMA,1
CH,LUNG INFILTRATION,1
CH,MALIGNANT NEOPLASM PROGRESSION,1
CH,MALNUTRITION,1
CH,MECHANICAL ILEUS,1
CH,MEMORY IMPAIRMENT,1
CH,MENTAL DISORDER,1
CH,METASTASES TO CENTRAL NERVOUS SYSTEM,1
CH,METASTASES TO LIVER,1
CH,MIOSIS,1
CH,MUCINOUS ADENOCARCINOMA OF APPENDIX,1
CH,MUCOSAL TOXICITY,1
CH,MUSCLE DISORDER,1
CH,MUSCLE NECROSIS,1
CH,MUSCULAR WEAKNESS,1
CH,MUSCULOSKELETAL STIFFNESS,1
CH,MYOCARDIAL ISCHAEMIA,1
CH,NEOPLASM PROGRESSION,1
CH,NEURALGIC AMYOTROPHY,1
CH,NEUROLOGICAL DECOMPENSATION,1
CH,NEUROPATHY PERIPHERAL,1
CH,NEUTROPENIC COLITIS,1
CH,NEUTROPENIC SEPSIS,1
CH,NON-HODGKIN^S LYMPHOMA,1
CH,NORMOCHROMIC NORMOCYTIC ANAEMIA,1
CH,OBESITY,1
CH,OCULAR TOXICITY,1
CH,ORAL DISCOMFORT,1
CH,OROPHARYNGEAL SWELLING,1
CH,ORTHOPNOEA,1
CH,OXYGEN SATURATION DECREASED,1
CH,PAIN OF SKIN,1
CH,PANIC ATTACK,1
CH,PAPULE,1
CH,PARANOIA,1
CH,PELVIC PAIN,1
CH,PERIPHERAL VENOUS DISEASE,1
CH,PLATELET COUNT INCREASED,1
CH,PNEUMONIA NECROTISING,1
CH,POISONING,1
CH,PRERENAL FAILURE,1
CH,PRESCRIBED OVERDOSE,1
CH,PRESCRIBED UNDERDOSE,1
CH,PRODUCT USE ISSUE,1
CH,PRODUCTIVE COUGH,1
CH,PROSTATE CANCER,1
CH,PRURITUS,1
CH,PRURITUS GENERALISED,1
CH,PSORIATIC ARTHROPATHY,1
CH,PULMONARY EMBOLISM,1
CH,PURPURA,1
CH,RASH MORBILLIFORM,1
CH,REGURGITATION,1
CH,RENAL ISCHAEMIA,1
CH,RENAL TUBULAR DISORDER,1
CH,RENAL TUBULAR DYSFUNCTION,1
CH,RESPIRATORY ACIDOSIS,1
CH,RESPIRATORY ARREST,1
CH,RESPIRATORY DISORDER,1
CH,RESPIRATORY TRACT INFECTION VIRAL,1
CH,RESTLESSNESS,1
CH,RETINAL DETACHMENT,1
CH,RETINOPATHY,1
CH,RHABDOMYOLYSIS,1
CH,RIGHT VENTRICULAR FAILURE,1
CH,SEDATION,1
CH,SKIN ATROPHY,1
CH,SKIN BURNING SENSATION,1
CH,SKIN DISORDER,1
CH,SKIN LESION,1
CH,SKIN MASS,1
CH,SKIN NECROSIS,1
CH,SKIN PLAQUE,1
CH,SKIN TEST POSITIVE,1
CH,SLEEP APNOEA SYNDROME,1
CH,SOMATIC HALLUCINATION,1
CH,SPEECH DISORDER,1
CH,SPLENOMEGALY,1
CH,SQUAMOUS CELL CARCINOMA,1
CH,STAPHYLOCOCCAL BACTERAEMIA,1
CH,STAPHYLOCOCCAL SEPSIS,1
CH,STEVENS-JOHNSON SYNDROME,1
CH,SUBILEUS,1
CH,SUDDEN DEATH,1
CH,SWOLLEN TONGUE,1
CH,SYNOVIAL CYST,1
CH,SYNOVITIS,1
CH,SYSTEMIC INFLAMMATORY RESPONSE SYNDROME,1
CH,TACHYARRHYTHMIA,1
CH,TENSION,1
CH,THERAPEUTIC RESPONSE DECREASED,1
CH,THINKING ABNORMAL,1
CH,THROMBOPHLEBITIS SEPTIC,1
CH,TUMOUR LYSIS SYNDROME,1
CH,TYPE 2 DIABETES MELLITUS,1
CH,TYPE I HYPERSENSITIVITY,1
CH,ULCER,1
CH,URINARY RETENTION,1
CH,URINARY TRACT OBSTRUCTION,1
CH,UTERINE POLYP,1
CH,UTERINE POLYPECTOMY,1
CH,VENOUS INSUFFICIENCY,1
CH,VENOUS THROMBOSIS,1
CH,VENTRICULAR HYPOKINESIA,1
CH,WEIGHT INCREASED,1
TW,ACUTE KIDNEY INJURY,1
TW,ACUTE MYOCARDIAL INFARCTION,1
TW,BENIGN PROSTATIC HYPERPLASIA,1
TW,BLOOD BILIRUBIN INCREASED,1
TW,BLOOD GLUCOSE INCREASED,1
TW,CHRONIC MYELOID LEUKAEMIA,1
TW,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,1
TW,DYSPNOEA,1
TW,FATIGUE,1
TW,HYPOGLYCAEMIA,1
TW,INFECTION,1
TW,PYREXIA,1
TN,CHEST PAIN,1
TN,DEATH,1
TN,VOMITING,1
TR,ANAEMIA,2
TR,BLOOD GLUCOSE INCREASED,2
TR,BONE MARROW FAILURE,2
TR,ELECTROCARDIOGRAM QT PROLONGED,2
TR,NAUSEA,2
TR,ANEURYSM RUPTURED,1
TR,ANGIOEDEMA,1
TR,ASPARTATE AMINOTRANSFERASE INCREASED,1
TR,DEATH,1
TR,DIABETES MELLITUS,1
TR,FAT EMBOLISM,1
TR,FATIGUE,1
TR,GAMMA-GLUTAMYLTRANSFERASE INCREASED,1
TR,GASTROINTESTINAL HAEMORRHAGE,1
TR,GENERALISED TONIC-CLONIC SEIZURE,1
TR,HYPERPARATHYROIDISM,1
TR,HYPOCALCAEMIA,1
TR,HYPOMAGNESAEMIA,1
TR,LIVER FUNCTION TEST ABNORMAL,1
TR,LOSS OF CONSCIOUSNESS,1
TR,LOW DENSITY LIPOPROTEIN INCREASED,1
TR,MUSCLE SPASMS,1
TR,PARAESTHESIA,1
TR,RENAL FAILURE ACUTE,1
TR,SMALL CELL LUNG CANCER,1
UG,ABDOMINAL PAIN UPPER,1
UG,CARDIOMEGALY,1
UG,CARDIOTHORACIC RATIO,1
UG,COUGH,1
UG,CREPITATIONS,1
UG,DRUG DOSE OMISSION,1
UG,DYSPNOEA,1
UG,ELECTROCARDIOGRAM ST-T CHANGE,1
UG,FLUID RETENTION,1
UG,HAEMOPTYSIS,1
UG,HEART SOUNDS ABNORMAL,1
UG,HEPATOMEGALY,1
UG,LEFT VENTRICULAR DYSFUNCTION,1
UG,LEFT VENTRICULAR HYPERTROPHY,1
UG,LOW DENSITY LIPOPROTEIN INCREASED,1
UG,MUSCULAR WEAKNESS,1
UG,PERICARDIAL EFFUSION,1
UG,PULSE VOLUME DECREASED,1
UG,SINUS TACHYCARDIA,1
UG,TREATMENT NONCOMPLIANCE,1
UA,ANGINA UNSTABLE,1
UA,ASTHENIA,1
UA,ATRIAL FIBRILLATION,1
UA,BODY MASS INDEX DECREASED,1
UA,BODY TEMPERATURE INCREASED,1
UA,CARDIAC FAILURE ACUTE,1
UA,CONDITION AGGRAVATED,1
UA,DIABETES MELLITUS,1
UA,ENCEPHALOPATHY,1
UA,HEPATITIS TOXIC,1
UA,HEPATOTOXICITY,1
UA,HYPERTENSIVE CRISIS,1
UA,HYPOGLYCAEMIC UNCONSCIOUSNESS,1
UA,MYOCARDIAL INFARCTION,1
UA,PANCREATITIS ACUTE,1
UA,PULMONARY OEDEMA,1
UA,PYELONEPHRITIS CHRONIC,1
UA,SINUS NODE DYSFUNCTION,1
UA,TREMOR,1
AE,DRY SKIN,1
AE,SKIN EXFOLIATION,1
AE,TRANSIENT ISCHAEMIC ATTACK,1
AE,UPPER GASTROINTESTINAL HAEMORRHAGE,1
GB,MALAISE,284
GB,ACUTE KIDNEY INJURY,272
GB,DIARRHOEA,207
GB,DYSPNOEA,189
GB,DIZZINESS,176
GB,CONFUSIONAL STATE,169
GB,VOMITING,168
GB,HYPONATRAEMIA,165
GB,FATIGUE,152
GB,NAUSEA,145
GB,HYPOTENSION,125
GB,MYALGIA,121
GB,ARTHRALGIA,111
GB,RENAL IMPAIRMENT,103
GB,ANGIOEDEMA,102
GB,COUGH,102
GB,BRADYCARDIA,100
GB,RENAL FAILURE ACUTE,100
GB,HEADACHE,94
GB,SWOLLEN TONGUE,92
GB,SYNCOPE,88
GB,ABDOMINAL PAIN,85
GB,HYPERKALAEMIA,85
GB,FALL,82
GB,CARDIAC ARREST,77
GB,DECREASED APPETITE,76
GB,PALPITATIONS,75
GB,PRURITUS,75
GB,ANXIETY,74
GB,PAIN IN EXTREMITY,74
GB,LIP SWELLING,73
GB,PAIN,72
GB,ASTHENIA,71
GB,PYREXIA,71
GB,MUSCULAR WEAKNESS,70
GB,BALANCE DISORDER,69
GB,ANAEMIA,68
GB,JOINT SWELLING,68
GB,DEHYDRATION,67
GB,LOWER RESPIRATORY TRACT INFECTION,67
GB,PERIPHERAL SWELLING,66
GB,SWELLING FACE,64
GB,PARAESTHESIA,60
GB,SOMNOLENCE,59
GB,SUICIDAL IDEATION,59
GB,MUSCLE SPASMS,56
GB,GAIT DISTURBANCE,55
GB,LIVER FUNCTION TEST ABNORMAL,55
GB,RASH,49
GB,TACHYCARDIA,49
GB,HYPERHIDROSIS,47
GB,HYPOCALCAEMIA,45
GB,INSOMNIA,45
GB,AMNESIA,44
GB,HYPERTENSION,44
GB,AGITATION,43
GB,DEPRESSION,43
GB,LOSS OF CONSCIOUSNESS,43
GB,ANAPHYLACTIC REACTION,42
GB,GENERAL PHYSICAL HEALTH DETERIORATION,42
GB,CHEST PAIN,41
GB,HALLUCINATION,41
GB,HYPERSENSITIVITY,41
GB,TOXICITY TO VARIOUS AGENTS,41
GB,TREMOR,41
GB,DRUG INEFFECTIVE,40
GB,DYSARTHRIA,40
GB,LETHARGY,40
GB,OEDEMA PERIPHERAL,40
GB,URTICARIA,40
GB,DYSPEPSIA,39
GB,ABDOMINAL PAIN UPPER,38
GB,ATRIAL FIBRILLATION,38
GB,HYPOAESTHESIA,38
GB,RENAL FAILURE,38
GB,WEIGHT DECREASED,38
GB,CONDITION AGGRAVATED,37
GB,HYPOKALAEMIA,37
GB,URINARY TRACT INFECTION,37
GB,SEIZURE,35
GB,WHEEZING,35
GB,HYPOGLYCAEMIA,34
GB,METABOLIC ACIDOSIS,34
GB,MUSCLE ATROPHY,34
GB,CIRCULATORY COLLAPSE,33
GB,CONSTIPATION,33
GB,DISCOMFORT,33
GB,WHITE BLOOD CELL COUNT INCREASED,33
GB,ABDOMINAL DISTENSION,32
GB,BLOOD POTASSIUM INCREASED,32
GB,CEREBROVASCULAR ACCIDENT,32
GB,CONTRAINDICATED DRUG ADMINISTERED,32
GB,DYSKINESIA,32
GB,JAUNDICE,32
GB,MYOCARDIAL ISCHAEMIA,32
GB,ACUTE MYOCARDIAL INFARCTION,31
GB,DISTURBANCE IN ATTENTION,31
GB,GASTROINTESTINAL HAEMORRHAGE,31
GB,HYPOMAGNESAEMIA,31
GB,MELAENA,31
GB,PNEUMONIA,31
GB,VISION BLURRED,31
GB,BACK PAIN,30
GB,BLOOD CREATINE PHOSPHOKINASE INCREASED,30
GB,BLOOD URINE PRESENT,30
GB,FEELING ABNORMAL,30
GB,INTERNATIONAL NORMALISED RATIO INCREASED,29
GB,SEPSIS,29
GB,ACCIDENTAL OVERDOSE,28
GB,MEMORY IMPAIRMENT,28
GB,ORTHOSTATIC HYPOTENSION,28
GB,RECTAL HAEMORRHAGE,28
GB,SLEEP DISORDER,28
GB,BLOOD PRESSURE INCREASED,27
GB,EPISTAXIS,27
GB,RASH ERYTHEMATOUS,27
GB,RHABDOMYOLYSIS,27
GB,DYSPHONIA,26
GB,GLOMERULAR FILTRATION RATE DECREASED,26
GB,HAEMATEMESIS,26
GB,LACTIC ACIDOSIS,26
GB,MOBILITY DECREASED,26
GB,NEUTROPENIC SEPSIS,26
GB,PRURITUS GENERALISED,26
GB,VERTIGO,26
GB,DEATH,25
GB,DYSPHAGIA,25
GB,HAEMOGLOBIN DECREASED,25
GB,OBSTRUCTIVE AIRWAYS DISORDER,25
GB,TINNITUS,25
GB,EYE PAIN,24
GB,HAEMATURIA,24
GB,MANIA,24
GB,MOOD ALTERED,24
GB,OROPHARYNGEAL PAIN,24
GB,CORONARY ARTERY DISEASE,23
GB,LOCAL SWELLING,23
GB,MYOCARDIAL INFARCTION,23
GB,PANCYTOPENIA,23
GB,PULMONARY OEDEMA,23
GB,CONTUSION,22
GB,HYPOXIA,22
GB,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,22
GB,PALLOR,22
GB,PRODUCT SUBSTITUTION ISSUE,22
GB,RESPIRATORY FAILURE,22
GB,BLOOD GLUCOSE INCREASED,21
GB,ELECTROCARDIOGRAM QT PROLONGED,21
GB,HEART RATE INCREASED,21
GB,THROAT IRRITATION,21
GB,UPPER GASTROINTESTINAL HAEMORRHAGE,21
GB,WITHDRAWAL SYNDROME,21
GB,CARDIAC FAILURE ACUTE,20
GB,DIABETIC KETOACIDOSIS,20
GB,DISORIENTATION,20
GB,FEBRILE NEUTROPENIA,20
GB,HAEMORRHAGE,20
GB,HYPOPHAGIA,20
GB,NEUTROPHIL COUNT DECREASED,20
GB,SWELLING,20
GB,THROMBOCYTOPENIA,20
GB,VISUAL IMPAIRMENT,20
GB,WEIGHT INCREASED,20
GB,ALANINE AMINOTRANSFERASE INCREASED,19
GB,ATRIOVENTRICULAR BLOCK FIRST DEGREE,19
GB,BLISTER,19
GB,BLOOD SODIUM DECREASED,19
GB,ERYTHEMA,19
GB,INFLUENZA,19
GB,PSORIASIS,19
GB,SPUTUM DISCOLOURED,19
GB,BLOOD CREATININE INCREASED,18
GB,BLOOD PRESSURE DECREASED,18
GB,NECK PAIN,18
GB,RASH GENERALISED,18
GB,URINARY INCONTINENCE,18
GB,VISUAL ACUITY REDUCED,18
GB,WHITE BLOOD CELL COUNT DECREASED,18
GB,ABNORMAL DREAMS,17
GB,ARRHYTHMIA,17
GB,CARDIAC FAILURE CONGESTIVE,17
GB,CHILLS,17
GB,CHROMATURIA,17
GB,HOT FLUSH,17
GB,INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION,17
GB,MENTAL DISORDER,17
GB,NIGHTMARE,17
GB,RENAL TUBULAR NECROSIS,17
GB,TACHYPNOEA,17
GB,ASCITES,16
GB,C-REACTIVE PROTEIN INCREASED,16
GB,DIPLOPIA,16
GB,EYE SWELLING,16
GB,FEELING HOT,16
GB,FLUSHING,16
GB,GASTRITIS,16
GB,GASTROOESOPHAGEAL REFLUX DISEASE,16
GB,MOOD SWINGS,16
GB,OEDEMA,16
GB,OESOPHAGITIS,16
GB,PULSELESS ELECTRICAL ACTIVITY,16
GB,TENDONITIS,16
GB,TRANSIENT ISCHAEMIC ATTACK,16
GB,ANGER,15
GB,BLEPHARITIS,15
GB,CHEST DISCOMFORT,15
GB,ERECTILE DYSFUNCTION,15
GB,EXTRAPYRAMIDAL DISORDER,15
GB,FLUID INTAKE REDUCED,15
GB,HYPERTENSIVE HEART DISEASE,15
GB,INTENTIONAL OVERDOSE,15
GB,MULTIFOCAL MOTOR NEUROPATHY,15
GB,NEUTROPHIL COUNT INCREASED,15
GB,PANCREATITIS,15
GB,POLYARTHRITIS,15
GB,UNRESPONSIVE TO STIMULI,15
GB,URINARY RETENTION,15
GB,CARDIAC FAILURE,14
GB,FEELING OF BODY TEMPERATURE CHANGE,14
GB,HYPERCALCAEMIA,14
GB,HYPERVENTILATION,14
GB,LUNG DISORDER,14
GB,LUPUS-LIKE SYNDROME,14
GB,PANCREATITIS ACUTE,14
GB,PRODUCTIVE COUGH,14
GB,PROTEINURIA,14
GB,PSYCHOTIC DISORDER,14
GB,RESPIRATORY TRACT INFECTION,14
GB,ABDOMINAL DISCOMFORT,13
GB,ACIDOSIS,13
GB,ASTHMA,13
GB,BLOOD ALKALINE PHOSPHATASE INCREASED,13
GB,BODY TEMPERATURE INCREASED,13
GB,CHOLELITHIASIS,13
GB,DRUG DISPENSED TO WRONG PATIENT,13
GB,ECZEMA,13
GB,FEELING COLD,13
GB,SYSTEMIC INFLAMMATORY RESPONSE SYNDROME,13
GB,ABASIA,12
GB,ABDOMINAL SEPSIS,12
GB,ANAPHYLACTIC SHOCK,12
GB,ARTERIOSCLEROSIS CORONARY ARTERY,12
GB,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,12
GB,COMA SCALE ABNORMAL,12
GB,DELUSION,12
GB,DRUG INTOLERANCE,12
GB,DYSGEUSIA,12
GB,FAECES PALE,12
GB,FOETAL EXPOSURE DURING PREGNANCY,12
GB,HYPERGLYCAEMIA,12
GB,MUSCULOSKELETAL PAIN,12
GB,OXYGEN SATURATION DECREASED,12
GB,PHOTOPHOBIA,12
GB,RAYNAUD^S PHENOMENON,12
GB,RHINORRHOEA,12
GB,RIGHT VENTRICULAR FAILURE,12
GB,SUBDURAL HAEMORRHAGE,12
GB,VIITH NERVE PARALYSIS,12
GB,AGEUSIA,11
GB,ALOPECIA,11
GB,ATRIOVENTRICULAR BLOCK COMPLETE,11
GB,BLINDNESS CORTICAL,11
GB,BLOOD MAGNESIUM DECREASED,11
GB,BLOOD POTASSIUM DECREASED,11
GB,BRONCHIECTASIS,11
GB,BURNING SENSATION,11
GB,CARDIOMEGALY,11
GB,COLD SWEAT,11
GB,DEPRESSED MOOD,11
GB,DIZZINESS POSTURAL,11
GB,EPILEPSY,11
GB,GASTROENTERITIS,11
GB,GROIN PAIN,11
GB,GYNAECOMASTIA,11
GB,HIATUS HERNIA,11
GB,INHIBITORY DRUG INTERACTION,11
GB,MATERNAL EXPOSURE DURING PREGNANCY,11
GB,MEDICATION ERROR,11
GB,MOUTH ULCERATION,11
GB,MUCOSAL INFLAMMATION,11
GB,NEUROLEPTIC MALIGNANT SYNDROME,11
GB,PLEURAL EFFUSION,11
GB,PRESYNCOPE,11
GB,RASH MACULAR,11
GB,RENAL DISORDER,11
GB,SHOCK,11
GB,SKIN EXFOLIATION,11
GB,SKIN ODOUR ABNORMAL,11
GB,TENDERNESS,11
GB,THINKING ABNORMAL,11
GB,VASCULITIS,11
GB,ACTIVITIES OF DAILY LIVING IMPAIRED,10
GB,ACUTE CORONARY SYNDROME,10
GB,ARTHRITIS,10
GB,BUNDLE BRANCH BLOCK LEFT,10
GB,CELLULITIS,10
GB,CHOLECYSTITIS,10
GB,COORDINATION ABNORMAL,10
GB,CYANOSIS,10
GB,DEPRESSED LEVEL OF CONSCIOUSNESS,10
GB,DERMATITIS ALLERGIC,10
GB,DYSPNOEA EXERTIONAL,10
GB,FAECES DISCOLOURED,10
GB,GOUT,10
GB,HAEMORRHAGE INTRACRANIAL,10
GB,HAEMORRHAGE SUBCUTANEOUS,10
GB,HEPATIC STEATOSIS,10
GB,JOINT STIFFNESS,10
GB,LID LAG,10
GB,MENTAL IMPAIRMENT,10
GB,OBSESSIVE-COMPULSIVE DISORDER,10
GB,OLIGOHYDRAMNIOS,10
GB,PHARYNGEAL OEDEMA,10
GB,PLEURISY,10
GB,POLLAKIURIA,10
GB,POLYDIPSIA,10
GB,POLYURIA,10
GB,PROCTITIS,10
GB,PROSTATE CANCER METASTATIC,10
GB,PSYCHIATRIC SYMPTOM,10
GB,RASH MACULO-PAPULAR,10
GB,RASH PRURITIC,10
GB,RESTLESSNESS,10
GB,SENSORY DISTURBANCE,10
GB,SPEECH DISORDER,10
GB,SWEAT GLAND DISORDER,10
GB,TEMPERATURE INTOLERANCE,10
GB,THROAT TIGHTNESS,10
GB,UROSEPSIS,10
GB,ARTERIOSPASM CORONARY,9
GB,ATAXIA,9
GB,ATRIOVENTRICULAR BLOCK,9
GB,AUTOIMMUNE HAEMOLYTIC ANAEMIA,9
GB,BASAL CELL CARCINOMA,9
GB,BLOOD TRIGLYCERIDES INCREASED,9
GB,DEAFNESS UNILATERAL,9
GB,DERMATITIS,9
GB,DUODENAL ULCER,9
GB,DYSURIA,9
GB,FEELING JITTERY,9
GB,HAEMOGLOBIN INCREASED,9
GB,HALLUCINATION_ VISUAL,9
GB,HEPATIC FUNCTION ABNORMAL,9
GB,HEPATOMEGALY,9
GB,HYPEROSMOLAR HYPERGLYCAEMIC STATE,9
GB,INCREASED APPETITE,9
GB,INFLAMMATORY MARKER INCREASED,9
GB,INFLUENZA LIKE ILLNESS,9
GB,INTRAOCULAR PRESSURE DECREASED,9
GB,LOBAR PNEUMONIA,9
GB,NEUROPATHY PERIPHERAL,9
GB,NIPPLE PAIN,9
GB,OTITIS MEDIA,9
GB,PARALYSIS,9
GB,PERIPHERAL COLDNESS,9
GB,PLATELET COUNT INCREASED,9
GB,SYSTEMIC LUPUS ERYTHEMATOSUS RASH,9
GB,THIRST,9
GB,AGGRESSION,8
GB,AMYLASE INCREASED,8
GB,AORTIC ARTERIOSCLEROSIS,8
GB,BLADDER CANCER,8
GB,BLOOD CREATINE INCREASED,8
GB,CAMPYLOBACTER INFECTION,8
GB,CARDIAC DISORDER,8
GB,CEREBRAL HAEMORRHAGE,8
GB,COMPLETED SUICIDE,8
GB,CONJUNCTIVAL HAEMORRHAGE,8
GB,DRUG DISPENSING ERROR,8
GB,DRUG DOSE OMISSION,8
GB,DRUG-INDUCED LIVER INJURY,8
GB,FLATULENCE,8
GB,FLIGHT OF IDEAS,8
GB,GLOSSODYNIA,8
GB,HEART RATE IRREGULAR,8
GB,HEPATIC FAILURE,8
GB,HEPATITIS ACUTE,8
GB,HOSPITALISATION,8
GB,INCORRECT DOSE ADMINISTERED,8
GB,INCREASED TENDENCY TO BRUISE,8
GB,INFECTION,8
GB,MASS,8
GB,MEAN CELL VOLUME INCREASED,8
GB,MUCOSAL ULCERATION,8
GB,MUSCLE SWELLING,8
GB,NEUTROPENIA,8
GB,NON-CARDIAC CHEST PAIN,8
GB,OESOPHAGEAL ULCER,8
GB,OSTEONECROSIS OF JAW,8
GB,OVERDOSE,8
GB,PANIC ATTACK,8
GB,PAPULE,8
GB,PHOTOPSIA,8
GB,PNEUMONITIS,8
GB,POOR QUALITY SLEEP,8
GB,PREMATURE BABY,8
GB,PROCTALGIA,8
GB,PRODUCT USE ISSUE,8
GB,PULMONARY EMBOLISM,8
GB,SKIN DISCOLOURATION,8
GB,SKIN PLAQUE,8
GB,SPLEEN CONGESTION,8
GB,SUBDURAL HAEMATOMA,8
GB,TRANSIENT PSYCHOSIS,8
GB,TYPE 2 DIABETES MELLITUS,8
GB,UPPER-AIRWAY COUGH SYNDROME,8
GB,ABNORMAL LOSS OF WEIGHT,7
GB,ABNORMAL WEIGHT GAIN,7
GB,ACUTE RESPIRATORY DISTRESS SYNDROME,7
GB,ANTIPSYCHOTIC DRUG LEVEL INCREASED,7
GB,ASTHENOPIA,7
GB,BURNING FEET SYNDROME,7
GB,CAESAREAN SECTION,7
GB,CANDIDA INFECTION,7
GB,CARDIOGENIC SHOCK,7
GB,CLOSTRIDIUM DIFFICILE INFECTION,7
GB,CREPITATIONS,7
GB,DIABETIC KETOACIDOTIC HYPERGLYCAEMIC COMA,7
GB,DISABILITY,7
GB,DRY MOUTH,7
GB,DUODENAL ULCER HAEMORRHAGE,7
GB,EYELID OEDEMA,7
GB,FIBROMYALGIA,7
GB,FLUID OVERLOAD,7
GB,GASTRIC ULCER,7
GB,HAEMOPTYSIS,7
GB,HEART RATE DECREASED,7
GB,HERPES ZOSTER,7
GB,IMPAIRED WORK ABILITY,7
GB,JOINT EFFUSION,7
GB,JOINT WARMTH,7
GB,MULTIPLE CONGENITAL ABNORMALITIES,7
GB,MYOPATHY,7
GB,MYOSITIS,7
GB,NIKOLSKY^S SIGN,7
GB,PARAESTHESIA ORAL,7
GB,PEMPHIGOID,7
GB,PLATELET COUNT DECREASED,7
GB,PNEUMONIA ASPIRATION,7
GB,POTENTIATING DRUG INTERACTION,7
GB,PREMATURE DELIVERY,7
GB,PRODUCT QUALITY ISSUE,7
GB,PULMONARY VALVE STENOSIS,7
GB,RENAL PAIN,7
GB,RETCHING,7
GB,ROSACEA,7
GB,SCROTAL DISORDER,7
GB,SENSATION OF FOREIGN BODY,7
GB,SEPTIC SHOCK,7
GB,SINUS BRADYCARDIA,7
GB,SKIN HAEMORRHAGE,7
GB,SKIN REACTION,7
GB,STEVENS-JOHNSON SYNDROME,7
GB,SYNOVIAL DISORDER,7
GB,THERAPEUTIC RESPONSE UNEXPECTED,7
GB,TONGUE DISCOLOURATION,7
GB,TOXIC EPIDERMAL NECROLYSIS,7
GB,WRONG TECHNIQUE IN DRUG USAGE PROCESS,7
GB,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,7
GB,AFFECTIVE DISORDER,6
GB,ANAESTHESIA,6
GB,BLOOD FOLLICLE STIMULATING HORMONE INCREASED,6
GB,BLOOD LACTIC ACID INCREASED,6
GB,BLOOD LUTEINISING HORMONE INCREASED,6
GB,CARDIAC FLUTTER,6
GB,CEREBRAL ARTERY EMBOLISM,6
GB,COLITIS ULCERATIVE,6
GB,DEAFNESS,6
GB,DELIRIUM,6
GB,DIABETES MELLITUS INADEQUATE CONTROL,6
GB,DIAPHRAGMATIC PARALYSIS,6
GB,DIVERTICULITIS,6
GB,DRUG DOSE TITRATION NOT PERFORMED,6
GB,DRUG HYPERSENSITIVITY,6
GB,DRUG PRESCRIBING ERROR,6
GB,ELECTROCARDIOGRAM T WAVE PEAKED,6
GB,EPISCLERITIS,6
GB,EROSIVE DUODENITIS,6
GB,ERYTHEMA MARGINATUM,6
GB,ERYTHEMA MULTIFORME,6
GB,EXTRASYSTOLES,6
GB,FLUID RETENTION,6
GB,GAMMA-GLUTAMYLTRANSFERASE INCREASED,6
GB,GASTRIC ULCER HAEMORRHAGE,6
GB,GASTROINTESTINAL DISORDER,6
GB,GINGIVITIS,6
GB,HAEMOLYTIC URAEMIC SYNDROME,6
GB,HALLUCINATIONS_ MIXED,6
GB,HEPATIC ENZYME INCREASED,6
GB,IMMUNOSUPPRESSION,6
GB,IMPAIRED DRIVING ABILITY,6
GB,LEUKOPENIA,6
GB,MATERNAL EXPOSURE TIMING UNSPECIFIED,6
GB,MOUTH SWELLING,6
GB,NEPHROPATHY TOXIC,6
GB,ORAL PAIN,6
GB,PELVIC FLOOR MUSCLE WEAKNESS,6
GB,PEMPHIGUS,6
GB,PERIARTHRITIS,6
GB,PLASMA CELL MYELOMA,6
GB,PNEUMOCYSTIS JIROVECII PNEUMONIA,6
GB,POLYMYOSITIS,6
GB,PRURITUS GENITAL,6
GB,RENAL FAILURE CHRONIC,6
GB,RHINITIS ALLERGIC,6
GB,SINUS TACHYCARDIA,6
GB,SLEEP PARALYSIS,6
GB,SLUGGISHNESS,6
GB,TESTICULAR SWELLING,6
GB,TONGUE BLISTERING,6
GB,ULNAR NERVE PALSY,6
GB,ABDOMINAL PAIN LOWER,5
GB,ACQUIRED EPIDERMOLYSIS BULLOSA,5
GB,ACUTE HEPATIC FAILURE,5
GB,ADVERSE DRUG REACTION,5
GB,AKATHISIA,5
GB,AMENORRHOEA,5
GB,ANGINA PECTORIS,5
GB,APHONIA,5
GB,APPENDICITIS PERFORATED,5
GB,BLOOD CAFFEINE INCREASED,5
GB,CHANGE OF BOWEL HABIT,5
GB,CHONDROCALCINOSIS PYROPHOSPHATE,5
GB,COGNITIVE DISORDER,5
GB,COLITIS,5
GB,CONTRAINDICATED PRODUCT ADMINISTERED,5
GB,DECREASED INTEREST,5
GB,DEEP VEIN THROMBOSIS,5
GB,DEMYELINATION,5
GB,DIABETES MELLITUS,5
GB,DISEASE RECURRENCE,5
GB,DIVERTICULUM INTESTINAL HAEMORRHAGIC,5
GB,DRUG DEPENDENCE,5
GB,DRUG LEVEL INCREASED,5
GB,EMOTIONAL POVERTY,5
GB,FACE OEDEMA,5
GB,FACIAL PAIN,5
GB,FEELING DRUNK,5
GB,FOREIGN BODY,5
GB,FREQUENT BOWEL MOVEMENTS,5
GB,GASTROINTESTINAL PAIN,5
GB,HEPATIC CANCER,5
GB,HYPERACUSIS,5
GB,IMPAIRED HEALING,5
GB,MUCOUS STOOLS,5
GB,OCCULT BLOOD POSITIVE,5
GB,PARAMNESIA,5
GB,PEPTIC ULCER,5
GB,POLYNEUROPATHY,5
GB,PULMONARY HYPERTENSION,5
GB,RECTAL ABSCESS,5
GB,RED BLOOD CELL SEDIMENTATION RATE INCREASED,5
GB,RHEUMATOID ARTHRITIS,5
GB,SCIATICA,5
GB,SKIN LESION,5
GB,SKIN ULCER,5
GB,SLEEP APNOEA SYNDROME,5
GB,SUSPICIOUSNESS,5
GB,TENSION HEADACHE,5
GB,TESTICULAR PAIN,5
GB,TONGUE OEDEMA,5
GB,TREATMENT FAILURE,5
GB,VULVOVAGINAL DISCOMFORT,5
GB,ACCIDENTAL EXPOSURE TO PRODUCT,4
GB,ACUTE PSYCHOSIS,4
GB,ANGIOPATHY,4
GB,ANURIA,4
GB,APPLICATION SITE ERYTHEMA,4
GB,APPLICATION SITE INFLAMMATION,4
GB,APPLICATION SITE PRURITUS,4
GB,APPLICATION SITE RASH,4
GB,ATRIAL FLUTTER,4
GB,BLEEDING TIME PROLONGED,4
GB,BLINDNESS,4
GB,BLOOD CALCIUM DECREASED,4
GB,BREAST PAIN,4
GB,BRONCHOSPASM PARADOXICAL,4
GB,DERMATITIS CONTACT,4
GB,DRY EYE,4
GB,DUODENITIS,4
GB,EJECTION FRACTION DECREASED,4
GB,ENCEPHALOPATHY,4
GB,ESSENTIAL HYPERTENSION,4
GB,GENERALISED OEDEMA,4
GB,GINGIVAL BLEEDING,4
GB,HEAD INJURY,4
GB,HEPATIC CIRRHOSIS,4
GB,HEPATITIS,4
GB,HOMICIDAL IDEATION,4
GB,HYPERCHLORHYDRIA,4
GB,HYPERSENSITIVITY VASCULITIS,4
GB,HYPOKINESIA,4
GB,IGA NEPHROPATHY,4
GB,ILEUS,4
GB,IMMUNE THROMBOCYTOPENIC PURPURA,4
GB,INCOHERENT,4
GB,INCONTINENCE,4
GB,INCORRECT ROUTE OF DRUG ADMINISTRATION,4
GB,JOINT INJURY,4
GB,KIDNEY INFECTION,4
GB,LABILE BLOOD PRESSURE,4
GB,LABYRINTHITIS,4
GB,LIBIDO DECREASED,4
GB,METRORRHAGIA,4
GB,MICROCYTIC ANAEMIA,4
GB,MULTI-ORGAN FAILURE,4
GB,MUSCLE FATIGUE,4
GB,MUSCLE TWITCHING,4
GB,NECROTISING MYOSITIS,4
GB,NEEDLE ISSUE,4
GB,OESOPHAGEAL CARCINOMA,4
GB,OLIGURIA,4
GB,OPTIC NEUROPATHY,4
GB,ORAL CANDIDIASIS,4
GB,OROANTRAL FISTULA,4
GB,OSTEONECROSIS,4
GB,PANCREATIC CARCINOMA,4
GB,PEAK EXPIRATORY FLOW RATE DECREASED,4
GB,PENILE SWELLING,4
GB,PYURIA,4
GB,RENAL MASS,4
GB,RESPIRATORY DISTRESS,4
GB,SEROTONIN SYNDROME,4
GB,SQUAMOUS CELL CARCINOMA,4
GB,SQUAMOUS CELL CARCINOMA OF SKIN,4
GB,SUBARACHNOID HAEMORRHAGE,4
GB,TEARFULNESS,4
GB,TONGUE EXFOLIATION,4
GB,TONGUE PRURITUS,4
GB,TREATMENT NONCOMPLIANCE,4
GB,URINE SODIUM INCREASED,4
GB,VAGINAL HAEMORRHAGE,4
GB,ANKLE FRACTURE,3
GB,ANOSMIA,3
GB,AORTIC STENOSIS,3
GB,APHAGIA,3
GB,ARTHRITIS BACTERIAL,3
GB,ATYPICAL FEMUR FRACTURE,3
GB,BALANOPOSTHITIS,3
GB,BARRETT^S OESOPHAGUS,3
GB,BLOOD BLISTER,3
GB,BLOOD PRESSURE IMMEASURABLE,3
GB,BLOOD PRESSURE INADEQUATELY CONTROLLED,3
GB,BLOOD UREA INCREASED,3
GB,BONE PAIN,3
GB,BUTTOCK CRUSHING,3
GB,CARDIOMYOPATHY,3
GB,CEREBELLAR HAEMORRHAGE,3
GB,CEREBRAL ISCHAEMIA,3
GB,CHOLECYSTITIS ACUTE,3
GB,CHRONIC GASTROINTESTINAL BLEEDING,3
GB,CIRCUMORAL OEDEMA,3
GB,CONGESTIVE CARDIOMYOPATHY,3
GB,DEAFNESS BILATERAL,3
GB,DEPRESSION SUICIDAL,3
GB,DIARRHOEA HAEMORRHAGIC,3
GB,DRUG ADMINISTRATION ERROR,3
GB,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,3
GB,EMOTIONAL DISTRESS,3
GB,FACIAL PARALYSIS,3
GB,FANCONI SYNDROME,3
GB,FLUID IMBALANCE,3
GB,GENITAL BURNING SENSATION,3
GB,GINGIVAL DISORDER,3
GB,GINGIVAL ERYTHEMA,3
GB,HAEMATOMA,3
GB,HAEMORRHAGE URINARY TRACT,3
GB,HAEMORRHAGIC HEPATIC CYST,3
GB,HAEMORRHAGIC STROKE,3
GB,HEART RATE ABNORMAL,3
GB,HEART VALVE INCOMPETENCE,3
GB,HEPATOTOXICITY,3
GB,HYPERBILIRUBINAEMIA,3
GB,HYPERNATRAEMIA,3
GB,HYPOTHYROIDISM,3
GB,ILEAL ULCER,3
GB,ILL-DEFINED DISORDER,3
GB,INTESTINAL ISCHAEMIA,3
GB,INVASIVE DUCTAL BREAST CARCINOMA,3
GB,IRON DEFICIENCY ANAEMIA,3
GB,IRRITABILITY,3
GB,ISCHAEMIC STROKE,3
GB,LARGE INTESTINE PERFORATION,3
GB,LEFT VENTRICULAR DYSFUNCTION,3
GB,LUNG NEOPLASM MALIGNANT,3
GB,MALIGNANT NEOPLASM PROGRESSION,3
GB,MEDICATION MONITORING ERROR,3
GB,MENORRHAGIA,3
GB,METASTASES TO CENTRAL NERVOUS SYSTEM,3
GB,METASTASES TO LIVER,3
GB,MUSCULOSKELETAL STIFFNESS,3
GB,NASAL CONGESTION,3
GB,NEPHROLITHIASIS,3
GB,NIGHT SWEATS,3
GB,NOCTURIA,3
GB,OPTIC NEURITIS,3
GB,OSTEOARTHRITIS,3
GB,PANIC REACTION,3
GB,PHARYNGITIS,3
GB,PHOTOSENSITIVITY REACTION,3
GB,POLYMYALGIA RHEUMATICA,3
GB,PRODUCT COATING ISSUE,3
GB,PROSTATE CANCER,3
GB,PROSTATOMEGALY,3
GB,PULSE ABNORMAL,3
GB,RENAL TUBULAR ACIDOSIS,3
GB,RESPIRATORY ARREST,3
GB,SCAB,3
GB,SKIN IRRITATION,3
GB,SMALL FIBRE NEUROPATHY,3
GB,SUDDEN DEATH,3
GB,TORSADE DE POINTES,3
GB,TUMOUR LYSIS SYNDROME,3
GB,UPPER RESPIRATORY TRACT INFECTION,3
GB,VIRAL INFECTION,3
GB,VISUAL FIELD DEFECT,3
GB,YELLOW SKIN,3
GB,ABDOMINAL RIGIDITY,2
GB,ABDOMINAL TENDERNESS,2
GB,ACTINIC KERATOSIS,2
GB,ADENOCARCINOMA OF COLON,2
GB,ADVERSE EVENT,2
GB,ALCOHOLIC LIVER DISEASE,2
GB,ALCOHOLIC PANCREATITIS,2
GB,ALLERGIC GRANULOMATOUS ANGIITIS,2
GB,ANAL HAEMORRHAGE,2
GB,ANAPHYLACTOID REACTION,2
GB,ANGIODYSPLASIA,2
GB,AORTIC ANEURYSM,2
GB,APHASIA,2
GB,ARTERIOSCLEROSIS,2
GB,ASPARTATE AMINOTRANSFERASE INCREASED,2
GB,ATRIAL TACHYCARDIA,2
GB,BIOPSY BONE MARROW ABNORMAL,2
GB,BLOOD ALDOSTERONE INCREASED,2
GB,BLOOD BILIRUBIN INCREASED,2
GB,BLOOD ELECTROLYTES ABNORMAL,2
GB,BLOOD GLUCOSE ABNORMAL,2
GB,BLOOD PRESSURE ABNORMAL,2
GB,BLOOD PRESSURE DIASTOLIC DECREASED,2
GB,BLOOD UREA ABNORMAL,2
GB,BRAIN INJURY,2
GB,BRAIN OEDEMA,2
GB,BREAST CANCER,2
GB,BRONCHOSPASM,2
GB,CARDIAC HYPERTROPHY,2
GB,CARDIAC MURMUR,2
GB,CARDIO-RESPIRATORY ARREST,2
GB,CEREBRAL INFARCTION,2
GB,CHOKING,2
GB,CHOLECYSTITIS INFECTIVE,2
GB,CHOLESTASIS,2
GB,CHOREA,2
GB,CHRONIC FATIGUE SYNDROME,2
GB,CHRONIC KIDNEY DISEASE,2
GB,COAGULOPATHY,2
GB,COMPLICATION ASSOCIATED WITH DEVICE,2
GB,CONVULSION,2
GB,CORONARY ARTERY STENOSIS,2
GB,CUSHING^S SYNDROME,2
GB,CYSTITIS,2
GB,DEMENTIA,2
GB,DENTAL CARIES,2
GB,DERMATITIS EXFOLIATIVE,2
GB,DISEASE PROGRESSION,2
GB,DREAMY STATE,2
GB,DRUG ERUPTION,2
GB,DRUG RESISTANCE,2
GB,DRUG WITHDRAWAL SYNDROME,2
GB,DUODENAL ULCER PERFORATION,2
GB,DYSPLASIA,2
GB,DYSPNOEA PAROXYSMAL NOCTURNAL,2
GB,ELECTROCARDIOGRAM T WAVE ABNORMAL,2
GB,EMOTIONAL DISORDER,2
GB,ENDOPHTHALMITIS,2
GB,EPIDIDYMITIS,2
GB,ESCHERICHIA INFECTION,2
GB,EXFOLIATIVE RASH,2
GB,EYE IRRITATION,2
GB,EYE MOVEMENT DISORDER,2
GB,FACTOR VIII INHIBITION,2
GB,FEMORAL NECK FRACTURE,2
GB,FOOD INTERACTION,2
GB,FOREIGN BODY ASPIRATION,2
GB,GASTRIC ULCER PERFORATION,2
GB,GASTROENTERITIS NOROVIRUS,2
GB,GASTROINTESTINAL INFLAMMATION,2
GB,GASTROINTESTINAL ULCER,2
GB,GLOMERULAR FILTRATION RATE ABNORMAL,2
GB,GLYCOSYLATED HAEMOGLOBIN INCREASED,2
GB,HAEMOLYSIS,2
GB,HAEMORRHAGIC TRANSFORMATION STROKE,2
GB,HAEMORRHOIDAL HAEMORRHAGE,2
GB,HALLUCINATION_ AUDITORY,2
GB,HELPLESSNESS,2
GB,HEMIPARESIS,2
GB,HEPATITIS E,2
GB,HEPATORENAL SYNDROME,2
GB,HERNIA,2
GB,HIP ARTHROPLASTY,2
GB,HORNER^S SYNDROME,2
GB,HYDRONEPHROSIS,2
GB,HYPERTENSIVE CRISIS,2
GB,ILEAL STENOSIS,2
GB,INDIFFERENCE,2
GB,INFARCTION,2
GB,INITIAL INSOMNIA,2
GB,INJECTION SITE RASH,2
GB,INJECTION SITE REACTION,2
GB,INTENTIONAL PRODUCT MISUSE,2
GB,INTERVERTEBRAL DISC PROTRUSION,2
GB,INTESTINAL DILATATION,2
GB,INTESTINAL OBSTRUCTION,2
GB,INTRA-ABDOMINAL HAEMORRHAGE,2
GB,ISCHAEMIA,2
GB,JOINT LOCK,2
GB,LARGE INTESTINE POLYP,2
GB,LARYNGEAL SQUAMOUS CELL CARCINOMA,2
GB,LEFT VENTRICULAR FAILURE,2
GB,LIP BLISTER,2
GB,LIVER TENDERNESS,2
GB,LOSS OF CONTROL OF LEGS,2
GB,LUNG CANCER METASTATIC,2
GB,LYMPHADENOPATHY,2
GB,LYMPHOEDEMA,2
GB,LYMPHOPENIA,2
GB,MIGRAINE,2
GB,MITRAL VALVE INCOMPETENCE,2
GB,MUSCULOSKELETAL CHEST PAIN,2
GB,NASOPHARYNGITIS,2
GB,NECROSIS,2
GB,NECROTISING FASCIITIS,2
GB,NEPHROPATHY,2
GB,NERVOUSNESS,2
GB,NEUROLOGICAL SYMPTOM,2
GB,OEDEMA GENITAL,2
GB,OESOPHAGEAL CANDIDIASIS,2
GB,OESOPHAGITIS ULCERATIVE,2
GB,ORAL HERPES,2
GB,ORTHOPNOEA,2
GB,PARKINSONISM,2
GB,PELVIC INFECTION,2
GB,PENILE BLISTER,2
GB,PENILE INFECTION,2
GB,PERIPHERAL ISCHAEMIA,2
GB,PERIPROSTHETIC FRACTURE,2
GB,PERSONALITY CHANGE,2
GB,PETECHIAE,2
GB,PIGMENTATION DISORDER,2
GB,POOR VENOUS ACCESS,2
GB,PREGNANCY WITH IMPLANT CONTRACEPTIVE,2
GB,PROCEDURAL PAIN,2
GB,PSEUDOCYST,2
GB,PULMONARY MASS,2
GB,PULMONARY TUBERCULOSIS,2
GB,PYELONEPHRITIS,2
GB,RALES,2
GB,RENAL FUNCTION TEST ABNORMAL,2
GB,RENAL NEOPLASM,2
GB,RENIN INCREASED,2
GB,RESPIRATORY SYNCYTIAL VIRUS INFECTION,2
GB,RETINAL DETACHMENT,2
GB,SEDATION,2
GB,SERUM FERRITIN DECREASED,2
GB,SKIN CANCER,2
GB,SKIN EROSION,2
GB,STICKY SKIN,2
GB,STOMATITIS,2
GB,STREPTOCOCCAL INFECTION,2
GB,STRESS,2
GB,SURGERY,2
GB,TENDON DISORDER,2
GB,THERAPY CHANGE,2
GB,THROMBOTIC MICROANGIOPATHY,2
GB,TONGUE DRY,2
GB,TONGUE ULCERATION,2
GB,TOOTH INFECTION,2
GB,TRICUSPID VALVE INCOMPETENCE,2
GB,TUBULOINTERSTITIAL NEPHRITIS,2
GB,TYPE 1 DIABETES MELLITUS,2
GB,ULCER,2
GB,UPPER LIMB FRACTURE,2
GB,VASCULITIC RASH,2
GB,VENOUS PRESSURE JUGULAR INCREASED,2
GB,VOMITING PROJECTILE,2
GB,VULVOVAGINAL PAIN,2
GB,WOUND INFECTION,2
GB,ABDOMINAL ABSCESS,1
GB,ABDOMINAL MASS,1
GB,ABDOMINAL WALL HAEMATOMA,1
GB,ABNORMAL BEHAVIOUR,1
GB,ABO INCOMPATIBILITY,1
GB,ACCIDENT,1
GB,ACCOMMODATION DISORDER,1
GB,ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS,1
GB,ACUTE MYELOID LEUKAEMIA,1
GB,ACUTE PULMONARY OEDEMA,1
GB,ADENOCARCINOMA GASTRIC,1
GB,ADRENAL ADENOMA,1
GB,ADRENAL ATROPHY,1
GB,ADRENAL MASS,1
GB,ADRENOCORTICAL INSUFFICIENCY ACUTE,1
GB,ALLERGIC OEDEMA,1
GB,ALTERED STATE OF CONSCIOUSNESS,1
GB,ALVEOLITIS,1
GB,ANAESTHETIC COMPLICATION,1
GB,ANAL CANCER,1
GB,ANAL SQUAMOUS CELL CARCINOMA,1
GB,ANGINA BULLOSA HAEMORRHAGICA,1
GB,ANORECTAL DISCOMFORT,1
GB,ANTI-ERYTHROCYTE ANTIBODY,1
GB,ANTICOAGULATION DRUG LEVEL ABOVE THERAPEUTIC,1
GB,ANTIPSYCHOTIC DRUG LEVEL BELOW THERAPEUTIC,1
GB,AORTIC VALVE DISEASE,1
GB,APHTHOUS ULCER,1
GB,APLASTIC ANAEMIA,1
GB,APPENDICITIS,1
GB,APPLICATION SITE PAIN,1
GB,ARTERECTOMY,1
GB,ARTERIAL OCCLUSIVE DISEASE,1
GB,ARTHROPATHY,1
GB,ASPHYXIA,1
GB,ATRIAL THROMBOSIS,1
GB,ATYPICAL FRACTURE,1
GB,AUTOIMMUNE DISORDER,1
GB,AUTOIMMUNE HEPATITIS,1
GB,AUTONOMIC NERVOUS SYSTEM IMBALANCE,1
GB,BACTERIAL INFECTION,1
GB,BACTEROIDES TEST POSITIVE,1
GB,BASAL GANGLIA INFARCTION,1
GB,BENIGN NEOPLASM,1
GB,BENIGN OVARIAN TUMOUR,1
GB,BLINDNESS UNILATERAL,1
GB,BLOOD ALBUMIN DECREASED,1
GB,BLOOD BILIRUBIN,1
GB,BLOOD CALCIUM INCREASED,1
GB,BLOOD CHOLESTEROL INCREASED,1
GB,BLOOD CREATININE ABNORMAL,1
GB,BLOOD LACTATE DEHYDROGENASE INCREASED,1
GB,BLOOD SODIUM INCREASED,1
GB,BLOOD URIC ACID INCREASED,1
GB,BODY TEMPERATURE DECREASED,1
GB,BODY TEMPERATURE FLUCTUATION,1
GB,BONE LESION,1
GB,BONE MARROW FAILURE,1
GB,BONE SCAN ABNORMAL,1
GB,BRAIN ABSCESS,1
GB,BRAIN NATRIURETIC PEPTIDE INCREASED,1
GB,BREAST CANCER METASTATIC,1
GB,BREAST CANCER STAGE III,1
GB,BREATH ODOUR,1
GB,BREATH SOUNDS ABNORMAL,1
GB,BRONCHOPNEUMONIA,1
GB,BRUXISM,1
GB,BURSITIS,1
GB,BURSITIS INFECTIVE,1
GB,C-REACTIVE PROTEIN ABNORMAL,1
GB,CALCINOSIS,1
GB,CAPSULE PHYSICAL ISSUE,1
GB,CARBON DIOXIDE INCREASED,1
GB,CARCINOID TUMOUR OF THE GASTROINTESTINAL TRACT,1
GB,CARDIAC COMPLICATION ASSOCIATED WITH DEVICE,1
GB,CARDIAC DEATH,1
GB,CARDIOTHORACIC RATIO INCREASED,1
GB,CARDITIS,1
GB,CAROTID ARTERY STENOSIS,1
GB,CATHETER SITE CELLULITIS,1
GB,CEREBELLAR ISCHAEMIA,1
GB,CEREBRAL DISORDER,1
GB,CEREBROVASCULAR DISORDER,1
GB,CERVICAL VERTEBRAL FRACTURE,1
GB,CERVIX CARCINOMA STAGE 0,1
GB,CHEST X-RAY ABNORMAL,1
GB,CHOLANGIOCARCINOMA,1
GB,CHOLANGITIS,1
GB,CHROMATOPSIA,1
GB,CHRONIC LYMPHOCYTIC LEUKAEMIA,1
GB,CHVOSTEK^S SIGN,1
GB,CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR,1
GB,CIRRHOSIS ALCOHOLIC,1
GB,CLAVICLE FRACTURE,1
GB,CLOSTRIDIAL INFECTION,1
GB,CLUSTER HEADACHE,1
GB,COELIAC DISEASE,1
GB,COLECTOMY,1
GB,COLON ADENOMA,1
GB,COLONIC FISTULA,1
GB,COMPUTERISED TOMOGRAM THORAX ABNORMAL,1
GB,CONCOMITANT DISEASE AGGRAVATED,1
GB,CONGENITAL ANOMALY IN OFFSPRING,1
GB,CONJUNCTIVITIS,1
GB,COOMBS DIRECT TEST POSITIVE,1
GB,CORONARY ARTERY EMBOLISM,1
GB,CORONARY ARTERY THROMBOSIS,1
GB,CREATININE RENAL CLEARANCE DECREASED,1
GB,CRYING,1
GB,CUTANEOUS LUPUS ERYTHEMATOSUS,1
GB,CUTANEOUS SARCOIDOSIS,1
US,DRUG INEFFECTIVE,6933
US,FATIGUE,5836
US,NAUSEA,5226
US,DIARRHOEA,5024
US,DYSPNOEA,4322
US,DIZZINESS,3889
US,PAIN,3882
US,HEADACHE,3663
US,ASTHENIA,3115
US,DRUG DOSE OMISSION,3043
US,FALL,2942
US,MYOCARDIAL INFARCTION,2796
US,VOMITING,2746
US,MALAISE,2742
US,COUGH,2683
US,ARTHRALGIA,2676
US,PAIN IN EXTREMITY,2655
US,WEIGHT DECREASED,2653
US,DRUG HYPERSENSITIVITY,2595
US,HYPERTENSION,2504
US,RASH,2289
US,CARDIAC FAILURE CONGESTIVE,2206
US,INSOMNIA,2178
US,DEATH,2166
US,PNEUMONIA,2121
US,BACK PAIN,2107
US,GASTROINTESTINAL HAEMORRHAGE,1982
US,PRURITUS,1975
US,CEREBROVASCULAR ACCIDENT,1960
US,FEELING ABNORMAL,1897
US,DECREASED APPETITE,1852
US,CONSTIPATION,1785
US,GAIT DISTURBANCE,1778
US,BLOOD GLUCOSE INCREASED,1761
US,DEPRESSION,1735
US,CHEST PAIN,1733
US,ANAEMIA,1718
US,ANXIETY,1706
US,MUSCLE SPASMS,1593
US,HYPOTENSION,1579
US,INJECTION SITE PAIN,1565
US,BLOOD PRESSURE INCREASED,1533
US,WEIGHT INCREASED,1512
US,ABDOMINAL PAIN UPPER,1407
US,ABDOMINAL PAIN,1386
US,PERIPHERAL SWELLING,1380
US,PRODUCT QUALITY ISSUE,1379
US,ABDOMINAL DISCOMFORT,1366
US,DEHYDRATION,1332
US,PYREXIA,1318
US,URINARY TRACT INFECTION,1304
US,PRODUCT USE ISSUE,1279
US,ACUTE KIDNEY INJURY,1213
US,CONDITION AGGRAVATED,1202
US,HYPOAESTHESIA,1196
US,NASOPHARYNGITIS,1178
US,MYALGIA,1176
US,ALOPECIA,1175
US,SOMNOLENCE,1162
US,PARAESTHESIA,1157
US,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,1108
US,MEMORY IMPAIRMENT,1079
US,INTENTIONAL PRODUCT MISUSE,1064
US,INCORRECT DOSE ADMINISTERED,1057
US,CONTUSION,1042
US,VISION BLURRED,1000
US,TREMOR,999
US,ANGIOEDEMA,989
US,ATRIAL FIBRILLATION,983
US,COMPLETED SUICIDE,974
US,CONFUSIONAL STATE,966
US,PSORIASIS,953
US,GASTROOESOPHAGEAL REFLUX DISEASE,942
US,HYPERSENSITIVITY,942
US,MUSCULAR WEAKNESS,928
US,DYSPEPSIA,898
US,CORONARY ARTERY DISEASE,894
US,SINUSITIS,891
US,OEDEMA PERIPHERAL,878
US,HYPERHIDROSIS,862
US,ERYTHEMA,856
US,JOINT SWELLING,849
US,BRONCHITIS,847
US,ARTHRITIS,835
US,EPISTAXIS,806
US,NEUROPATHY PERIPHERAL,805
US,DYSGEUSIA,802
US,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,799
US,FLUSHING,798
US,RENAL FAILURE,790
US,BALANCE DISORDER,768
US,LOSS OF CONSCIOUSNESS,758
US,ACUTE MYOCARDIAL INFARCTION,746
US,INFLUENZA,732
US,DIABETES MELLITUS,724
US,OROPHARYNGEAL PAIN,719
US,VISUAL IMPAIRMENT,712
US,URTICARIA,709
US,MUSCULOSKELETAL PAIN,700
US,TOXICITY TO VARIOUS AGENTS,699
US,CHILLS,694
US,DRY MOUTH,694
US,SYNCOPE,680
US,RECTAL HAEMORRHAGE,670
US,ABDOMINAL DISTENSION,668
US,HEART RATE INCREASED,664
US,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,655
US,PALPITATIONS,651
US,DYSPHAGIA,646
US,HAEMOGLOBIN DECREASED,644
US,CARDIAC DISORDER,627
US,SEPSIS,616
US,CHEST DISCOMFORT,611
US,THROMBOSIS,610
US,HAEMORRHAGE,605
US,WHITE BLOOD CELL COUNT DECREASED,599
US,PLATELET COUNT DECREASED,596
US,INJECTION SITE ERYTHEMA,595
US,CATARACT,594
US,BURNING SENSATION,593
US,DEEP VEIN THROMBOSIS,589
US,DRUG EFFECT DECREASED,587
US,DRUG EFFECT INCOMPLETE,583
US,INFLUENZA LIKE ILLNESS,577
US,OSTEOARTHRITIS,574
US,PULMONARY EMBOLISM,573
US,INFECTION,569
US,RHEUMATOID ARTHRITIS,568
US,BLOOD CHOLESTEROL INCREASED,564
US,SWELLING,553
US,DYSPHONIA,548
US,INJECTION SITE HAEMORRHAGE,539
US,DISEASE PROGRESSION,537
US,ASTHMA,536
US,FLATULENCE,536
US,THERAPEUTIC RESPONSE UNEXPECTED,532
US,OVERDOSE,527
US,HOT FLUSH,516
US,CELLULITIS,514
US,INJECTION SITE BRUISING,510
US,UNDERDOSE,510
US,RHINORRHOEA,507
US,BLOOD PRESSURE DECREASED,504
US,SWELLING FACE,495
US,DRY SKIN,490
US,PANCREATITIS,486
US,BLOOD GLUCOSE DECREASED,480
US,MUSCULOSKELETAL STIFFNESS,479
US,RESPIRATORY FAILURE,477
US,TYPE 2 DIABETES MELLITUS,476
US,AMNESIA,474
US,STRESS,474
US,NECK PAIN,473
US,RENAL FAILURE ACUTE,469
US,SEIZURE,466
US,STOMATITIS,460
US,NERVOUSNESS,457
US,UPPER GASTROINTESTINAL HAEMORRHAGE,456
US,ADVERSE EVENT,452
US,OSTEOPOROSIS,452
US,NASAL CONGESTION,443
US,MIGRAINE,436
US,HAEMATURIA,433
US,ARTHROPATHY,430
US,BLOOD CREATININE INCREASED,430
US,POLLAKIURIA,430
US,PLEURAL EFFUSION,425
US,CARDIAC ARREST,424
US,HAEMORRHAGIC ANAEMIA,420
US,INJECTION SITE PRURITUS,420
US,MOBILITY DECREASED,420
US,FLUID RETENTION,419
US,MALIGNANT NEOPLASM PROGRESSION,413
US,BONE PAIN,410
US,INJURY,409
US,OEDEMA,409
US,TRANSIENT ISCHAEMIC ATTACK,403
US,UPPER RESPIRATORY TRACT INFECTION,400
US,INCORRECT DRUG ADMINISTRATION DURATION,397
US,UNEVALUABLE EVENT,397
US,WHEEZING,394
US,RASH PRURITIC,393
US,HERPES ZOSTER,390
US,DRUG INTOLERANCE,388
US,HAEMATOCHEZIA,384
US,FEELING HOT,380
US,PRODUCTIVE COUGH,378
US,WRONG TECHNIQUE IN DRUG USAGE PROCESS,375
US,THROMBOCYTOPENIA,373
US,MULTIPLE SCLEROSIS RELAPSE,371
US,PRODUCT USE IN UNAPPROVED INDICATION,371
US,SLEEP DISORDER,371
US,BLISTER,369
US,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,367
US,INTENTIONAL PRODUCT USE ISSUE,362
US,LETHARGY,359
US,HALLUCINATION,358
US,HYPERKALAEMIA,358
US,EMOTIONAL DISTRESS,357
US,NEPHROLITHIASIS,353
US,LIP SWELLING,351
US,LOCAL SWELLING,351
US,ADVERSE DRUG REACTION,349
US,RENAL IMPAIRMENT,349
US,SLEEP APNOEA SYNDROME,348
US,DEVICE MALFUNCTION,347
US,SKIN DISCOLOURATION,346
US,SKIN EXFOLIATION,346
US,VERTIGO,345
US,IRRITABILITY,341
US,DYSURIA,339
US,COAGULOPATHY,336
US,HOSPITALISATION,336
US,RENAL DISORDER,336
US,SUICIDAL IDEATION,336
US,THERAPY CESSATION,336
US,VISUAL ACUITY REDUCED,329
US,GLYCOSYLATED HAEMOGLOBIN INCREASED,327
US,HEPATIC ENZYME INCREASED,324
US,AGITATION,322
US,CARDIAC FAILURE,322
US,INTERVERTEBRAL DISC PROTRUSION,318
US,CHOLELITHIASIS,317
US,DYSPNOEA EXERTIONAL,315
US,THROAT IRRITATION,315
US,DRUG ADMINISTRATION ERROR,314
US,MENTAL STATUS CHANGES,314
US,TACHYCARDIA,314
US,SWOLLEN TONGUE,313
US,BLOOD POTASSIUM DECREASED,311
US,PULMONARY OEDEMA,311
US,STAPHYLOCOCCAL INFECTION,310
US,DRUG WITHDRAWAL SYNDROME,309
US,HYPONATRAEMIA,309
US,CROHN^S DISEASE,305
US,EYE PAIN,304
US,SPEECH DISORDER,303
US,ORAL PAIN,302
US,ROAD TRAFFIC ACCIDENT,294
US,ACTIVITIES OF DAILY LIVING IMPAIRED,293
US,GASTROINTESTINAL DISORDER,292
US,ABASIA,288
US,INJECTION SITE REACTION,287
US,BODY HEIGHT DECREASED,285
US,CYSTITIS,284
US,TINNITUS,283
US,NEUTROPENIA,281
US,TREATMENT NONCOMPLIANCE,281
US,INJECTION SITE MASS,280
US,HEAD INJURY,279
US,LIMB DISCOMFORT,278
US,EXPIRED PRODUCT ADMINISTERED,276
US,INJECTION SITE SWELLING,274
US,DEVICE ISSUE,271
US,HEART RATE DECREASED,271
US,HYPOGLYCAEMIA,271
US,GOUT,270
US,LOWER GASTROINTESTINAL HAEMORRHAGE,270
US,INTERNAL HAEMORRHAGE,269
US,HAEMOPTYSIS,266
US,CORONARY ARTERY OCCLUSION,265
US,GASTRIC DISORDER,265
US,HYPOTHYROIDISM,265
US,DISCOMFORT,262
US,IMPAIRED HEALING,262
US,DIVERTICULITIS,258
US,PRURITUS GENERALISED,258
US,CARDIO-RESPIRATORY ARREST,255
US,CHRONIC KIDNEY DISEASE,255
US,BLOOD URINE PRESENT,254
US,EYE IRRITATION,253
US,BRADYCARDIA,252
US,DISTURBANCE IN ATTENTION,252
US,PAIN IN JAW,252
US,CRYING,251
US,NIGHT SWEATS,249
US,NO ADVERSE EVENT,249
US,RIB FRACTURE,249
US,BLOOD PRESSURE ABNORMAL,246
US,HYPOKALAEMIA,246
US,BONE DISORDER,245
US,DYSARTHRIA,245
US,DIABETIC KETOACIDOSIS,243
US,HIP FRACTURE,243
US,CEREBRAL HAEMORRHAGE,242
US,INTERVERTEBRAL DISC DEGENERATION,242
US,PLASMA CELL MYELOMA,242
US,FIBROMYALGIA,240
US,GENERAL PHYSICAL HEALTH DETERIORATION,240
US,SPINAL OSTEOARTHRITIS,240
US,URINARY INCONTINENCE,240
US,FOOT FRACTURE,239
US,OXYGEN SATURATION DECREASED,239
US,WHITE BLOOD CELL COUNT INCREASED,239
US,ANGINA PECTORIS,238
US,HAEMORRHOIDS,238
US,HYPERSOMNIA,238
US,GASTRITIS,237
US,RASH GENERALISED,236
US,DEPRESSED MOOD,235
US,HYPERLIPIDAEMIA,235
US,INTERNATIONAL NORMALISED RATIO INCREASED,232
US,URINARY RETENTION,232
US,ROTATOR CUFF SYNDROME,231
US,LOCALISED INFECTION,230
US,RED BLOOD CELL COUNT DECREASED,230
US,OCULAR HYPERAEMIA,227
US,THERAPEUTIC RESPONSE DECREASED,227
US,EYE SWELLING,226
US,SKIN ULCER,226
US,DYSSTASIA,225
US,LACRIMATION INCREASED,224
US,HAEMATOMA,222
US,ACUTE RESPIRATORY FAILURE,221
US,EYE DISORDER,221
US,NEURALGIA,221
US,FUNGAL INFECTION,219
US,SKIN DISORDER,219
US,INTENTIONAL DRUG MISUSE,218
US,PANIC ATTACK,218
US,HYPOACUSIS,215
US,HYPOXIA,215
US,OSTEOMYELITIS,215
US,ARRHYTHMIA,214
US,HIATUS HERNIA,214
US,PANCYTOPENIA,214
US,CORONARY ARTERIAL STENT INSERTION,213
US,PRODUCT SUBSTITUTION ISSUE,213
US,SINUS DISORDER,211
US,HAIR COLOUR CHANGES,210
US,CARDIOMYOPATHY,209
US,BACK DISORDER,208
US,BLINDNESS,208
US,BLOOD POTASSIUM INCREASED,208
US,LUNG DISORDER,208
US,RASH ERYTHEMATOUS,208
US,RETCHING,208
US,UPPER LIMB FRACTURE,208
US,SURGERY,207
US,HEART RATE IRREGULAR,206
US,MEDICATION ERROR,206
US,PRE-EXISTING CONDITION IMPROVED,206
US,PROSTATIC SPECIFIC ANTIGEN INCREASED,205
US,AGEUSIA,204
US,CONVULSION,204
US,LIMB INJURY,203
US,DRY EYE,202
US,PSORIATIC ARTHROPATHY,201
US,RASH MACULAR,201
US,VAGINAL HAEMORRHAGE,201
US,JOINT INJURY,200
US,COLITIS,199
US,SKIN LESION,199
US,HYPOPHAGIA,198
US,INJECTION SITE NODULE,198
US,RESTLESSNESS,198
US,JOINT STIFFNESS,197
US,VIRAL INFECTION,197
US,DISORIENTATION,196
US,DRUG PRESCRIBING ERROR,196
US,FEMUR FRACTURE,196
US,LACERATION,196
US,OSTEOPENIA,195
US,ABNORMAL DREAMS,194
US,ANAPHYLACTIC REACTION,194
US,ANKLE FRACTURE,191
US,BLOOD PRESSURE FLUCTUATION,191
US,MUSCULOSKELETAL DISCOMFORT,190
US,SEPTIC SHOCK,190
US,BREAST CANCER,189
US,CLOSTRIDIUM DIFFICILE INFECTION,188
US,ERECTILE DYSFUNCTION,188
US,PHARYNGEAL OEDEMA,188
US,VITAMIN D DEFICIENCY,188
US,FEELING COLD,187
US,HAIR TEXTURE ABNORMAL,187
US,HYPERGLYCAEMIA,187
US,INTESTINAL OBSTRUCTION,187
US,PULMONARY MASS,187
US,NIGHTMARE,186
US,EATING DISORDER,184
US,PRODUCT ADHESION ISSUE,184
US,ACNE,183
US,PRESYNCOPE,183
US,ALANINE AMINOTRANSFERASE INCREASED,182
US,LYMPHADENOPATHY,182
US,PANCREATITIS ACUTE,182
US,WITHDRAWAL SYNDROME,182
US,ASPARTATE AMINOTRANSFERASE INCREASED,180
US,BLOOD GLUCOSE ABNORMAL,180
US,CHROMATURIA,180
US,COGNITIVE DISORDER,180
US,CARPAL TUNNEL SYNDROME,179
US,LACTIC ACIDOSIS,179
US,WOUND,179
US,BLOOD SODIUM DECREASED,178
US,ERUCTATION,178
US,GLAUCOMA,178
US,FULL BLOOD COUNT DECREASED,176
US,DYSKINESIA,175
US,POOR QUALITY SLEEP,175
US,ABNORMAL BEHAVIOUR,174
US,MULTIPLE SCLEROSIS,173
US,MUSCULOSKELETAL CHEST PAIN,173
US,BLOOD TESTOSTERONE DECREASED,172
US,FEELING JITTERY,171
US,INTENTIONAL OVERDOSE,171
US,LABORATORY TEST ABNORMAL,171
US,PULMONARY HYPERTENSION,170
US,FAECES DISCOLOURED,169
US,HAEMORRHAGE INTRACRANIAL,169
US,PERICARDIAL EFFUSION,169
US,BLOOD COUNT ABNORMAL,168
US,MENTAL DISORDER,168
US,NEOPLASM MALIGNANT,168
US,OSTEONECROSIS OF JAW,168
US,CORONARY ARTERY BYPASS,166
US,DEAFNESS,166
US,GALLBLADDER DISORDER,166
US,SCIATICA,164
US,TOOTH DISORDER,164
US,BLOOD TRIGLYCERIDES INCREASED,162
US,APHASIA,161
US,INFLAMMATION,161
US,ATELECTASIS,159
US,INCORRECT ROUTE OF DRUG ADMINISTRATION,159
US,MOOD SWINGS,159
US,DEMENTIA,158
US,GASTROENTERITIS VIRAL,158
US,ANGER,157
US,DIVERTICULUM,157
US,DRUG DISPENSING ERROR,157
US,IRRITABLE BOWEL SYNDROME,157
US,CARDIOMEGALY,156
US,GLOSSODYNIA,156
US,ANGINA UNSTABLE,155
US,EXTRA DOSE ADMINISTERED,155
US,SNEEZING,155
US,SPINAL FRACTURE,155
US,LIVER DISORDER,154
US,EXOSTOSIS,153
US,GASTRIC ULCER,153
US,HAEMATEMESIS,153
US,METABOLIC ACIDOSIS,153
US,MULTIPLE FRACTURES,153
US,RASH PAPULAR,153
US,LIVER FUNCTION TEST ABNORMAL,152
US,RHABDOMYOLYSIS,152
US,SUBDURAL HAEMATOMA,152
US,TOOTHACHE,152
US,EAR INFECTION,151
US,NEOPLASM PROGRESSION,151
US,SPINAL COLUMN STENOSIS,151
US,AGGRESSION,149
US,ARTERIOSCLEROSIS,149
US,RESPIRATORY TRACT CONGESTION,149
US,THYROID DISORDER,149
US,HERNIA,148
US,IRON DEFICIENCY ANAEMIA,148
US,MOVEMENT DISORDER,148
US,APPLICATION SITE ERYTHEMA,147
US,OBESITY,147
US,SINUS CONGESTION,147
US,CHOKING,146
US,NERVE INJURY,146
US,EYE PRURITUS,145
US,FLUID OVERLOAD,145
US,DIPLOPIA,144
US,HAEMORRHAGIC STROKE,144
US,MYOCARDIAL ISCHAEMIA,143
US,ABNORMAL LOSS OF WEIGHT,142
US,HAEMATOCRIT DECREASED,142
US,ILL-DEFINED DISORDER,142
US,MENTAL IMPAIRMENT,142
US,PROSTATE CANCER,142
US,RESTLESS LEGS SYNDROME,142
US,SHOCK,142
US,CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR,141
US,LUNG NEOPLASM MALIGNANT,141
US,SKIN BURNING SENSATION,141
US,THROAT TIGHTNESS,141
US,DIABETES MELLITUS INADEQUATE CONTROL,140
US,DIABETIC NEUROPATHY,140
US,ISCHAEMIC STROKE,140
US,LEUKOCYTOSIS,140
US,TOOTH INFECTION,140
US,UNRESPONSIVE TO STIMULI,140
US,VENTRICULAR TACHYCARDIA,140
US,INCREASED TENDENCY TO BRUISE,139
US,NOCTURIA,138
US,APPLICATION SITE PAIN,137
US,EAR PAIN,137
US,FREQUENT BOWEL MOVEMENTS,137
US,ASCITES,136
US,BURSITIS,136
US,HAIR DISORDER,136
US,LOWER LIMB FRACTURE,136
US,LUNG INFECTION,136
US,MUSCLE TWITCHING,136
US,HEPATIC STEATOSIS,135
US,BLOOD MAGNESIUM DECREASED,134
US,WRIST FRACTURE,134
US,INCORRECT PRODUCT STORAGE,133
US,PRESCRIBED OVERDOSE,133
US,ORTHOSTATIC HYPOTENSION,132
US,FEAR,130
US,GINGIVAL BLEEDING,130
US,RESPIRATORY ARREST,130
US,INCREASED APPETITE,129
US,MOOD ALTERED,129
US,SUICIDE ATTEMPT,129
US,THIRST,129
US,BASAL CELL CARCINOMA,126
US,BLOOD GLUCOSE FLUCTUATION,126
US,MADAROSIS,126
US,RENAL CYST,126
US,ARTERIOSCLEROSIS CORONARY ARTERY,125
US,INJECTION SITE RASH,125
US,IMPAIRED WORK ABILITY,124
US,ORAL DISCOMFORT,124
US,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,124
US,BLOOD UREA INCREASED,123
US,CARDIOVASCULAR DISORDER,123
US,EMOTIONAL DISORDER,123
US,KNEE ARTHROPLASTY,123
US,APPLICATION SITE PRURITUS,122
US,EMPHYSEMA,122
US,FEBRILE NEUTROPENIA,122
US,HEAD DISCOMFORT,122
US,INFUSION RELATED REACTION,122
US,KIDNEY INFECTION,122
US,LARGE INTESTINE POLYP,122
US,MASS,122
US,RESPIRATORY DISTRESS,122
US,TOOTH FRACTURE,122
US,ANHEDONIA,121
US,THINKING ABNORMAL,121
US,COLD SWEAT,120
US,DENTAL CARIES,120
US,SKIN CANCER,120
US,ELECTROCARDIOGRAM QT PROLONGED,119
US,NODULE,119
US,STENT PLACEMENT,119
US,MITRAL VALVE INCOMPETENCE,118
US,SCAR,118
US,EYE HAEMORRHAGE,117
US,NERVOUS SYSTEM DISORDER,117
US,LIGAMENT SPRAIN,116
US,MACULAR DEGENERATION,116
US,HEMIPARESIS,115
US,INJECTION SITE EXTRAVASATION,115
US,DELIRIUM,114
US,EJECTION FRACTION DECREASED,113
US,MALABSORPTION,113
US,METASTASES TO BONE,113
US,MIDDLE INSOMNIA,113
US,SKIN IRRITATION,113
US,SMALL INTESTINAL OBSTRUCTION,113
US,ENCEPHALOPATHY,112
US,MUSCULOSKELETAL DISORDER,111
US,ACCIDENTAL EXPOSURE TO PRODUCT,110
US,BACK INJURY,110
US,CANDIDA INFECTION,110
US,MUSCLE TIGHTNESS,110
US,NERVE COMPRESSION,109
US,PRODUCT PHYSICAL ISSUE,109
US,PSYCHOLOGICAL TRAUMA,109
US,VITAMIN D DECREASED,109
US,ACCIDENTAL OVERDOSE,108
US,DRUG ADMINISTERED AT INAPPROPRIATE SITE,108
US,FEEDING DISORDER,108
US,METASTASES TO LIVER,108
US,SEASONAL ALLERGY,108
US,DIZZINESS POSTURAL,107
US,LEUKOPENIA,107
US,MELAENA,107
US,PANCREATIC CARCINOMA,107
US,TOOTH ABSCESS,107
US,ACUTE CORONARY SYNDROME,106
US,CEREBRAL INFARCTION,106
US,IMPAIRED DRIVING ABILITY,106
US,MICTURITION URGENCY,106
US,PROTEINURIA,106
US,HYPOAESTHESIA ORAL,105
US,MEDICATION RESIDUE PRESENT,105
US,PELVIC PAIN,105
US,HEPATIC FAILURE,104
US,HYPOKINESIA,104
US,PERIPHERAL COLDNESS,104
US,PROCEDURAL PAIN,104
US,COMA,103
US,PULMONARY CONGESTION,103
US,RESPIRATORY TRACT INFECTION,103
US,ARTERIAL OCCLUSIVE DISEASE,102
US,BLOOD BILIRUBIN INCREASED,102
US,SPINAL COMPRESSION FRACTURE,102
US,MUSCLE STRAIN,101
US,PAIN OF SKIN,101
US,PNEUMONIA ASPIRATION,101
US,TENDERNESS,101
US,ESSENTIAL HYPERTENSION,100
US,PSYCHOTIC DISORDER,100
US,SUPRAVENTRICULAR TACHYCARDIA,100
US,ABDOMINAL PAIN LOWER,99
US,ATRIAL FLUTTER,99
US,BLOOD PRESSURE INADEQUATELY CONTROLLED,99
US,CONTRAINDICATED PRODUCT ADMINISTERED,99
US,PERIPHERAL VASCULAR DISORDER,99
US,RESPIRATORY DISORDER,99
US,SENSORY DISTURBANCE,99
US,CARDIAC MURMUR,98
US,ECCHYMOSIS,98
US,RENAL FAILURE CHRONIC,98
US,SECRETION DISCHARGE,98
US,INJECTION SITE URTICARIA,97
US,TENDONITIS,97
US,HYPOMAGNESAEMIA,96
US,SCOLIOSIS,96
US,ANORECTAL DISCOMFORT,95
US,BLINDNESS UNILATERAL,95
US,DISABILITY,95
US,TOOTH LOSS,95
US,ULCER,95
US,VIRAL UPPER RESPIRATORY TRACT INFECTION,95
US,VITREOUS FLOATERS,95
US,JOINT RANGE OF MOTION DECREASED,94
US,PARAESTHESIA ORAL,94
US,TENDON RUPTURE,94
US,CYST,93
US,FOOT DEFORMITY,93
US,PRODUCT TASTE ABNORMAL,93
US,SUBARACHNOID HAEMORRHAGE,93
US,CHOLECYSTECTOMY,92
US,DRY THROAT,92
US,HYPERCHOLESTEROLAEMIA,92
US,JOINT DISLOCATION,92
US,PROSTATOMEGALY,92
US,SEROTONIN SYNDROME,92
US,ABSCESS,91
US,APHONIA,91
US,INCONTINENCE,91
US,NEUTROPHIL COUNT DECREASED,91
US,PALLOR,91
US,SCAB,91
US,BLOOD ALKALINE PHOSPHATASE INCREASED,90
US,PARKINSON^S DISEASE,90
US,WEIGHT FLUCTUATION,90
US,FLANK PAIN,89
US,PRESCRIBED UNDERDOSE,89
US,BLOOD IRON DECREASED,88
US,DRUG DEPENDENCE,88
US,GLUCOSE TOLERANCE IMPAIRED,88
US,PULMONARY THROMBOSIS,88
US,WALKING AID USER,88
US,BLADDER DISORDER,87
US,GASTROENTERITIS,87
US,PHOTOPHOBIA,87
US,SKIN HAEMORRHAGE,87
US,TREATMENT FAILURE,87
US,BONE LESION,86
US,DERMATITIS,86
US,PNEUMOTHORAX,86
US,CENTRAL NERVOUS SYSTEM LESION,85
US,DECREASED INTEREST,85
US,HEPATIC CIRRHOSIS,85
US,LUNG INFILTRATION,85
US,MALNUTRITION,85
US,OESOPHAGITIS,85
US,POST PROCEDURAL HAEMORRHAGE,85
US,SPLENOMEGALY,85
US,BEDRIDDEN,84
US,COORDINATION ABNORMAL,84
US,DECUBITUS ULCER,84
US,GINGIVAL PAIN,84
US,HUNGER,84
US,LOWER RESPIRATORY TRACT INFECTION,84
US,ORAL CANDIDIASIS,84
US,BIPOLAR DISORDER,83
US,CARDIOGENIC SHOCK,83
US,HEARING IMPAIRED,83
US,INTRAOCULAR PRESSURE INCREASED,83
US,SKIN FISSURES,83
US,SPINAL DISORDER,83
US,TRICUSPID VALVE INCOMPETENCE,83
US,BLOOD PRESSURE SYSTOLIC INCREASED,82
US,BLOOD TEST ABNORMAL,82
US,DEVICE FAILURE,82
US,ISCHAEMIC CARDIOMYOPATHY,82
US,BLOOD CHOLESTEROL ABNORMAL,81
US,ECZEMA,81
US,LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES,81
US,MENISCUS INJURY,81
US,ORAL MUCOSAL BLISTERING,81
US,PULMONARY FIBROSIS,81
US,SHOCK HAEMORRHAGIC,81
US,ATAXIA,80
US,DEVICE DISLOCATION,80
US,IMMUNE SYSTEM DISORDER,80
US,UPPER-AIRWAY COUGH SYNDROME,80
US,CLOSTRIDIUM DIFFICILE COLITIS,79
US,COLON CANCER,79
US,FACIAL PAIN,79
US,MENORRHAGIA,79
US,TRANSFUSION,79
US,COLITIS ISCHAEMIC,78
US,END STAGE RENAL DISEASE,78
US,GLOMERULAR FILTRATION RATE DECREASED,78
US,GROIN PAIN,78
US,POOR QUALITY DRUG ADMINISTERED,78
US,SENSORY LOSS,78
US,BLOOD CREATINE PHOSPHOKINASE INCREASED,77
US,COLITIS ULCERATIVE,77
US,EAR DISCOMFORT,77
US,ELECTROLYTE IMBALANCE,77
US,FURUNCLE,77
US,GAIT INABILITY,77
US,HIP ARTHROPLASTY,77
US,HYPOVOLAEMIA,77
US,INJECTION SITE WARMTH,77
US,MUCOSAL INFLAMMATION,77
US,PANCREATIC CARCINOMA METASTATIC,77
US,TEMPERATURE INTOLERANCE,77
US,TUBULOINTERSTITIAL NEPHRITIS,77
US,HYPERKERATOSIS,76
US,LIVER FUNCTION TEST INCREASED,76
US,MALIGNANT MELANOMA,76
US,MOUTH ULCERATION,76
US,BARRETT^S OESOPHAGUS,75
US,EYE INFECTION,75
US,RENAL CANCER,75
US,RENAL TUBULAR NECROSIS,75
US,SINUS BRADYCARDIA,75
US,ULCER HAEMORRHAGE,75
US,BLADDER CANCER,74
US,BODY TEMPERATURE INCREASED,74
US,CHOLECYSTITIS,74
US,DEVICE USE ERROR,74
US,HALLUCINATION_ VISUAL,74
US,PHOTOSENSITIVITY REACTION,74
US,PNEUMONITIS,74
US,POST PROCEDURAL COMPLICATION,74
US,URINE OUTPUT DECREASED,74
US,AORTIC ANEURYSM,73
US,DEVICE RELATED INFECTION,73
US,HAEMORRHOIDAL HAEMORRHAGE,73
US,IMPAIRED GASTRIC EMPTYING,73
US,INITIAL INSOMNIA,73
US,INJURY ASSOCIATED WITH DEVICE,73
US,PROCTALGIA,73
US,APHAGIA,72
US,HEPATITIS C,72
US,METASTASES TO LUNG,72
US,RENAL PAIN,72
US,SLUGGISHNESS,72
US,WOUND INFECTION,72
US,ARTHROPOD BITE,71
US,BOWEL MOVEMENT IRREGULARITY,71
US,CONCUSSION,71
US,HYPERCALCAEMIA,71
US,LIBIDO DECREASED,71
US,MUSCLE SPASTICITY,71
US,NICOTINE DEPENDENCE,71
US,POLYP,71
US,RENAL INJURY,71
US,DYSLIPIDAEMIA,70
US,ILEUS,70
US,SYSTEMIC LUPUS ERYTHEMATOSUS,70
US,AORTIC ARTERIOSCLEROSIS,69
US,HAND FRACTURE,69
US,LARYNGITIS,69
US,MUSCLE ATROPHY,69
US,ORAL HERPES,69
US,SINUS TACHYCARDIA,69
US,BLOOD CALCIUM INCREASED,68
US,DERMATITIS CONTACT,68
US,EYE DISCHARGE,68
US,FRACTURE,68
US,GASTROINTESTINAL PAIN,68
US,GENERALISED OEDEMA,68
US,HICCUPS,68
US,HYPERTENSIVE CRISIS,68
US,HYPOCALCAEMIA,68
US,LEFT VENTRICULAR HYPERTROPHY,68
US,POST-TRAUMATIC STRESS DISORDER,68
US,SQUAMOUS CELL CARCINOMA,68
US,APPLICATION SITE RASH,67
US,BLOOD CALCIUM DECREASED,67
US,INJECTION SITE INDURATION,67
US,LUMBAR SPINAL STENOSIS,67
US,MUSCLE DISORDER,67
US,ONYCHOCLASIS,67
US,SINUS HEADACHE,67
US,SPINAL PAIN,67
US,TOOTH EXTRACTION,67
US,BONE LOSS,66
US,CAROTID ARTERY OCCLUSION,66
US,DECREASED ACTIVITY,66
US,EXPOSED BONE IN JAW,66
US,EYELID OEDEMA,66
US,JAUNDICE,66
US,NON-CARDIAC CHEST PAIN,66
US,PSYCHOMOTOR HYPERACTIVITY,66
US,VENTRICULAR EXTRASYSTOLES,66
US,CATARACT OPERATION,65
US,DEFORMITY,65
US,DIVERTICULUM INTESTINAL HAEMORRHAGIC,65
US,LEFT VENTRICULAR DYSFUNCTION,65
US,LYMPHOEDEMA,65
US,ORAL DISORDER,65
US,PARANASAL SINUS HYPERSECRETION,65
US,PLATELET COUNT INCREASED,65
US,HAIR GROWTH ABNORMAL,64
US,HUMERUS FRACTURE,64
US,INTERSTITIAL LUNG DISEASE,64
US,INTERVERTEBRAL DISC DISORDER,64
US,MANIA,64
US,ONYCHOMYCOSIS,64
US,PHARYNGITIS,64
US,RENAL HAEMORRHAGE,64
US,SEDATION,64
US,TORSADE DE POINTES,64
US,TRANSAMINASES INCREASED,64
US,VENTRICULAR FIBRILLATION,64
US,DEPRESSED LEVEL OF CONSCIOUSNESS,63
US,DIARRHOEA HAEMORRHAGIC,63
US,DRUG EFFECT DELAYED,63
US,HYPERTHYROIDISM,63
US,MYOCLONUS,63
US,NEPHROPATHY,63
US,UROSEPSIS,63
US,BENIGN PROSTATIC HYPERPLASIA,62
US,FACE OEDEMA,62
US,GOITRE,62
US,HEPATOMEGALY,62
US,INCREASED UPPER AIRWAY SECRETION,62
US,INTESTINAL ANGIOEDEMA,62
US,MOTOR DYSFUNCTION,62
US,PARANOIA,62
US,POLYURIA,62
US,POST PROCEDURAL INFECTION,62
US,WRONG DRUG ADMINISTERED,62
US,DISEASE RECURRENCE,61
US,MOUTH HAEMORRHAGE,61
US,OSTEOSCLEROSIS,61
US,RASH MACULO-PAPULAR,61
US,TROPONIN INCREASED,61
US,BACTERIAL INFECTION,60
US,ELECTROCARDIOGRAM ABNORMAL,60
US,FEELING DRUNK,60
US,HYPERAESTHESIA,60
US,IMMUNODEFICIENCY,60
US,INTENTIONAL UNDERDOSE,60
US,RETINAL DETACHMENT,60
US,VASCULAR GRAFT,60
US,WOUND COMPLICATION,60
US,BONE DENSITY DECREASED,59
US,BRAIN INJURY,59
US,CARDIAC PACEMAKER INSERTION,59
US,GASTRIC ULCER HAEMORRHAGE,59
US,GINGIVITIS,59
US,LYMPHOCYTE COUNT DECREASED,59
US,NAIL DISORDER,59
US,PRODUCT PACKAGING ISSUE,59
US,PULMONARY ARTERIAL HYPERTENSION,59
US,SECOND PRIMARY MALIGNANCY,59
US,ABDOMINAL HERNIA,58
US,APPARENT DEATH,58
US,CAROTID ARTERY STENOSIS,58
US,MOUTH SWELLING,58
US,PELVIC FRACTURE,58
US,PETECHIAE,58
US,PURULENT DISCHARGE,58
US,BREAST CANCER FEMALE,57
US,DIVERTICULUM INTESTINAL,57
US,MULTIPLE ALLERGIES,57
US,SPINAL OPERATION,57
US,COMPRESSION FRACTURE,56
US,FAILURE TO THRIVE,56
US,FOREIGN BODY,56
US,INJECTION SITE DISCOLOURATION,56
US,MULTI-ORGAN FAILURE,56
US,MYELODYSPLASTIC SYNDROME,56
US,OSTEONECROSIS,56
US,RETINAL HAEMORRHAGE,56
US,URINE ODOUR ABNORMAL,56
US,BACTERAEMIA,55
US,BLOOD DISORDER,55
US,CORONARY ARTERY STENOSIS,55
US,DEMENTIA ALZHEIMER^S TYPE,55
US,DRUG ABUSE,55
US,LIVER INJURY,55
US,LYMPHOMA,55
US,MAJOR DEPRESSION,55
US,PARALYSIS,55
US,PERONEAL NERVE PALSY,55
US,SEXUAL DYSFUNCTION,55
US,AFFECT LABILITY,54
US,CHOLECYSTITIS CHRONIC,54
US,IMPAIRED QUALITY OF LIFE,54
US,LIPASE INCREASED,54
US,WOUND HAEMORRHAGE,54
US,CALCIUM DEFICIENCY,53
US,CARDIAC VALVE DISEASE,53
US,DIASTOLIC DYSFUNCTION,53
US,DRUG-INDUCED LIVER INJURY,53
US,HYDRONEPHROSIS,53
US,JOINT EFFUSION,53
US,NO THERAPEUTIC RESPONSE,53
US,SKIN MASS,53
US,SPUTUM DISCOLOURED,53
US,STEVENS-JOHNSON SYNDROME,53
US,SYNOVIAL CYST,53
US,VISUAL FIELD DEFECT,53
US,ABNORMAL FAECES,52
US,BREAST PAIN,52
US,CARDIAC OPERATION,52
US,DELUSION,52
US,INGUINAL HERNIA,52
US,NEOPLASM,52
US,PERIPHERAL ARTERIAL OCCLUSIVE DISEASE,52
US,PHARYNGITIS STREPTOCOCCAL,52
US,SCRATCH,52
US,SKIN ATROPHY,52
US,TARDIVE DYSKINESIA,52
US,THERAPY NON-RESPONDER,52
US,TONGUE DISORDER,52
US,ANAPHYLACTIC SHOCK,51
US,ATRIOVENTRICULAR BLOCK,51
US,EXPOSURE DURING PREGNANCY,51
US,GASTRIC HAEMORRHAGE,51
US,HEPATITIS,51
US,METASTASES TO SPINE,51
US,NEEDLE ISSUE,51
US,RHINITIS ALLERGIC,51
US,RIGHT VENTRICULAR FAILURE,51
US,YELLOW SKIN,51
US,FORMICATION,50
US,KNEE OPERATION,50
US,MULTIPLE ORGAN DYSFUNCTION SYNDROME,50
US,RASH PUSTULAR,50
US,THROMBOPHLEBITIS SUPERFICIAL,50
US,ACCIDENT,49
US,ACUTE RESPIRATORY DISTRESS SYNDROME,49
US,BREAST CANCER METASTATIC,49
US,ENERGY INCREASED,49
US,HEART VALVE INCOMPETENCE,49
US,PRODUCT SIZE ISSUE,49
US,BLINDNESS TRANSIENT,48
US,CONJUNCTIVITIS,48
US,DERMATITIS ALLERGIC,48
US,DEVICE OCCLUSION,48
US,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,48
US,FACIAL BONES FRACTURE,48
US,GYNAECOMASTIA,48
US,PROCEDURAL COMPLICATION,48
US,WHEELCHAIR USER,48
US,WOUND SECRETION,48
US,WRONG TECHNIQUE IN DEVICE USAGE PROCESS,48
US,ASPIRATION,47
US,BUNDLE BRANCH BLOCK RIGHT,47
US,CERVICAL VERTEBRAL FRACTURE,47
US,FAECAL INCONTINENCE,47
US,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,47
US,METASTASES TO CENTRAL NERVOUS SYSTEM,47
US,NASAL DRYNESS,47
US,OCULAR DISCOMFORT,47
US,OVERWEIGHT,47
US,PAROSMIA,47
US,PATHOLOGICAL FRACTURE,47
US,POSTOPERATIVE WOUND INFECTION,47
US,QUALITY OF LIFE DECREASED,47
US,TEMPOROMANDIBULAR JOINT SYNDROME,47
US,TENDON DISORDER,47
US,TIBIA FRACTURE,47
US,TRIGGER FINGER,47
US,ANOSMIA,46
US,ATRIOVENTRICULAR BLOCK FIRST DEGREE,46
US,DRUG EFFECT INCREASED,46
US,INTERVERTEBRAL DISC SPACE NARROWING,46
US,METASTASES TO LYMPH NODES,46
US,OESOPHAGEAL PAIN,46
US,OSTEOLYSIS,46
US,PHYSICAL DISABILITY,46
US,SKIN INFECTION,46
US,SPONDYLOLISTHESIS,46
US,ADVERSE REACTION,45
US,AORTIC STENOSIS,45
US,AORTIC VALVE INCOMPETENCE,45
US,DEVICE LEAKAGE,45
US,EUPHORIC MOOD,45
US,GENERALISED TONIC-CLONIC SEIZURE,45
US,HEPATIC LESION,45
US,INTENTIONAL DEVICE MISUSE,45
US,LOW DENSITY LIPOPROTEIN INCREASED,45
US,LOW TURNOVER OSTEOPATHY,45
US,MASTICATION DISORDER,45
US,OVARIAN CYST,45
US,PHOTOPSIA,45
UM,DEHYDRATION,1
UM,DRUG INEFFECTIVE,1
UM,FATIGUE,1
UM,FRUSTRATION TOLERANCE DECREASED,1
UM,NEGATIVE THOUGHTS,1
UM,RETINOPATHY,1
UM,SKIN DISORDER,1
UM,VISUAL ACUITY REDUCED,1
VE,FLUSHING,1
VE,HEPATIC CIRRHOSIS,1
VE,HEPATIC ENCEPHALOPATHY,1
VE,HYPERSENSITIVITY,1
VE,IMMUNE SYSTEM DISORDER,1
VE,PSORIASIS,1
VE,PYREXIA,1
VN,CARDIAC FAILURE,1
VN,HAEMORRHAGE INTRACRANIAL,1
VN,INTRAVENTRICULAR HAEMORRHAGE,1
VI,ASTHENIA,1
VI,DRY SKIN,1
VI,HIP ARTHROPLASTY,1
VI,MALIGNANT NEOPLASM PROGRESSION,1
VI,MULTIPLE FRACTURES,1
VI,MUSCLE ATROPHY,1
VI,RASH PAPULAR,1
VI,ROAD TRAFFIC ACCIDENT,1
VI,WEIGHT DECREASED,1
YE,CREATININE RENAL CLEARANCE DECREASED,1
YE,MENTAL DISORDER,1
YE,WEIGHT DECREASED,1
